University of Tennessee, Knoxville

TRACE: Tennessee Research and Creative
Exchange
Doctoral Dissertations

Graduate School

5-2004

The Development of Optical Nanosensor Technology for Single
Cell Analysis
Paul Misiko Kasili
University of Tennessee - Knoxville

Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss
Part of the Life Sciences Commons

Recommended Citation
Kasili, Paul Misiko, "The Development of Optical Nanosensor Technology for Single Cell Analysis. " PhD
diss., University of Tennessee, 2004.
https://trace.tennessee.edu/utk_graddiss/2273

This Dissertation is brought to you for free and open access by the Graduate School at TRACE: Tennessee
Research and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized
administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact
trace@utk.edu.

To the Graduate Council:
I am submitting herewith a dissertation written by Paul Misiko Kasili entitled "The Development
of Optical Nanosensor Technology for Single Cell Analysis." I have examined the final electronic
copy of this dissertation for form and content and recommend that it be accepted in partial
fulfillment of the requirements for the degree of Doctor of Philosophy, with a major in Life
Sciences.
Tuan Vo-Dinh, Major Professor
We have read this dissertation and recommend its acceptance:
Jeffrey M. Becker, Robert C. DeNovo, Russ F. Knapp
Accepted for the Council:
Carolyn R. Hodges
Vice Provost and Dean of the Graduate School
(Original signatures are on file with official student records.)

To the Graduate Council:
I am submitting herewith a dissertation written by Paul Misiko Kasili entitled “The
Development of Optical Nanosensor Technology for Single Cell Analysis.” I have
examined the final electronic copy of this dissertation form and content and
recommended that it be accepted in partial fulfillment of the requirements for the
degree of Doctor of Philosophy, with a major in Life Sciences.

Tuan Vo-Dinh Ph.D.
Major Professor

We have read this dissertation
and recommended its acceptance:
Jeffrey M. Becker Ph.D.
Robert C. DeNovo DVM, MS
Russ F. Knapp Jr. Ph.D.

Acceptance for the Council:
Anne Mayhew
Vice Provost and Dean of Graduate Studies

(Original signatures are on file with official student records)

The Development of Optical Nanosensor Technology for
Single Cell Analysis

A Dissertation Presented for the
Doctor of Philosophy Degree
The University of Tennessee, Knoxville

Paul Misiko Kasili
May 2004

DEDICATION

This dissertation is dedicated to my father, the late Prof. Edward G. Kasili,
and mother, Speranza K. Kasili for their great inspiration and encouragement, for
teaching me the value of education, discipline and hard-work, and my sisters Brenda
and Angela for their moral support and for believing in me and being there for me.

ii

ACKNOWLEDGEMENTS

“All Those Who Made This Ph.D. Possible.”

First and foremost, I would like to thank God for blessing me with the
knowledge, wisdom, will, discipline, strength, and courage that made it possible for
me complete my Doctor of Philosophy degree in Biomedical Sciences.
I would like to thank Dr. Tuan Vo-Dinh, a great scientist and mentor, to have
given me the great opportunity to work with him, for his guidance, patience,
encouragement, support and his open door policy.
I would like to thank the members of the Advanced Biomedical and
Technology Group, Oak Ridge National Laboratory (1998 – present), for their
immeasurable assistance in my graduate career, especially Dr. Joel Mobley and Dr.
Brian Cullum.
I would like to thank my beloved wife Serene Williams-Kasili for believing in
me and for her unwavering support, our son Eric Kasili, for his great smiles –truly a
bundle of joy!
Finally, I extend my deepest gratitude to my family and friends (AJ Blige,
Paul Waya), for their prayers, encouragement and support.

iii

ABSTRACT
Advances in modern biosciences and optical biosensor technology have
provided exciting new insights and capabilities. The integration of these fields has
witnessed revolutionary advances, which include the development of optical
nanosensors. Optical nanosensors are devices based on a direct spatial coupling
between biologically active molecules and a signal transducer element interfaced to
electronic equipment for signal amplification, acquisition and recording. Optical
nanosensors consist of biorecognition molecules covalently immobilized onto the
nanotips nanoscale optical fiber that serves as the transducing element. By combining
the specificity of biorecognition molecules and the excellent sensitivity of laser-based
optical detection, optical nanosensors are capable of detecting and differentiating
biochemical constituents of complex systems enabling the provision of sensitive and
specific identification of specific molecular events inside living cells.
This work explores and focuses on the development and application of novel
optical nanosensors for single living cell analysis. In this context, single cell analysis
involves the application of optical nanosensor technology to observe and possibly
map molecular events inside single living cells. Previous studies have focused on the
bulk response of cells and this largely increases the probability of missing critical
underlying mechanisms specific to the single cell. The ability to perform single cell
analysis can dramatically improve our understanding of basic cellular processes e.g.,
signal transduction as well as improving our knowledge of the intracellular transport
and the fate of therapeutic agents at the single cell level. This is important not only
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because of the capability to perform minimally invasive analysis, but also to
overcome the problem of ensemble averaging. This capability to overcome ensemble
averaging has the potential to yield new information that is not available from
population averaged cellular measurements.
This work involves the development and application of optical nanosensors
for specific and sensitive chemical and protein analysis within single living cells. The
ability of these sensors to successfully perform chemical and protein analysis at the
single cell level, lay in their design specifications, size, specificity, sensitivity and
eliminating interferences. With regard to their specifications, their size was in the
nanometer regime, which is relative to the scale of a single mammalian cell (~ 10 µm)
to allow non-invasive-to-minimally-invasive measurements in single living cells. In
addition, they incorporated biological recognition molecules to achieve specificity
and finally, near-field evanescent wave excitation and detection to achieve high
sensitivity. High specificity and sensitivity allowed for precise and accurate
identification of physicochemically detectable substances in complex matrices to
eliminate any potential interference.
The optical nanosensor intracellular measurement process is straightforward
and begins with a sparsely distributed cell culture in a petri dish to allow viewing of
single cells using an inverted fluorescence microscope. The optical nanosensor is
secured onto the manipulating arms of the microscope and gently manipulated toward
the single cell, interacting with the cell, penetrating but not disrupting cellular
membranes. The optical nanosensor is briefly incubated in a single living cell and the
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laser is turned on and excitation light is launched into the optical nanosensor and
propagated to the near field of the nanotip where the target analyte is excited by
evanescent optical waves. The fluorescence signal generated when the target analyte
is excited is collected by the optical set-up of the inverted fluorescence microscope,
passes through spectral and spatial filters before detection with a sensitive photon
counting photomultiplier tube (PMT). The PMT signal is amplified and recorded via
a universal counter interfaced to a personal computer (PC). Data acquisition and
recording are controlled using an integrated custom-written program, built on
LabView platform.
During in vitro and in vivo measurements, the optical nanosensor response is
determined in terms of the sensitivity, specificity, linear dynamic range, response
time, nanosensor stability, and reproducibility. In the course of experimental
measurements, it was evident that optical nanosensors have characteristics including
fast response times (msec range), sensitivity (pM range), selectivity, and excellent
reproducibility. In addition to the above figures of merit, optical nanosensors
demonstrated biocompatibility with no observed detrimental effects on the cell under
investigation in control growth conditions. This demonstrated the utility of optical
nanosensor technology for minimally invasive measurement of cellular reactions
without altering or destroying the chemical make-up of the cell. This work also
illustrates the potential of optical nanosensors in playing an important role in
elucidating and enhancing our understanding of cell signaling and transduction
pathways in real-time.
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PROJECT OVERVIEW
By convention, we take the cell to the analysis tools, but in this work, we use
a radical approach and take the analysis tools into the cell. The main objective of this
dissertation project was to conduct fundamental research with the aim to develop an
innovative approach for using Optical Nanosensor Technology for Single Cell
Analysis. More specifically, this dissertation addresses the capability of optical
nanosensors to analyze the workings of individual cells without causing physiological
or biological damage that may have resultant biochemical consequences. This
dissertation entitled, “Development and Applications of Optical Nanosensor
Technology for Single Living Cell Analysis,” is divided into two major sections, the
Developmental Section and the Application Section. The Developmental Section
involves the development, optimization, evaluation, and characterization of optical
nanosensors. The Application Section is further divided into three sub-categories
corresponding to one of three-immunochemical assay formats used, which include,
Direct Immunoassay Format used for chemical analysis, Indirect Immunoassay
Format, and Peptide Substrate Immunoassay Format, used for protein analysis. These
assay formats are based on the type of biorecognition molecule used and biosensing
technique. The direct immunoassay format used to detect and identify fluorescent
species, registers primary immunocomplex formation at the transducer surface by
optical changes in fluorescent properties. The advantage of this format is that
measurement of the antibody-antigen interaction can be accomplished quickly
without any need for additional antibodies or markers. Indirect Immunoassay format
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used to detect and identify poorly-to-non-fluorescent species, mainly proteins with
very weak fluorescent properties involves the use of primary (capture) and secondary
(reporter) antibody. Capture antibody is immobilized onto the transducer element and
binds the target molecule to form a primary immunocomplex. Shortly afterwards, the
primary immunocomplex is complexed to a labeled reporter antibody that binds to a
different epitope on the target molecule, for colorimetric or fluorometric detection.
Finally, the peptide substrate immunoassay format is used to detect and identify
protease or enzymatic activity. The substrate consists of a tetrapeptide sequence that a
specific enzyme recognizes and cleaves, complexed to a fluorescent molecule. The
way this immunoassay works is the fluorescence emission of the fluorescent molecule
is quenched by the tetrapeptide sequence. Once cleaved, the fluorescent molecule can
be excited and fluorescence emission detected and measured.
Corresponding to the two preceding major sections, this dissertation is divided
into six parts each having its own abstract, introduction, description of experimental
methods and materials, the results obtained and a summary (discussion), except for
Part two which describes the technical aspects involved in the development of the
optical nanosensor. Parts three, five, and six, correspond to a publication, an accepted
manuscript and a submitted manuscript respectively.
Part one is the introduction to the dissertation and discusses the importance of
single cell analysis and the optical nanosensor and the importance of optical
nanosensors for single cell analysis. It also explains why the optical nanosensor offers
the ability to monitor with spacio-temporal resolution cellular activity in a single
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living cell at the single cell level. Part two describes the nanofabrication,
optimization, characterization and evaluation of the optical nanosensor. Part three
focuses on the first application of the optical nanosensor for the measurement of the
carcinogen Benzo[a]pyrene in single living cells using the direct immunoassay
format. Part four demonstrates the application of the optical nanosensor for the in
vitro and pseudo in vivo measurement of apoptosis. Part five describes the application
of the optical nanosensor for the measurement of caspase-9 activity in single living
cells, with emphasis on nanosensor development. Part six focuses on the application
of the optical nanosensor for the measurement of apoptosis in single living cells with
emphasis on photosensitizer induced apoptosis. Part six also discusses the figures of
merit, which are criteria used to determine why optical nanosensors are best suited for
single cell analysis. In addition, a comprehensive summary discusses both the
advantages, limitations and potential of the optical nanosensor and the possible
outcomes together with future direction of this work.
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Part One
Introduction to Single Cell Analysis: Analyzing One Cell At A Time

1

1.0 The Cell: The Basic Unit of Life
The main aim of this dissertation project is to try answering the fundamental
question, “Can we probe the workings of cells without causing physiological of
biological damage that may have resultant biochemical consequences?” [1]. As we
have gained a better understanding the overall nature of bulk cell assays over time,
and achieved a greater understanding of many macroscopic biological processes, we
have been led to ponder the purpose of an increasingly smaller important entity, the
basic unit of life, the single cell. The cell is the fundamental unit of life, a very small
compartment with the capability to replicate itself. It is full of proteins, which support
its life, replication, and interactions with other cells as well as its environment.
Proteins are molecules made up of amino acids arranged in a specific order
determined by the genetic code and are essential for all life processes.
Since the mid-1940's, biomedical researchers have made enormous progress
in identifying and understanding proteins and how they interact in many cellular
processes. Much of this research was “basic”, scientific research that sought to
discover how systems work and develop a base of knowledge that other scientists can
use in order to achieve practical goals, such as treatments or cures for diseases[2, 3].
In the 1950's, scientists started to develop the current picture of the cell as a
complex and highly organized entity. They found that a typical cell is like a miniature
body containing tiny "organs," called organelles. One organelle is the command
center, others provide the cell with energy, while still others manufacture proteins and
additional molecules that the cell needs to survive and to communicate with its
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environment. The cell components are enclosed in a plasma membrane that not only
keeps the cell intact, but it also provides channels that allow communication between
the cell and its external environment [2, 3].

1.1 The Importance of Single Living Cell Analysis
In recent years, many details of the biochemical mechanisms involved in the
normal cell cycle have been discovered. Scientists have found that cell signaling
pathways are regulated by highly complex interactions between proteins in
biochemical pathways. To understand cellular function, most scientists study parts of
specific biochemical pathways, such as the cell cycle, that involve individual
molecules, cells, groups of cells, and whole organisms. The ultimate goal is to be able
to put all the parts together to understand normal cellular activities and how they
function in normal cellular activities or how they malfunction in diseases. These
studies are usually performed using bulk cell assays that are blind to heterogeneity of
cells and the fact that cells in a population behave asynchronously to external stimuli.
A good example is the apoptosis pathway. The differences between cells in their
ability to activate caspases involved in apoptosis pathway contribute to their
responsiveness of any given cell within a population to apoptotic stimuli. Therefore,
to study and understand molecular mechanisms that underlie such differences it is
necessary to measure caspase activity in intact individual living cells [4-6]. By
measuring caspase activity in single living cells, it should be possible to test
hypotheses and determine the molecular mechanisms that underlie cell-to-cell
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variability in response to apoptotic stimuli. In this context, it is important to
understand the dynamic relationships between chemicals and molecular events in
living cells in the context of a cell as a system rather than a collection of organelles
and individual processes. The information obtained from such studies can be used to
accurately map biological behavior and function and in the process be used to
effectively pursue drug discovery. It is also important to analysis cellular components
such as proteins in their native form and environment. Protein analysis techniques
often involve exposing proteins to pretreatment conditions such as solubilization,
denaturation and reduction. Exposing proteins to such conditions can cause
modification that can end up causing artifacts in the results [7]. In addition, it is
important to have the ability to monitor slight differences in the amounts of protein
and other biomolecules within the smallest possible detection volumes down to the
single cell level for diagnostic and technological purposes. This can be invaluable in
the sense that it would permit studies that would be otherwise difficult to perform,
such as, performing experiments in primary human cells from surgical specimens that
are only available in very small numbers.
Accurate cellular studies can be performed if we did not have to study parts or
components of a cell and then piece all the parts together like a jigsaw puzzle in order
to study cell-signaling pathways. This means that we require technologies capable of
performing sensitive and specific biochemical analysis within single living cells.
Technologies for performing sensitive and specific biochemical analyses at the single
cell level are mainly important for understanding intracellular signaling pathways that
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control cell function and behavior. Such technologies should have the capability of
penetrating cell membranes without disrupting or terminating cellular reactions.
Disruption of the cell membrane can lead to significant changes in the parameter of
interest which can occur during the course of cell lysis, resulting in an inaccurate
view of the actual physiologic state of a cell [7, 8]. Cell lysis leads to disruption of the
plasma membrane, which can result in order of magnitude changes in the
concentrations of the analyte or proteins of interest. In addition, compartmentalized
enzymes can be released and activated leading to a high background that can
potentially obscure the detection of the target analyte or protein. If we could “go
easier” on the cells, this information might become available to researchers.
This work focuses on the development and application of optical nanosensor
technology for possibly determining all of the many molecular interactions, their
components, and the order in which they occur during a biochemical-signaling
pathway. The main aim of this work is to identify and possibly catalogue components
in the apoptosis pathway. The hope is to yield information of the processes of
apoptosis that can potentially aid researchers seeking to study or treat diseases in
which cellular processes go awry and are only armed with bulk cell assay information
that is not representative of what is happening at the single cell level. This
information can also be used by scientists seeking to learn more about the ways single
cells respond to external signals, which are often conveyed when molecules bind to
special receptors in cell membranes or when molecules traverse the cell membrane.
The fundamental knowledge developed through single cell analysis studies can lead
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to new ways to diagnose, treat, cure, or even prevent diseases such as Alzheimer’s
Disease (AD), which involves neuronal apoptosis, or cancer, which involves a defect
in the apoptosis machinery of a cell.
Single cell analysis involves monitoring the activities of single cells,
preferably live, in their physiological conditions. These types of studies are important
due to the enhanced sensitivity of single living cells to their environment. The results
obtained from such studies are important because they can give an additional
dimension to standard cellular assays that rely on population-averaged studies that are
blind to heterogeneity and the presumed existence of subpopulations. Studies on
single cells are crucial to determine the activities and functional relationships of
signaling molecules within the complex cellular networks that comprise biological
systems. However, to accurately measure the complex interrelationships of the
elements in the biological systems, measurements must be performed on individual
cells with their signaling pathways intact. Therefore, continued progress in
understanding cellular physiology requires technologies capable of biochemical
measurements in solitary living cells with spacio-temporal control over the regions of
cells interrogated, techniques that do not compromise the integrity of the cell
membrane or cause physiological damage with biochemical consequences. The
disruption of the cell membrane can lead to significant changes in the parameter of
interest, resulting in an inaccurate view of the actual physiologic state of the cell. This
means that the accurate measurement of many cellular properties will require a
technique that is minimally invasive and does not disrupt the cell, and perhaps no
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recent technology has greater potential for this application the optical nanosensors [2,
3].

1.2 Optical Nanosensors
1.2.1 What Is An Optical Nanosensor?
An optical nanosensor is a measurement device consists of two components: a
bioreceptor and a transducer. The bioreceptor is a biomolecule that recognizes the
target analyte whereas the transducer converts the recognition event into a measurable
optical signal. The uniqueness of optical nanosensors is that the two components are
integrated into one single sensor. Figure 1.1 shows the basic principle of optical
nanosensors. This combination enables one to measure the target analyte without
using reagents. For example, the Benzo(a)Pyrene (BaP) can be measured directly
within a single living cell by an optical nanosensor which is made specifically for
BaP measurement by inserting the nanosensor in the cell. This is in contrast to the
conventional assay in which many steps are used and each step may require a reagent
to treat the cells. The simplicity and the speed of measurement is the main advantages
of optical nanosensors. One major requirement for optical nanosensors is that the
bioreceptor molecule has to be immobilized in direct spatial coupling to the
transducer. The immobilization is done either by physical entrapment or chemical
attachment. Only minute quantities of bioreceptor molecules are needed, and they are
used repeatedly for measurements. The transducer element should be capable of
converting the biorecognition event into a measurable optical signal and this is done
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Electrical Signal
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Figure 1.1 shows the basic principle of optical nanosensors. The analyte is
bound by the bioreceptor (antibody) immobilized onto the optical transducer element.
Molecular recognition leads to the production of an optical signal (fluorescence)
which is detect by an signal transducer (photomultiplier tube). This signal is
converted to a measurable electrical signal, which is acquired and analyzed and
processed.
.
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by measuring the change that occurs in the course of the bioreceptor reaction. The
working requirements of optical nanosensors for single cell analysis include:
relevance of output signal to measurement environment, accuracy and repeatability,
sensitivity and spatial resolution, dynamic range, speed of response (temporal
resolution), and insensitivity to electrical and other environmental interference
In the last decade, optical nanosensors have attracted much interest for their
unique and novel optical properties. From the standpoint of practical applications, by
confining one or more dimensions to the nanometer scale, optical nanosensors display
extreme photonic interactions due to the highly enhanced role of interfaces such as
quantum confinement and efficient energy transfer over nanometer distances. Optical
nanosensors are small devices placed directly on or in a sample and designed to
produce an optical signal that can be correlated in a specific way with the presence
and concentration of the target analyte. If the target analyte is present or absent in a
sample under investigation, the optical nanosensor should accordingly follow the
variation in both directions and should deliver analytical information similar to or at a
rate greater than the rate of change of the system
In recent years, two conspicuous research groups have made tremendous
contributions and technological advances in the development of optical nanosensors
for single cell analysis, namely, the Kopelman group at the University of Michigan,
and the Vo-Dinh group at the Oak Ridge National Laboratory. The difference
between the optical nanosensor technologies developed by the two groups is the type
of analysis performed. The Kopelman group develops chemical nanosensors that use
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a chemical mechanism for the molecular recognition step in chemical analysis, while
the Vo-Dinh group develops biochemical nanosensors (nano-biosensors) that use a
biochemical mechanism for the molecular recognition step in biochemical.

1.2.2 Chemical Optical Nanosensors
The development and application of chemical nanosensors was first reported
by Kopelman and coworkers 1992 [9, 10] who produced small chemical nanosensors
that enabled optical, spectral and chemical imaging on a nanometer scale. The optical
nanosensors developed were for intracellular pH measurements in single living cells.
These nanosensors reduced the sample volume and detection limit a billion-fold, and
simultaneously the response time by a factor of a thousand [9]. Kopelman and
coworkers used a micropipette puller to pull multimode and single-mode fibers down
to diameters of 100-1000 nm at the tip. The pulled nanotipss were then used in the
production

of

pH

nanosensors

that

consisted

of

a

pH

sensitive

dye,

acrylofluoresceinamine, attached to the optical nanotip [11, 12]. The response time of
the sensor (300 ms) was found to be 100-fold faster than conventional fiber-optic
chemical sensors and was shown to be stable and reversible with respect to pH
changes. The first reported application of optical chemical nanosensors was to
monitor the biological process organogenesis in live rat-embryos. In this study, pH
nanosensors similar to the ones described above were inserted into the extraembrionic space of a rat conceptus, with minimal damage to the surrounding viseral
yolk sac, and pH measurements were made. Values of the pH in the extraembrionic
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fluid of rat conceptuses ranging in age from 10 to 12 days were then compared for
any differences [9, 10, 13]
Kopelman and coworkers also produced fluorescent optical nanosensors for
the detection of zinc. This is a ratiometric sensor that was fabricated and incorporates
two fluorescent dyes; one is sensitive to zinc and the other acts as a reference. The
sensing components are entrapped within a polymer matrix by a microemulsion
polymerisation process that produces sensors that are in the size region of 20 to 200
nm. Cellular measurements are made possible by the nanoscalel sensor size and the
biocompatibility of the cellular matrix. These nanosensors are capable of inter- and
intra-cellular imaging and are insensitive to interference from proteins. The small size
and inert matrix of these nanosensors allows them to be inserted into living cells with
minimal physical and chemical perturbations to their biological functions [14].

1.2.3 Biochemical Optical Nanosensors
Due to the complexity of biological systems and the biochemical interferences
caused by nanoparticles delivered using liposomal delivery, gene gun bombardment
or picoinjection into single live cells, there was a need for a specific and suitable
delivery and measurement technique. The need for a biochemical sensors that could
be used to non-invasively-to-minimally invasively probe complex biological systems
such as that of the mammalian cell led to the development of antibody-based optical
nanosensors (nano-biosensors). The first application of antibody-based optical
nanosensors to the field of biochemical analysis was reported in 1996 by Vo-Dinh
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and coworkers [15]. The antibody-based optical nanosensor is a novel and unique
technology first developed by the Vo-Dinh group and has the capability to perform
qualitative and quantitative measurements in single live cells. This nanosensor has
previously been used to successfully measure two carcinogenic compounds, benzo [a]
pyrene (BaP) and its metabolite benzopyrene tetrol (BPT) in single cells [16, 17].
Using these nanosensors, it was possible to probe individual chemical species in
specific locations within single living cells [17, 18]. The ability to monitor in vivo
processes within living cells can dramatically improve our understanding of cellular
function at the single cell level potentially revolutionizing cell biology [19].
The fabrication of these optical nanosensors involves a four-step process.
First, a 600-micron diameter fiber optic was pulled down to 50 nm at the tip and
coated with approximately 100-200 nm of silver to prevent light leakage and
maximise the delivery of light to the distal end of the optical nanosensor, in essence
creating quantum confinement. Following the silver metal coating procedure, the
nanofibers are silanized to facilitate the immobilization of antibodies. The silanized
nanotips are activated to allow covalent coupling and immobilization of antibodies.
This binding procedure first called for the activation of the silanized nanotips with a
solution of carbonyl diimidazole (CDI), followed by incubation of the activated
nanotips with the antibody of interest for 12 hours at 4 °C. Once the antibodies are
bound, the optical nanosensors are ready for studies such as to testing for the
retention of antibody binding as well as sensitivity and absolute detection limits.
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In previous studies, in-vivo measurements of single cells using optical
nanosensor have been performed [18, 20-25]. In one such study, antibody-based
optical nanosensors for BPT were prepared and used for the measurement of
intracellular concentrations of BPT in the cytosol of two different cell lines: (1) human
mammary carcinoma cells; and

(2)

rat liver epithelial cells [18, 20] The cells in both

lines are spherical in shape and have diameters of approximately 10 microns. Several
hours prior to making a measurement, the culture media of the cells was spiked with a
known amount of BPT. Then immediately prior to measurement, the culture media
was aspirated and the cells rinsed several times and finally replaced with BPT free
media. The results from this work, demonstrated that the concentration of BPT in
each of the different cell lines was the same, suggesting that the means of transport of
the BPT into the cells was the same in both cases (probably by diffusion). By
performing similar measurements inside various subcellular compartments, it could
be possible to obtain critical information about the location of BPT formation within
cells and its transport throughout the cell during the process of carcinogenesis. It was
also shown in this work that the insertion of a nano-biosensor into a mammalian cell
does not effect the cell’s normal function, as was evidenced by the monitoring of cell
division prior to and following a measurement [19]. Additional tests were performed
by placing the nano-biosensors in a measurement system like the one described for
chemical nanosensors and inserting the distal end of the sensor into a solution of
BPT. From these measurements, it was found that the antibodies had retained greater
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than 95 % of their binding affinity for BPT and that the absolute detection limit for
BPT using these sensors was approximately 300 zeptomoles (zepto = 10-21) [18, 25].

1.3 Optical Nanosensors for Single Cell Analysis
1.3.1 Principles of Optical Nanosensors
Despite the wide variety of bioreceptors and optical transducer elements
employed, they are all based on the same principle (previously shown in Figure 1.1):
General principles of optical nanosensor). Bioreceptors can be biological molecules
such as antibodies, enzymes, non-enzymatic proteins, peptide substrates or nucleic
acids. Optical transduction describes the measurement technique e.g., absorption,
fluorescence, phosphorescence, Raman, surface enhanced Raman scattering (SERS),
refraction, dispersion spectrometry, etc. These spectroscopic techniques can be used
to measure any of many different optical properties including the amplitude, energy,
polarization, decay time and/or phase. The most commonly measured parameter of
the electromagnetic spectrum is amplitude, as it can generally be correlated with the
concentration of the analyte of interest easily. While amplitude is the most commonly
measured, the other parameters can also provide a great deal of information about the
analyte of interest as well. For instance, the energy of the electromagnetic radiation
measured can often provide information about changes in the local environment
surrounding the analyte, its intramolecular atomic vibrations (i.e. Raman or infrared
absorption spectroscopies) or the formation of new energy levels (i.e. luminescence,
UV-vis absorption). Therefore, the resulting interaction between the analyte and the
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bioreceptor then produces an effect that can be measured via the transducer, which
converts this effect into some type of measurable signal.

1.3.2 Optical Nanosensor Immunoassay Formats
One key characteristic in determining the utility of optical nanosensors is their
ability to specifically measure the analyte of interest, without having other chemical
species interfere with the measurement. The specificity is dependent on two factors,
the type of biorecognition molecule and the target analyte (whether inherently
fluorescent or not). These factors dictate the type of immunoassay that can be applied
for analysis. In addition, the type of immunoassay format should allow measurements
to be made in complex matrices such as that of mammalian cells. Two different types
of immunoassay formats are described, direct and indirect immunoassay format, with
the ultimate aim of single cell analysis (Figure 1.2). Direct and indirect immunoassay
format register immunochemical complex formation at the transducer surface via
optical changes. The advantage of a direct immunosensor is that measurement of the
primary immunocomplex formation (antigen–antibody interaction) can be
accomplished immediately without any need for additional antibodies or markers. For
indirect immunoassay format, the measurement of the secondary immunocomplex
formation (antigen–antibody-labeled antibody interaction) is accomplished
immediately with additional antibodies or markers. The direct immnuoassay format
consists of antibodies as biorecognition molecules where antibodies bind target
molecules in the bio-sensitive layer of the sensor. The resulting interaction between
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Figure 1.2 shows the direct and indirect immunoassay format used for single
cell analysis. Immunochemical complex formation at the transducer surface was
monitored via optical changes.
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the antibody and target molecule produces a measurable fluorescent signal when
excited by the appropriate wavelength. The direct assay format is the simplest, and
often most sensitive, of the above assay formats. In a direct measurement format, the
target molecule interacts with and binds to the immobilized antibody, at which time
an optical property of the antigen is measured. This direct measurement technique is
most often used in the analysis of molecules that are intrinsically fluorescent, due to
the high sensitivity of the fluorescence technique [26]. The challenge associated with
direct immunoassay format is the limitation to measuring intrinsically fluorescent
target molecules, though this can be solved by using the indirect immunoassay
format. The indirect assay format is a versatile and sensitive assay based on the
capture of the analyte by one antibody (capture antibody) and the subsequent
detection by secondary antibody (reporter antibody). The target antigen must have
two epitopes and the capture and reporter antibodies must have different antigenic
specificities. Many proteins in fact have repeating epitopes so this is not a major
problem. The reporter antibody is labeled with a fluorescent molecule, such as Cy5 to
facilitate detection of target analyte when the secondary immunocomplex is formed.
The first step is to bind the antigen using the capture antibody immobilized to the
surface of the transducer element. The second step is to bind fluorescent-labeled
reporter antibody to the antigen forming a “sandwich like” structure. Once bound, the
fluorescence intensity of the labeled reporter antibody is measured when excited by
the appropriate wavelength. and correlated to the amount of target molecule that is
present [19].
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The third immunoassay format, tetrapeptide enzyme-substrate assay, consists
of an enzyme substrate complexed to an indicator dye. Tetrapeptide enzyme subsrates
can only be cleaved by specific enzymes. An activated target enzyme would
recognize the sequence it specifically cleaves and the resulting interaction between
the enzyme and the enzyme substrate complex would yield a fluorescent indicator dye
that would fluoresce when excited by the appropriate wavelength. An illustration of
this biosensing scheme is shown in Figure 1.3. In this work, optical nanosensors are
for the first time used that employ an enzyme-substrate system that is specifically
used to measure caspase activity in single cells. Tetrapeptide enzyme substrates are
specifically used to measure enzyme activity. They consist of a synthetic peptide
sequence complexed to a fluorescent molecule. During the enzymatic response, the
activated enzyme cleaves the tetrapeptide sequence producing a fluorescent product
that is readily measurable by fluorescence spectroscopy. This is based upon the
enzyme having a region whose three dimensional structure has a specific geometrical
configuration that exactly matches the three dimensional configuration of the
substrate of interest. Enzymes accelerate the rate of chemical reactions and each
enzyme has a unique shape that determines its function and is complementary to its
substrate meaning one enzyme specifically works on one type of substrate. Enzymesubstrate-based optical nanosensors can be extremely sensitive and have extremely
low detection limits [19]. The ultimate goal of single cell analysis studies is to offer
insight into cell function when perturbations in the local environment have occurred
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Figure 1.3 is an illustration of the tetrapeptide substrate immunoassay format.
An activated target enzyme (caspase-9 or caspase-7) would recognize the sequence
(LEHD = Leucine-Glutamate-Histidine-Aspartate OR DEVD = AspasrtateGlutamate-Valine-Aspartate) it specifically cleaves and the resulting interaction
between the enzyme and the enzyme substrate complex would yield a fluorescent
indicator dye (AMC = 7-amino-4-meathylcoumarin) that would fluoresce when
excited by 325 nm Helium-Cadmium laser.
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with the cellular machinery intact. Optical nanosensors can be implemented in the
direct chemical analysis of single cells whereby the internal environment of an
individual cell is directly monitored by correlating the binding of antigen to antibody
based on a fluorescent intensity signal as a function of time or concentration of the
analyte. Previous methods used to analyze single cells are too slow requiring times of
the order of seconds to remove the cell contents for analysis during which
concentrations of metabolites of interest could undergo order-of-magnitude changes.
Optical nanosensors have the capability to quantitate reactions that occur in subsecond times without altering or destroying the chemical makeup of the cell. This will
also enable measurement of cellular processes, such as apoptosis and the functioning
of proteins in their native environment and form.
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Part Two
Development of Optical Nanosensors
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2.0 Overview
This chapter discusses the design and development of two classes of optical
nanosensors (i) antibody based optical nanosensors and (ii) enzyme substrate based
optical nanosensor. Antibody based optical nanosensors are used for two
immunoassay formats, direct and indirect immunoassay format. Direct immunoassay
format involves the use of antibodies on a solid-state platform to capture a target
analyte (antibody-antigen), while indirect immunoassay format involves the use of a
set of antibodies to capture and identify a target analyte (antibody-antigen[labeled[antibody) forming a sandwich type structure. The immobilized capture
antibodies bind one epitope of the target analyte, while the reporter antibodies bind
another epitope of the target analyte. The enzyme substrate based technique as the
name implies utilizes a enzyme substrate that is recognized by a specific enzyme,
cleaved and generates a fluorescent product tat is detected. This section is divided
into 5 sub-sections involving the (i) introduction (ii) principle of operation (iii)
nanofabrication (iv) characterization (v) optimization and (vi) evaluation.

2.1 Introduction to Optical Nanosensors
Optical nanosensors are in general nanoscale devices consisting of two
components, a biorecognition molecule and an optical signal transducer element in
direct spatial coupling. The biorecognition molecule recognizes the target analyte and
the transducer converts the recognition event into a measurable signal. The
uniqueness of optical nanosensors lies in their size, novel optical properties, and the
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two components (biorecognition molecule and transducer element) integrated into
one single nanosensor. With dimensions in the nanometer range, the photonic
interactions of optical nanosensors exhibit dramatic changes. Key contributory factors
include confinement of light within the nanosensor and efficient energy over
nanoscale distances, due the highly enhanced role of interfaces. The finely tailored
scale of the optical nanosensors provides a high surface area-to-volume ratio, which
is important for surface chemistry to facilitate immobilization of biorecognition
molecules. At the nanoscale, in contrast to conventional assay in which many steps
are used and each step may require a reagent to treat the sample, the optical
nanosensor offers simplicity and speed of measurement. The general principle of an
optical nanosensor is illustrated in Figure 2.1. The most important part is the
biosensing element (biorecognition molecule) at which the molecular recognition
process takes place, since this defines the overall selectivity of the entire nanosensor.
The sensing-element surface is functionalized facilitate covalent immobilization
process and to prevent interfering substances from reaching the sensing-element
surface. The target analyte recognition process takes place at the surface of the
biosensing element leading to change in an optical property that can be transformed
into an electrical signal by an optical signal transducer e.g., photon counting
photomultiplier tube (PMT). The optical signal transducer can improve the sensitivity
of detection of the physicochemical interaction. The electrical signal from the optical
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Figure 2.1: Schematic representation of biosensing principle: The interaction
of between the analyte and biorecognition molecule secured on the optical transducer
is designed to produce an effect that can be converted by the optical signal transducer
to a measurable electrical signal. Inset is an image of an optical nanosensor and single
living MCF-7 cell

26

2.1.2 Description of Optical Nanosensors
Optical nanosensors can be defined as analytical devices containing a sensing
element of biological origin, which is either integrated within or in intimate contact
with an optically transparent transducer element. The optical transducer in intimate
contact with the sensing element in used to convert the biological recognition,
association or dissociation, event into a measurable signal [27]. The end goal is to
produce a continuous electronic signal, which is directly proportional to the
fluorescence signal generated when the target chemical or biomolecule in a sample
are excited. The sensing element of biological origin may be biocatalytic e.g.,
enzymes, or affinity systems e.g., antibodies. Figure 2.2 shows a diagrammatic
representation of an optical nanosensor

2.1.3 Optical Nanosensor Principle of Operation
The type of physical transducers used to create optical nanosensors form the
basis of their characterization. Optical nanosensors for example, are fabricated from
optical fiber, which is optically transparent enabling optical measurements. They use
fluorescence of light by a product formed or reactant depleted involving the
biorecognition molecule. Optical nanosensors are used to relate the fluorescent
intensity produced during the product formation or reactant depletion to the presence
or absence of analyte. Some types of molecules when illuminated with light
corresponding to the region of absorbance are promoted from ground state to excited
state. At excited state, they can release energy by emitting light of a longer
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Figure 2.2 shows a diagrammatic representation of an optical nanosensor
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wavelength and less energy. This phenomenon is known as fluorescence and is
described in Figure 2.3 by the Jablonski diagram. Fluorescence can be defined as an
optical phenomenon that occurs when a molecule of substance is irradiated and
absorbs energy in the form of a photon. The absorbed energy produces a change in
the electronic state of the molecule, where the electron is moved to a higher energy
level, singlet state. This is a temporary short-lived state and the electron returns to its
normal ground state by emitting a photon of less energy (light at different
wavelength). Due to the loss of energy, the emitted fluorescent radiation has a longer
wavelength than that of the absorbed light. The distribution in the wavelength that the
molecule absorbs is known as the absorption spectrum, and the distribution in the
wavelength emitted is known as fluorescence emission spectrum [28].

2.2 The Fluorescence Phenomenon
Fluorescence has three major advantages over other light-based investigation
methods: high (i) sensitivity, (ii) speed of detection, and (iii) safety. Sensitivity is an
important factor mainly because the fluorescence signal generated is proportional to
the concentration of target analyte under investigation and relatively small changes in
concentration within living cells that can have significant physiological effects can be
detected and measured. Fluorescent techniques have the capability to reliably and
accurately determine concentrations only as low as pico- and even femtomolar. In
some cases, quantities less than an attomole (<10-18 mole) have been detected [29].
Fluorescence measurements can also be used to monitor very rapid changes in
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Figure 2.3 Simplified Jablonski Diagram illustrating the processes involved in
the creation of an excited electronic singlet state by optical absorption and subsequent
emission of fluorescence.
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concentration that occur within nanoliter to femtoliter volumes. Fluorescent
measurements detecting changes in fluorescence intensity on the order of picoseconds
can be detected if necessary. Furthermore, since fluorescence is a non-invasive
technique, it does not interfere with a sample. The excitation light levels required to
generate a fluorescence signal are low, reducing the effects of photo-bleaching, and
single living cells can be investigated with no adverse effects on its natural
physiological behavior. The point of safety implies that samples are not affected or
destroyed in the process, and no hazardous byproducts are generated during
fluorescent measurements [29].
Fluorescence is an established and powerful technique for studying molecular
interactions in analytical chemistry, biochemistry, cell biology, photochemistry, and
environmental science whilst boasting phenomenal sensitivity [30]. The levels of
fluorescence from a single fluorophore are extremely low (hundreds to thousands of
photons per second). The fluorescence generated is observed by imaging the
fluorescent signal through a pinhole onto a photomultiplier tube (PMT), with which
we can count the number of photons detected. This should give us a very high signal
to noise ratio, and allow us clearly to determine when the fluorophore binds to the
fluorescent molecules, and when it associates or dissociates. In this work, as in other
optical sensors, one partner of the reaction is immobilized on the waveguide surface
and binding a fluorescent complementary partner is monitored. The excitation light is
guided through the wave-guide leading to an excitation of those molecules that are in
close proximity to the wave-guide surface within the evanescent field and the emitted
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fluorescence is monitored using PMT. Fluorescence signal is collected by the
objective, and passes through spectral and spatial filters before detection with a PMT.
The PMT signal is amplified and plotted vs. time on a PC to form electropherograms.
Depending on the assay principle, fluorescent signal intensity is recorded as a
function of time and as a function of concentration.

2.3 Components of Fluorescence Measurement System
The Fluorescence measurement systems consist of the following components;
a light source emitting selected wavelengths to excite the fluorophore. (selected light
sources are obtained by using lasers), optical fiber that serves as the waveguide to
deliver light to the sensing region, the biorecognition element which is in direct
contact with the optical device and target analyte to be analyzed, optics or an optical
system to collect and convey the light emitted by the fluorophore to a photodetector
e.g., photomultiplier tube (PMT), a photodetector for detecting the emitted light,
device for signal amplification, data processing and output.
The following section describes the basic physics behind the relationship
between total internal reflection and evanescent optical waves. This will be followed
by a description of the three-immunoassay formats: Direct, Indirect and tetrapeptide
substrate, respectively, used in this work
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2.4 Optical Nanosensor Principle of Operation
Optical nanosensor based on evanescent fluorescence were developed and
used in the work. They work via evanescent optical waves produced by total internal
reflection (TIR). TIR is an optical phenomenon that occurs when light energy
propagating in a dense medium e.g., silica, meets an interface with a less dense
medium e.g., cytosol of a cell. However, some of the light energy propagates a short
distance (a few hundred nanometers) into the cytosol of a cell, generating an
evanescent wave. Evanescent optical waves travel into restricted regions of materials
with exponentially diminishing energy. With evanescent optical waves, there is no
free-beam propagation and the laser energy can be confined to a layer less than half
the wavelength of the excitation source providing for near-field excitation. The
evanescent optical waves produced enable detection of particular components of
complex biomolecular assemblies with exquisite sensitivity and selectivity. If this
energy is not absorbed, it passes back into the glass. However, if a fluorescent
molecule is within the evanescent wave it can absorb photons and be promoted from
ground to excited state. The fluorescence signal is produced at the nanotips when the
components of the immunocomplex or complex biomolecular assemblies are excited
with evanescent optical waves lie in the near-field of the optical nanosensor. This
means that it is possible to capture fluorescence with a very low background of
excitation light creating a high signal-to-noise ratio. Optical nanosensors utilize the
formation of an evanescent field, which provides a highly localized excitation area in
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the near field of the optical nanosensor, for the excitation of fluorescent molecules
[31, 32]

2.5 Total Internal Reflection and Evanescent Wave Theory
Total internal reflection and evanescent wave theory explains that if a material
of a higher refractive index borders a medium of lower refractive index,
corresponding to Newton’s and Snell’s law, the light is reflected and refracted at the
border between the two media. In the case of the optical nanosensor, the light is
totally internally reflected, it is kept within the high refractive index material layer by
multiple reflections on both interfaces sides and guided through the optical fiber. The
critical angle (θ) is the minimum angle at which total internal reflection takes place
and no light passes through the low refractive index layer except at the nanotip. Using
Snell’s law the critical angle can be calculated using the equation [33]. Thus the
critical angle is defined by the equation;

n
sinθ = n 2
1

At TIR, no wave exists traveling through the higher index medium. However, a wave
results at the nanotip, along the interface and decaying exponentially. Thus at the
interface of the nanotip, a electromagnetic field (evanescent field) is created. The
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penetration depth of the evanescent field depends on the refractive indices of the
media and the critical angle, calculated by Snell’s law [33, 34]

2.6 Penetration Depth (dp) of Evanescent Wave Interaction
A diagrammatic representation of the penetration depth (dp) of evanescent
wave interaction is shown in Figure 2.4. The near-field light oozing out from the
probe irradiates an area through the tip of the aperture creating an evanescent field.
The evanescent field provides a highly localized excitation area (distances <0.5λ).The
binding interaction event takes place and the analyte is excited by the evanescent
wave on the surface of the waveguide. Using the penetration depth equation, the
penetration depth (dp) of the evanescent wave of different laser wavelengths can be
calculated. The following penetration depths were calculated for Helium-Neon laser
(632.8nm) δ = 351.6nm, Argon-Ion laser (514nm) δ = 285.6nm, Argon Ion laser
(488nm) δ = 271.1nm and Helium-Cadmium (325nm) δ = 180.6nm. From the
equation to calculate the dp, it can be seen that greater differences in refractive indices
(n1 and n2) allow greater angles of incidence for the light guide, due to the effect of
the critical angle. The thinner the guiding layer (the high refractive index layer, n2)
the greater the number of reflection incidences whereas dp becomes shorter. The
result of both effects is an increase of the interacting area of the evanescent wave[33].
In optical nanosensors, this increases the sensitivity if the device. The penetration
depth (dp) is given by the following equation;
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Figure 2.4 shows the formation of an evanescent field at the nanotip when
laser light is launched into the optical nanofiber. Inset is a representation of the
penetration depth (dp) of the evanescent wave which is dependent of the wavelength
of light transmitted through the core.
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dp =

λ
2π(n21 sin2θ - n22)½

2.7 Nanofabrication of Optical nanosensor
The nanofabrication of optical nanosensors involves a number of parameters
each of which must be optimized for efficient and effective experimental design. One
important parameter is the method of choice for attachment of biorecognition
molecule. Some of the issues to be considered in choosing an appropriate support and
the associated attachment chemistry include: the level of scattering and fluorescence
background inherent in the support material and added chemical groups; the chemical
stability and complexity of the construct; the amenability to chemical modification or
derivatization; surface area; loading capacity and the degree of non-specific binding
of the final product. [35]. The solid support selected for immobilization of
biorecognition molecule was silica-based optical fiber for the following reasons.
Silica-based optical fiber is a readily available and inexpensive support medium,
possessing a relatively homogeneous chemical surface whose properties have been
well studied and which is amenable to chemical modification using very versatile and
well developed silanization chemistry [36]. Although silanized proteins can be
covalently linked to an unmodified silica surface, most attachment protocols involve
chemically modifying the silica surface to facilitate attachment of the biorecognition
molecule [37].
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Figure 2.5 outlines the multi-step nanofabrication process. Briefly, the
nanofabrication process involves the following steps: (i) fiber preparation, polishing
and pulling process, (ii) silver deposition process, (iii) protein immobilization
chemistry and (iv) immunochemical assay formats for single cell analysis. The
immobilization of the biorecognition molecule is very important for the performance
of the optical nanosensor itself due to the influence on the stability, activity and
reproducibility of the sensing layer. The biological recognition molecules are linked
to the sensor surface by covalent immobilization which is achieved by modifying the
silica surface using a four step process, that involves washing, silanization, activation
and finally protein immobilization. Covalent attachment is more stable than physical
absorption or photo-immobilization. Preparation of two-dimensional surfaces usually
involves treatment silane couplng reagents for silanol modifications [35, 38]. Silanol
modifications are chemically stable, and ussually eliminate undesired steric
interference from the support, and are hydrophilic enough to be freely soluble in
aqueous solution and not produce non-specific binding to the support [35]).
The surface density of the optical nanosensor is an important parameter
because a low surface coverage will yield a correspondingly low conjugation signal,
and decrease the conjugation rate, while reasonably high surface densities may yield a
high conjugation signal [35]. The relatively high surface area to volume ratio of the
optical nanosensors greatly increases the loading capacity of biorecognition
molecules such as antibodies. The surface area permits relatively large amounts of
antibody to be linked to the surface resulting in strong signal intensities and a good
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specificity though at this scale, the optical nanosensor suffer from a limited dynamic
range.
Immobilization of proteins to solid supports such as polystyrene or silica can
be achieved using multiple methods. Based on previous laboratory experience and
information in the literature, the linking reagents glycidoxypropyltrimethoxysilane
(GOPS) and 1,1’- carbonyldiimadazole (CDI), and its associated bonding procedures
was selected. This immobilization procedure has been thoroughly evaluated by Alarie
et al., [39] based on two criteria, the amount of antibody that can be loaded, and the
retention of antibody activity, i.e., the ability of the immobilized antibody to
recognize its specific antigen after immobilization as determined by the ratio of the
moles of antigen bound to the moles of antibody immobilized. These criteria are
important because in direct and indirect assays, sensitivity is directly proportional to
antibody loading [40, 41]. In addition, the preservation of the antibody activity on
bonding to the solid silica support influences both sensitivity and selectivity.

2.7.1 Cleaving, Polishing and Pulling
600µm diameter plastic clad optical fiber was used to construct the optical
nanosensors. Optical fiber consists of a central core and median cladding made of
fused silica (SiO2), and an outer jacket made of a hard polymer. Lengths of optical
fiber measuring eight inches are sectioned off a reel of optical fiber. The fiber tips are
polished for about one to two hours to facilitate coupling of incident excitation
radiation. The fibers are polished using a fiber polisher (UltraTech,, Santa Ana, CA)
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with a 32 µ sized aluminum oxide (Al2O3) lapping paper. After polishing the fiber,
the hard polymer jacket is manually stripped off using a sharp razor. The fibers are
passed through a flame to remove parts of the jacket that were not stripped off with
the razor. After cleaning the fibers with kimwipes, the fibers are drawn from 600 µm
(core diameter) down to about 50 nm using Sutter P-2000 laser-based fiber puller
(Sutter Instrument Company, Novato, CA). Figure 2.6 shows a digital image and a
schematic profile of the fiber pulling instrument. Figure 2.7 details the fiber pulling
process and the product of this process, a 50 nm diameter optical nanofiber.

2.7.2 Silver Deposition Process
The pulled optical nanofibers with a final tip diameter of about 50 nm were
coated with 200 nm of silver metal (99.999% pure) using a thermal source vacuum
evaporator (Cooke Vacuum Products, South Norwalk, CT) operating at 10-26 Torr
achieving a final diameter of 250nm (Figure 2.8). The coating was deposited by
placing the nanofibers on a rotating stage with the tips pointed away from the silver
source at an angle of approximately 45°, thus preventing coating of the sensing
region. The Thermal deposition system is equipped with a crystal for monitoring the
metal thickness during the deposition process. This system has an on board computer
which determines the thickness deposition rate which is typical 0.5 Å/s. Following the
silver coating process, the optical nanosensor tips are functionalized to facilitate the
immobilization of the biorecognition molecule.
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Figure 2.6 shows a digital image of the fiber-pulling instrument (LEFT) and a
top-view and side-view diagrammatic profile of the fiber-pulling instrument.
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Figure 2.7 (above) shows the details the fiber pulling process and (below) the
product of this process, a Scanning Electron Micrograph of a 50 nm diameter optical
nanofiber
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Figure 2.8 shows how the pulled optical nanofibers with a final tip diameter of
50 nm are coated with ~200 nm of silver metal using a thermal source vacuum
evaporator (ABOVE) achieving a final tip diameter of 250nm. Above LEFT shows
the 45o orientation of the nanofibers in the thermal deposition chamber during the
silver coating process. Above RIGHT is an image of the thermal vacuum deposition
chamber without the bell jar.
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2.7.3 Protein Immobilization Chemistry
Immobilization of proteins onto SiO2 surfaces is of great interest for many
applications, particularly in developing biosensors. The immobilization of proteins by
covalent coupling usually leads to very stable preparations. The covalent binding
method is based on the attachment of proteins to solid SiO2 supports. The reaction
involves only functional groups of the protein that are not essential for its activity.
The major aspects which have to be considered for the covalent immobilization of
proteins are the following: Optical transduction principles that allow the use of the
evanescent field has facilitated the development of optical nanosensors whereby/ in
which one binding partner is immobilized on the transducer element followed by the
binding of the target analyte. This generated evanescent field is used to excite the
captured target analyte. Immobilization of protein onto solid-phase supports is thus an
important/ essential step in the nanofabrication of optical nanosensors. The
immobilization of antibodies/ protein on the surface of the transducer in optical
nanosensors has to achieve the following criteria; (i) result in a reproducible amount
of antibody on the surface, (ii) result in stable binding of the antibody to the optical
transducer surface (iii) maintain the activity of the antibody and (iii) non-specific
binding interactions.
Optical nanofibers are functionalized to facilitate covalent immobilization of
protein. Figure 2.9 describes the antibody binding chemistry procedure performed to
facilitate this process. Briefly, the silver coated nanotips were acid cleaned by
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Figure 2.9 describes the multistep surface chemistry procedure performed to
functionalize the optical nanofiber tips to facilitate protein immobilization onto the
optical nanofibers
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immersion in a 1:1 mixture of concentrated hydrochloric acid (HCl) and methanol for
30 minutes followed by rinsing several times in doubly distilled water. Next the
substrates were allowed to air dry. The air-dried nanofibers were suspended in 20mL
of 10% (v/v) aqueous (anhydrous acetonitrile) GOPS. The mixture is heated for 3h at
90oC with the pH maintained at 3 using 1M HCl. After the activation of the silica
nanotips and direct GOPS attachment, the silica nanotips were dried overnight in a
vacuum oven at 105oC. After drying in the vaccum oven, the nanotips were washed
with anhydrous acetonitrile and then suspended in 20ml of acetonitrile and 2g of CDI
added while stirring (30 minutes). Finally, they were washed with acetonitrile before
immobilizing antibody. For the methods, the immobilization of 0.5-1.0 mg/ml of
antibody was added to centrifugation vials. The nanotips were incubated for 12 hours
at 4oC. The antibody bound to the activated aldehydic sites. The fiber tips were rinsed
in PBS and remain in PBS overnight to hydrolyze and unreacted sites after the
incubation step.
A 0.05 (or 0.5) mg/ml solution of specific antibody and control antibody in
PBS was placed on the substrate coated with silane and cross-linker and allowed to
incubate for one hour after which the substrate was rinsed and washed in PBS.

2.8 Optical Nanosensing Schemes for Single Cell Analysis
2.8.1 Immunochemical Assay Formats
This work describes the use of two basic immunoassay formats for single cell
analysis based on biochemical interactions between the biorecognition molecule and
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the target analyte. These two immunosensing formats can be distinguished as
bioaffinity and biocatalytic reactions (Figure 2.10). Bioaffinity reactions involve
antigen – antibody (Ag – Ab) interactions which take advantage of physicochemical
changes that accompany complex formation e.g., changes in layer thickness,
refractive index, light absorption or emission. Bioaffinity reactions are characterized
by high specificity and high sensitivity that typifies an Ag – Ab reaction. Two
different types of bioaffinity reactions have been described direct and indirect
immunoassay. Direct immunoassay format register immunochemical complex
formation at the transducer surface via optical changes such as fluorescence emission.
The advantage of a direct immunoassay is that measurement of the antigen– antibody
interaction can be accomplished immediately without any need for additional
antibodies or markers (fluorescent tags). In contrast, indirect immunoassay format is
based on the measurement of the antibody – antigen– antibody interaction can where
one of the antibody partners in the immune interaction has a fluorescent label for
detection. Indirect immunoassay format combine the high selectivity of an
immunoreaction with the high sensitivity characteristic of the fluorescent label effect.
On the other had, biocatalytic reactions are important in biosensing
applications in cases where the target analyte does is not inherently fluorescent. The
biocatalytic reaction is based on the specific recognition of an enzyme substrate and
its subsequent chemical conversion to the corresponding products. The biocatalytic
reaction itself accomplishes specific binding between the active site of the enzyme
and the substrate, conversion of the substrate to product, and release of the product
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Figure 2.10: The two immunosensing formats can be distinguished as
Bioaffinity immunoassays: (i) direct immunoassay format, (ii) indirect immunoassay
format, and Biocatalytic immunoassay: (iii) tetrapeptide substrate format
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from the active center, which in turn leads to regeneration of the binding affinity and
catalytic state of the enzyme. A fluorescent molecule can be coupled to the substrate
and upon release of product for the enzymes active center, the fluorescent molecule
can be detected. This work exploits a tetrapeptide substrate coupled to a fluorescent
molecule for he detection of specific enzymatic activity. The use of biocatalytic
reaction facilitates both sensitivity and selectivity.
The two basic approaches to sensing direct optical interaction with an analyte,
and indirect optical interaction with an analyte were applied to optical nanosensors.
Direct optical interaction involves the use of primary antibody to bind a fluorescent
target analyte, while the indirect approach used indicator dye bound to biological
substrate molecules that change their optical properties after reacting with analyte.

2.8.2 Immobilization of Fluorogenic Tetrapepetide Substrate
This approach involves the immobilization of fluorogenic tetrapepetide
substrate onto the optical nanosensor to measure the activity of caspases (-9 and –7).
Caspase-9 and -7 are synthesized in the cytosol of mammalian cells as inactive
zymogens, which become active through intracellular caspase cascades. By mapping
the cleavage site of the substrates of caspase-9 and caspase-7, tetrapeptides LeucineGlutamic acid-Histidine-Aspartic acid (LEHD) and Aspartatic acid-Glutamic acidValine-Aspartic acid (DEVD) consensus cleavage sites were identified. Conjugation
to a fluorimetric moiety to DEVD provides a substrate for analyzing caspase like
protease activity. The following figure shows the cleavage reactions central to
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fluorimetric detection method. The fluorogenic tetrapeptide is immobilized. The
fluorimetric assay detects emission of the molecule 7-amino-4-methylcoumarin
(AMC) after cleavage from the AMC-substrate conjugate, LEHD-AMC and DEVDAMC respectively (Figure 2.11).

2.9 Components of Intracellular Measurement System
The components of the intracellular fluorescent measurement system are shown in
Figure 2.12. The components include three lasers, a Helium-Cadmium (HeCd) laser
emitting at 325nm, Helium-Neon (HeNe) laser emitting at 632.8 nm, Argon (Ar) ion
laser emitting at 488 nm and 514 nm, depending on the source required for excitation.
Optical fiber for laser delivery. Band pass filters (UV fluorescence) were used to
reject the laser-line and collect the fluorescence emission. Nikon inverted
fluorescence microscope, fluorescence signal detector using a photomultiplier tube
(PMT). Signal acquisition and recording using a custom written LabView software
program and a PC. Calibration curves were prepared by measuring (over 50msec) the
rates of fluorescence increase.
The measurement system is designed so that the output from laser source is
directed into an optical nanosensor. The optical nanosensor acts as a waveguide, and
the evanescent wave generated at the nanotip excites fluorophores that are associated
with bound protein at the surface of the nanotip. Some fluorescence is collected and is
filter and then detected by a PMT. Our system has been designed so that optical fibers
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Figure 2.11 shows the cleavage reactions central to fluorimetric detection of
caspase activity. The fluorogenic tetrapeptide substrate is immobilized onto the
optical nanosensor (shown in blue) and the fluorimetric assay detects emission of the
molecule 7-amino-4-methylcoumarin (AMC) after cleavage from the LeucineGlutamic Acid- Histidine- Aspartic Acid AMC-substrate conjugate (LEHD-AMC).

52

HeCd Laser
Incubator
Nanosensor
Compact Disc

197319792003

Pow er

Cell

Reset

HP universal
counter

Data acquisition PC
PMT
HP power supply

Nikon inverted
fluorescence microscope

Figure 2.12 shows the components of the laser-induced fluorescence measurement
system. The excitation source (HeCd laser) is interchangeable and are chosen and
used depending on the excitation wavelength of the target analyte
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that are used as sensing elements are inserted into a SMA connector/collar which,
when inserted into the cell compartment, immediately aligns the proximal end of the
fiber to assure high efficiency of transmission of light into and back from the
waveguide. The system has been used for the development of methods of
immobilization of antibodies, and as a sensing platform to develop methods for
detection of BPT [18]. The results demonstrated that our system can selectively detect
BPT at the femtomolar concentration level for a sample of 100 ul within a 50 ms of
exposure of the sensor to sample and 10 sample accumulations. Perhaps most
importantly, it is now clear that this system can be used for the sensitive and specific
analysis of protein-ligand interactions at a solid interface.

2.10 Optimization of Optical Nanosensors
This section describes the optimization of optical nanosensors, which was
performed to improve and maximize the efficacy of the production of uniform
nanotips. Production of uniform nanotips is important minimize the variability from
fiber to fiber and to enhance the reproducibility factor. Optimization of nanotips was
achieved by fine-tuning the parameters, Heat, Velocity, Delay, and Pull Strength of
the current state-of-the-art in micropipette puller technology, the P-2000 system
(Sutter Instruments, Novato, CA). The P-2000 integrates a CO2 laser-based heat
source. The CO2 laser has several features that make it amendable as a heat source of
choice. These features include nominal emission wavelength of the laser
approximates the resonant frequency of the SiO2 lattice in glass, CO2 laser heat is
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clean and leaves no residue on the SiO2 as do conventional heating filaments, and
finally, laser heat can be turned off instantly, leaving no residual filament heat. The
user can program the amount and distribution of heat supplied to the glass. The P2000 system has microprocessor-controlled programmability with 100 separate
programs, each program consisting of up to 8 command lines. Programmable
parameters include; laser power level, scan width, trip velocity, delay/ laser on time,
and hard pull strength (heat, filament, velocity, delay and pull). These programmable
parameters were adjusted in order to draw nanotips of different tip diameters.
Drawn nanotips were evaluated using Hitachi S-4700 scanning electron
microscope (SEM). In scanning electron microscopy an electron beam is focused into
a small probe and is raster scanned across the surface of the nanotips. Several
interactions with the nanotipse that result in the emission of electrons or photons
occur as the electrons penetrate the surface. These emitted particles are collected with
the appropriate detector and processed with image visualization software to yield
measurement information about the nanotips. The Hitachi S-4700 is highly suited for
this purpose because of its capability of high-resolution imaging with resolution of at
least 3 nm.
Dozens of nanotips were drawn for the optimization study by varying the
program parameters of the Sutter Instruments P-2000 fiber-pulling instrument. The
optical nanosensor for this optimization study were prepared using a three-step
process. Before this process, individual programs were written and write-protected in
order to secure them from inadvertent changes. Eight inch pieces of PCS were
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cleaved using a fiber cleaver. Both ends of the optical fiber were polished using 30µm
Al2O3 lapping paper. The fibers were then secured on the tension mounts of the P2000 Laser based fiber puller using clamps. For each program used, I pulled five
eight-inch fibers resulting in a total of ten nanofibers for each program used. The
nanofibers were labeled in order to keep track and link the fiber to the program after
acquiring SEM images.

2.10.1 Experimental Procedure
600 µm plastic clad silica (PCS) optical fiber was purchased from Fiberguide
Industries, Stirling, New Jersey. The benefits o PCS optical fiber include, cost
effective, high numerical aperture (NA) for efficient light collection from extended
sources, radiation resistant, laser damage resistant, dielectric nonmagnetic
construction, broad operating wavelength range from 220nm to 700n, excellent laser
beam delivery. PCS optical fibers were cut into 8 inch pieces and each end of the
fiber was polished using Aluminium oxide lapping paper. The fibers were drawn to
various tip diameters using Sutter P-2000 micropipette puller. The P-2000 works well
with small diameter glasses such as PCS optical fibers. The programmable parameters
laser power level, scan width, trip velocity, delay/ laser on time, and hard pull
strength, were modified before each pulling to obtain nanotips of different diameters.
After pulling the optical fiber to nanotips, they were coated with 99.999 % silver
metal in silver thermal deposition chamber. After coating the nanotips with silver,
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scanning electron microscope (SEM) images of the nanotips were acquired with
Hitachi S-4700 SEM at theHigh Temperature Materials Laboratory, ORNL.

2.10.2 Results and Discussion
Table 2.1 shows the programmable parameters include; heat, trip velocity,
delay/ laser on time, and hard pull strength (heat, filament, velocity, delay and pull)
that were adjusted to draw nanotips of different tip diameters. This table shows the
change in each parameter and the results obtained. Figures 2.13 show SEM
micrographs of the nanotips acquired with Hitachi S-4700 SEM. From the results, it
can be concluded that increasing the pull strength, decreases the tip diameters
obtained. These results were used as guide in the production of uniform optical
nanosensors to enhance the reproducibility factor between single cell measurements.

2.11 Characterization of Optical Nanosensors
The greatest challenge of developing nanoscale materials and structures lies in
being able to look at what has been created and to determine the presence or absence
of elements and their distribution. I devised a simple but straightforward method to
characterize the optical nanosensor and in the process confirm protein immobilization
chemistry. The optical nanosensors were characterized by immobilizing Cy-5 labeled
antibody onto functionalized nanotips and detecting the presence or absence of Cy-5
labeled antibody. Cy-5 was used because of its intense fluorescence, low
hydrophobicity, [42] and their high photostability which renders them useful for
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Table 2.1shows the programmable parameters include; heat, trip velocity, delay/ laser
on time, and hard pull strength that were adjusted to draw nanotips of different tip
diameters

Sutter P-2000 Input Parameters
Program Heat (oC) Velocity Delay
Pull
40
850
20
150
10
850
60
126
3
850
60
126
9
850
40
126
22
850
40
126
19
850
20
126
18
850
20
126

200
130
160
170
180
190
200

Size (nm)
50
1000
500
400
300
200
100
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20µm

20µm

2.0µm

20µm

20µm

20µm

10µm

20µm

Figures 2.13 shows SEM micrographs of the nanotips of different tip
diameters acquired with Hitachi S-4700 SEM. Note the different measurement scale
on each micrograph.
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single molecule fluorescence detection [43-45]. In this study, anti-cytochrome c was
labeled according to the following protocol and immobilized on nanotips (antibody
was labeled in a column and collected). 1mg of protein was labeled to a final average
molar dye/ protein ratio of 8 (this assumes an average protein molecular weight of
155 KDa). Cytochrome c antibody was labeled according to the following protocol
and immobilized on nanotips. Protein (1mg/ml in PBS) + Coupling buffer + Reactive
Cy-5 dye. Mixture is incubated at room temperature for 30 minutes. Separation of
labeled protein from non-conjugated (free) dye using a gel filtration column.
Collection tubes used to collect labeled protein. One batch of functionalized nanotips
were incubated in the labeled protein solution while the others were incubated in
unlabeled protein solution. Interaction between the Cy-5 labeled and unlabeled
antibody, with the nanotip was investigated. Interaction between the Cy-5 labeled
antibody and the nanotip was investigated. Fluorescence signal produced when the
antibody-antigen complex is excited; is converted to a measurable electrical signal

2.11.1 Experimental Procedure
Analytical grade materials were used as long as they were commercially
available. Cy-5 labeling kit containing, buffers, Cy-5 monofunctional dye as well as
PD-10 columns were purchased from Amersham Pharmacia Biotech. Cytochrome c
antibody was purchased from Santa Cruz Biotechnology, Inc (Santa Cruz, CA).
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2.11.2 Labeling of Cytochrome c with Cy5
In the standard procedure, the contents of 1 vial (to label 1 mg of protein) of
Cy-5 monofunctional dye was dissolved in 50 µL of DMSO. Cytochrome c antibody
was dissolved in buffer provided, typically at 1 mg/mL protein concentration. 10 µL
of dye/DMSO mixture was pipetted into 200 µL cytochrome c solution under slow
vortexing. After 30 min incubation at 25°C in the dark the reaction was terminated by
freezing at –4oC. For separation of unbound dye, 300 µL of 100 mM NaH2PO4 (to
suppress further labeling after thawing) was added to a frozen sample and the sample
was incubated in a 25°C water bath until thawed. The sample was loaded on a PD-10
column (10 mL bed of Sephadex G-25M), which had been pre-equilibrated in buffer.
After washing the column with buffer A (2 *1 mL) the labeled protein was eluted by
adding 2 mL of buffer to the column top. Another 10 mL of buffer was added to elute
all unbound dye, and the column was regenerated with 20 mL of buffer. Higher Cy-5
dye concentrations can be achieved by dissolving 2 vials of Cy-5 dye in 50 µL of
DMSO.

2.11.3 Immobilization of Labeled Anti-Cytochrome c
Preparation of anti-cytochrome c optical nanosensors involved the
construction of nanofibers and functionalizing the nanotips to facilitate antibody
immobilization. PCS optical fibers were pulled using the laser based fiber puller,
from 600 µm diameter to 50 nm diameters. The pulled fibers were coated with silver
metal in silver thermal deposition chamber. After coating the nanotips with silver, the
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nanotips were functionalized as described previously to allow the immobilization of
Cy5 labeled anti-cytochrome c. The measurements were performed using labeled
antibody for the experimental and unlabeled antibody for the control.

2.11.4 Results and Discussion
Figure 2.14 is a schematic representation of the fluorescence excitation and
measurement procedure used for Cy5 detection during the characterization study of
optical nanosensor. Figure 2.15 shows the results of the characterization study, which
involved the detection of Cy5 labeled anti-cytochrome c immobilized on the nanotips.
This study involved two treatment groups, optical nanosensor with Cy5 labeled anticytochrome c and without Cy5 labeled anti-cytochrome c. These results show a
difference of an order of magnitude in the fluorescent intensity measurements. This
difference is significant enough to determine the successful immobilization of Cy5
labeled anti-cytochrome c.

2.12 Characterization of Optical Nanosensor: -AFM measurements
In addition, we attempted to determine the distribution of antibody using a
recently acquired an atomic force microscope (AFM). AFM is a method of measuring
surface topography on a scale from angstroms to 100 microns. The technique
involves imaging a sample through the use of a probe, or tip, with a radius of 20 nm.
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Figure 2.14 is a schematic representation of the fluorescence excitation and
measurement procedure used to detect Cy5 labeled anti-cytochrome c in the
evaluation study. Inset is the excitation and emission spectrum of Cy5.
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Figure 2.15: shows the results of evaluation study that involved immobilizing
Cy5 labeled anti-cytochrome c on functionalized nanotips and monitoring their
presence. The top graph represents the detection of Cy5 labeled anti-cytochrome c
(experimental) and the graph below represents the control group.
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The tip is held several nanometers above the surface using a feedback mechanism that
measures surface–tip interactions on the scale of nanoNewtons. Variations in tip
height are recorded while the tip is scanned repeatedly across the sample, producing a
topographic image of the surface. The AFM has the ability to image at atomic
resolution (sub-angstrom level) and can achieve a resolution of 10 pm, and unlike
electron microscopes, can image samples in air and under liquids. The
AFM’sresolution combined with its ability to image a wide variety of samples under
a wide variety of conditions such as air and in fluids. Images have appeared in the
literature showing DNA, single proteins, structures such as gap junctions, and living
cells [46]. AFM operates by measuring attractive or repulsive forces between a tip
and the sample [47]. In its repulsive "contact" mode, the instrument lightly touches a
tip at the end of a leaf spring or "cantilever" to the sample. As a raster-scan drags the
tip over the sample, some sort of detection apparatus measures the vertical deflection
of the cantilever, which indicates the local sample height. Thus, in contact mode the
AFM measures hard-sphere repulsion forces between the tip and sample. In noncontact mode, the AFM derives topographic images from measurements of attractive
forces; the tip does not touch the sample [47].

2.12.1 Experimental Procedure
PCS optical fibers were pulled using the laser based fiber puller, from 600 µm
diameter to 50 nm diameters. The pulled fibers were coated with 99.999 % silver
metal in silver thermal deposition chamber. After coating the nanotips with silver, the
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nanotips were functionalized to allow the immobilization of Cy-5 labeled cytochrome
c antibody. After the construction of antibody-modified nanotips, we imaged the
nanotips using contact mode to locate the distribution of the immobilized cytochrome
c antibody. Contact mode is the most common method of operation of the AFM and
as the name suggests the tip and sample remain in close contact as the scanning
proceeds.

2.12.2 Results and Discussion
Figure 2.16 shows AFM images of optical nanosensor tips. The results obtained
revealed that we were unable to achieve sub-angstrom resolution and therefore unable
to determine the distribution of cytochrome c antibody immobilized on the
nanotips.However, we were able to obtain, with the acquired images, the dimensions
of the nanotips. Idealistically, if this worked and we were able to determine the
location and distribution of cytochrome c antibody, it would essentially allow us to
study the biophysics of molecular interactions and its role in important processes such
as signal transduction.

2.13 Evaluation of Optical Nanosensors
Since I had already positively demonstrated the immobilization of antibody
onto functionalized nanotips, the next step was to demonstrate that an
immunochemical assay was possible using the optical nanosensors. Evaluation of the
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Figure 2.16 shows AFM images of optical nanosensor tips captured using an
atomic force microscope in contact mode. The graphs show the dimensions of the
nanotips at different locations
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optical nanosensors was performed to assess the reactivity of antibody immobilized
onto the functionalized nanotips. Basically it involved determining whether or not the
immobilized antibody could effectively and efficiently bind target analyte and in
essence demonstrate that an antibody-antigen interaction can be detected. The
evaluation process was performed by immobilizing antibody to fluorescein onto
functionalized nanotips and detecting fluorescein molecules in solution. Fluorescein
was chosen because of the following advantages: it has a relatively high absorptivity,
an excellent fluorescence quantum yield, and excitation maxima ~494 nm closely
matches the 488 nm spectral line of the Argon-ion laser.

2.13.1 Experimental Procedure
PCS optical fibers were pulled using the laser based fiber puller, from 600 µm
diameter to 50 nm diameter. The pulled fibers were coated with 99.999 % silver metal
in silver thermal deposition chamber. After coating the nanotips with silver, the
nanotips were functionalized to facilitate the immobilization of antibody to
fluorescien for the experimental group, and without antibody to fluorescein for the
control group. Anti-fluorescein solution is prepared by dissolving the lyophilizate in 1
ml double distilled water results in a concentration of 0.1 mg antibody/ml. The
antibody is suitable for the detection of fluorescein and fluorescein-labeled
compounds. The detection of bound antibody can be carried out directly in one step
using an antibody to fluorescein. Both groups of optical nanosensors were incubated
4
in fluorescein (10- M) prepared in PBS. Both were incubated for 5 minutes in
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fluorescein and the evaluation of optical nanosensors study involved two groups,
experimental : antibody to fluorescein was immobilized on functionalized nanotips,
and, control : without antibody on functionalized nanotips. Figure 2.17 shows
fluorescence excitation and measurement process.

2.13.2 Results and Discussion
The characterization study was performed to determine the coupling and
compatibility of the optical nanosensor fabrication process and protein binding
chemistry procedure. This involved immobilizing anti-fluorescein onto functionalized
nanotips to detect fluorescein in situ. Figure 2.18 shows the results of the
characterization study involving measurerements performed using anti-fluoresceinbased optical nanosensors. The top fluorescence intensity plot represents optical
nanosensors used to make the experimental group measurements, while the bottom
fluorescence intensity plot shows results obtained using optical nanosensors used to
make the control group measurements. The difference between the experimental
group and the control group is approximately more than an order of magnitude. This
diffrence is significant illustrating the poitive detection of fluorescein using antifluorescein-based optical nanosensors.
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Figure 2.17 is a schematic representation of the fluorescence excitation and
measurement procedure used for fluorescein detection during the characterization
study of optical nanosensors employing the direct immunoassay format. Inset is the
excitation and emission spectrum of fluorescein.
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Figure 2.18 shows the results of characterization study for the detection of
fluorescein using anti-fluorescein-based optical nanosensors. The top graph is the
experimental group while the graph below is the control.

71

2.14 Summary
This work demonstrates the successful optimization process of optical nanosensor
fabrication performed by fine-tuning the input parameters of Sutters Instrument P2000. I was able to characterize the optical nanosensors by immobilizing labeled Cy5 labeled antibody and detecting the presence (experimental) and the discerning the
absence (control) on the nanotips. I was unsuccessful in using the AFM to determine
the localization and distribution of Cy-5 abeled antibody on the nanotips. It is worth
mentioning that AFM has been used toimage single lysozyme molecules [24] and
therefore with more effort, it will be possible to demonstrate the localization and
distribution of immobilized antibody. I was also successful in demonstrating the
ability to immobilized antibody to fluorescein to bind fluorescein in solution thereby
detecting an antibody-antigen interaction. Optical Nanosensors developed in this
work were subsequently used for the following in vitro and in vivo analyses, which
employ different immunochemical assay formats;
•

Chemical analysis, utilizing direct antibody binding assay format for
measuring the carcinogen benzo[a] pyrene

•

Protein interaction analysis, utilizing indirect antibody binding assay format
for monitoring cytochrome c and caspase-9

•

Protein Analysis, utilizing tetrapeptide substrate assay format for monitoring
caspase-9 and caspase-7 activity
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The Development and Application of Antibody-based
Optical Nanosensors for Measuring the Carcinogen Benzo[a]Pyrene
in a Single Living Cell
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Part three is a version of a paper published in the Journal of Nanoscience and
Nanotechnology in December 2002 by Paul M. Kasili, Brian M. Cullum, Guy D.
Griffin and Tuan Vo-Dinh: Kasili P.M, Cullum B.M, Griffin G.D, and Vo-Dinh T.,
Nanosensor for in vivo measurement of the carcinogen benzo[a]pyrene in a single
cell, Journal of Nanoscience and Nanotechnology 2 (6): 653-658 DEC 2002.

3.0 Abstract
This work describes the development and application of an antibody-based
optical nanosensor for in situ measurements of the carcinogen, benzo[a]pyrene (BaP)
in a single cell. This antibody-based optical nanosensor is miniaturized enabling the
detection of fluorescent analytes in single cells. In addition to measuring fluorescent
analytes in single cells, the nanosensor has the potential to be applied for both
diagnostic and proteomics purposes. In this work, the human breast carcinoma cell
line, MCF-7, was used as the model system to perform BaP measurements in single
cells. A standard concentration curve for BaP was established and used to perform
quantitative analyses of BaP in individual cells. From these analyses, it was estimated
that the concentration of BaP in the individual cells investigated was ~3.61 x 10-10M.
The results obtained demonstrate the application of antibody-based nanosensors for
performing in situ measurements inside single living MCF-7 cells.

79

3.1 Introduction
In recent years, much research effort has been expended in trying to combine
the two technologies of biosensors and immunoassay to produce sensors capable of
measuring the formation of an immunochemical complex [48]. A wide range of
techniques have been assessed in an attempt to match the performance of biosensors
with that of conventional immunoassay techniques. Some of the techniques evaluated
include, electrochemistry [49], solid-state devices [50, 51] and optical techniques [52,
53]. Even though both electrochemical and solid-state immunosensors have shown to
produce dose-response curves, they lack the sensitivity to be useful devices. In an
attempt to overcome problems associated with sensitivity, many researchers have
opted to use optical transducers for the construction of immunosensors. Optical
transducers have a number of advantages in the fabrication of optical biosensors, they
are well-characterized materials from which to fabricate the device e.g., quartz or
silica, sensitive methods of detecting the signal produced and have rapid signal
generation, processing and recording times [54].
Optical biosensors represent the second major family of biosensors, after
electrochemical biosensors. This has been made possible, mainly by progress in fiberoptic technology, and laser miniaturization. Optical biosensors can be miniaturized to
different scales depending on the prescribed function and can thus be categorized
depending on their relative dimensions. In this work we use miniaturized optical
biosensors, at the scale of a billionth of a meter, aptly named optical nanosensors
[54]. Optical nanosensors can typically be classified into one of two broad categories,
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chemical or biological, depending on the probe being used to perform the
measurements[55]. Kopelman and coworkers have developed and used both
biological and chemical nanosensors to perform physiological measurements of
calcium[56] and nitric oxide [57], among other physicochemicals. They can be fully
inserted into a single living cell and have been developed and applied for minimally
invasive intracellular chemical analysis in cells [58-60]. Similarly, these nanosensors
have been used to monitor biological processes such as pathogenesis due to chemical
pollutants

thereby

providing

a

method

of

monitoring

chemicals

in

microenvironments.
Among the two categories of nanosensors, biological nanosensors have been
developed and used by Vo-Dinh and coworkers to perform in situ measurements of
the fluorescent analyte benzopyrene tetrol (BPT), a metabolite of the carcinogen
benzo[a]pyrene (BaP) in single living cells [61, 62]. These nanosensors fall under the
biological category of optical nanosensors based on the fact that they have antibodies
immobilized on the optical fiber. The antibody-based nanosensors can be partially
inserted into a single living cell without affecting the life cycle of the cell [19]. A cell
survival study was previously performed [61] whereby an investigation was
performed to determine whether penetration of the cell by the nanosensor resulted in
intracellular or membrane damage of such a nature as to compromise cellular
viability. The cell survival study was critical because it provided much needed insight
as to whether or not penetration of the cell by the optical nanosensor affected cell
viability. It was determined by microscopic observation that the process of mitosis
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continued normally and that nanosensor insertion and withdrawal did not affect the
life cycle of the cell. In retrospect, optical nanosensors that fall into the abovementioned categories are beneficial because they reduce sample volume and absolute
detection limit a billion-fold, and simultaneously reduce the response time by a factor
of a thousand [58]. It is important for analytical purposes to perform molecular
recognition with high specificity and sensitivity to be able to detect and quantify the
extent of the antibody-antigen interactions. The application of an antibody-based
nanosensor for in situ measurements of BPT in a single cell was previously reported
in our group [55, 63]. Here, we report the application of anti-benzo[a]pyrene (BaP)
based optical nanosensors for in situ measurements of the fluorescent analyte and the
carcinogen benzo[a]pyrene. We selected the fluorescent molecule BaP as the analyte
model system because it is a PAH of environmental and toxicological interest as a
result of its mutagenic/carcinogenic properties and its ubiquitous presence in the
environment [61, 64]. Therefore, detection of BaP transport inside single cells is of
great biomedical interest since it can serve as a means for monitoring BaP exposure,
which can lead to DNA damage [61].
BaP (C20 H12) is one of the more potent carcinogens among the polynuclear
aromatic hydrocarbons (PAH’s) and is a fundamental indicator of exposure and
carcinogenic activity of all PAH’s. The PAH group of compounds are ubiquitous
environmental contaminants that are formed by the incomplete combustion of organic
materials, such as wood or fossil fuels. PAH, molecules are made up of three or more
benzene rings, at least two of which are fused with two neighboring rings sharing two
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adjacent carbon atoms. In addition to PAH that are composed of carbon and hydrogen
atoms only, some PAH contain heteroatoms such as nitrogen and sulphur. PAH form
a large and heterogeneous group, but the most toxic members of this family known
to-date are PAH molecules that have four to seven rings. BaP is the most studied of
this family of compounds and is a relatively large unsubstituted five-ring compound.
BaP is lipophilic, sparingly soluble in water, and soluble in organic solvents [65].
Because of its relatively high environmental levels and high level of toxicity resulting
in larger health impact than any other PAH identified in the environment, BaP is
often selected as a surrogate for other PAH compounds and therefore it the most
studied of the PAH family of compounds. Moreover, because of it relatively high
environmental levels and high level of toxicity resulting in larger health impact than
any other PAH identified in the environment. Since DNA adduct formation is the
critical step in the process of carcinogenesis, it is important to measure BaP in order
to determine exposure to PAH’s before DNA damage occurs [66]. Figure 3.1
describes DNA adduct formation leading to BaP carcinogenesis.
Measurement of BaP is dependent on the scale at which the measurement is
being performed and the type of environment being probed. Currently, the optical
nanosensor is the only available technology capable of measuring BaP in single living
cells. This is possible by the small scale of the nanosensor in comparison to the scale
of the cell under investigation. In addition, the optical nanosensor allows for
minimally invasive cell analysis and in the process allows for the continuation of
normal cellular processes such as mitosis. In order to perform these measurements, it
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is necessary to use antibodies targeted to BaP. With the nanosensor with immobilized
antibodies, it is possible to specifically detect BaP molecules due to the specific
binding of anti-BaP to BaP. The nanosensor system was designed utilizing molecular
covalent methods where a receptor unit, the antibody, was covalently linked to the
sensor unit, the optical fiber. The fluorescent BaP molecules are bound by interaction
with the immobilized antibody receptor, forming a receptor-ligand complex.
Following laser excitation of this complex, a fluorescence response from BaP
provides a basis for the quantification of BaP concentration in the cell being
monitored. The fluorescence signal generated allows for a high sensitivity of
detection. By utilizing the interaction between the anti-BaP and BaP, it is possible to
determine fluorescence differences that can determine the presence of anti-body-BaP
complexes.
The intracellular measurements of BaP depend on the reaction times involved.
In a previous study, the reaction time established for antibody-BPT complexing was 5
minutes [61]. Similarly, the reaction time established in thus study for antibody-BaP
complexing was 5 minutes. This was used as a standard time to enable calibration
from fiber to fiber. Additionally, the nanosensors were calibrated using standard
analytical procedures using measurements of known concentration of BaP reference
solutions.
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3.2 Experimental Procedure
3.2.1 Cell Lines
Human breast cancer cell line, MCF-7, were obtained from American Type
Culture Collection (Rockville, MD, USA, Cat-no. HTB22). MCF-7 cells were grown
in Dulbecco's Modified Eagle's Medium ((DMEM) (Mediatech, Inc., Herndon, VA))
supplemented with 1 mM L-Glutamine (Gibco, Grand Island, NY) and 10% fetal
bovine serum (Gibco, Grand Island, NY). Baseline static culture productivity for each
cell line was established in growth medium (described above) in standard T25 flasks
(Corning, Corning, NY). The flasks were incubated at 37°C, 5% CO2 and 86%
humidity. Cell growth was monitored daily by microscopic observation until a 60–
70% state of confluence was achieved. The growth conditions were chosen so that the
cells would be in log phase growth during BaP treatment, but would not be so close to
confluence that a confluent monolayer would form by the termination of the chemical
exposure [7]. In preparation for experiments, cells were harvested from the T25 flasks
and 0.25ml (4.0 x 105 cells/ ml) seeded into 60mm tissue culture dishes (Corning
Costar Corp., Corning, NY) for overnight attachment. From a 4.464 x 10-3M stock
solution of BaP in ethanol, a range of 0.0001-1% solutions were prepared by adding
the BaP solution in DMEM. The resultant solutions were added to multiple culture
dishes and left in contact with the cells for a 4-hour incubation period. The amount of
BaP in ethanol used was in small enough quantities such that normal cell growth did
not seem affected by microscopic observation. BaP was prepared as a 1mM stock
solution in reagent grade ethanol and further diluted before addition to the cells.
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Following incubation of the MCF-7 cells with BaP, the medium containing BaP was
aspirated, the dishes were rinsed once with sterile PBS, and the PBS was replaced
with fresh growth medium before performing intracellular measurements using the
nanosensor.

3.2.2 Preparation of Antibody-based Nanosensors
Preparation of antibody-based optical nanosensors has been previously
described [61]. Briefly, this process involved cutting and polishing plastic clad silica
(PCS) fibers with a 600-µm-size core (Fiberguide Industries, Stirling, New Jersey).
Briefly, the fibers were pulled to a final tip diameter of 50 nm and then coated with
200 nm of silver metal (99.999% pure) using a thermal evaporation deposition system
(Cooke Vacuum Products, South Norwalk, CT) achieving a final diameter of 250nm
(Figure 3.2). The fused silica optical fibers were acid-cleaned followed by several
rinses with distilled water. Finally, the substrates were allowed to air dry at room
temperature in a dust free environment. The fiber tips were then silanized and treated
with an organic cross-linking reagent. The silanization agent covalently binds to the
silica surface of the optical nanosensor tips modifying the hydroxyl group to a
terminus of choice that is compatible with the organic cross-linking reagent. Silanes
were determined to be the reagents most preferred for the attachment of antibodies
since these silanes produced highly uniform and reproducible films and have a
terminus amendable for use with a variety of hetero-bifunctional cross-linkers [67].
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Tip size ~ 50 nm

Tip size ~ 250 nm

Figure 3.2 shows scanning electron micrographs of optical nanotips diameter
of 50 nm (LEFT) and then coated with 200 nm of silver metal using a thermal
evaporation deposition system achieving a final diameter of 250nm (RIGHT)
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The choice of imidazole-terminal film is particularly attractive since the protein to be
immobilized can be used without chemical modification. Antibodies bound using this
procedure remained securely immobilized during washing and subsequent
manipulations in immunoassay procedures, as opposed to procedures that use
adsorption to attach proteins [68, 69]. Antibody to BaP was produced by co-author,
Dr. G.D. Griffin. The tapered tips of the optical nanotips with silane groups and
cross-linkers were immersed in a solution of anti-BaP in PBS and allowed to incubate
for 3 days after which the nanosensors were inserted into single cells and used to
detect and measure BaP.

3.2.3 Measurement System and Procedure
Figure 3.3 shows a schematic representation of the fluorescence measurement
system. The 325 nm laser line of a HeCd laser (Omnichrome, <5mW laser power)
was focused onto a 600-µm-delivery fiber that is terminated with a subminiature A
(SMA) connector. The antibody-immobilized tapered fiber was coupled to the
delivery fiber through the SMA connector and secured to the microscope with
micromanipulators. The fluorescence emitted from the cells was collected by the
microscope objective and passed through a 330-380 nm bandpass filter and then
focused onto a photon-counting photomultiplier tube (PMT) for detection. The output
from the PMT was recorded using a universal counter and a personal computer (PC)
with custom-designed software for data treatment and processing. The experimental
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Figure 3.3 shows the components of the laser-induced fluorescence measurement
system consists of HeCd laser (325nm), optical fiber, Nikon inverted fluorescence
microscope equipped with UV fluorescence filters (330-380nm) to reject the laserline and collect the fluorescence emission, a highly sensitive photomultiplier tube
(PMT), a universal counter and a data acquisition PC
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setup used to probe single cells was adapted to this purpose from a standard
micromanipulation/microinjection apparatus. Figure 3.4 shows the Nikon Diaphot
300 inverted microscope (Nikon, Inc., Melville, NY) having a Diaphot 300/Diaphot
200 Incubator, to maintain the cell cultures at 37°C on the microscope stage, was
used for these experiments. The micromanipulation equipment used consisted of MN2 (Narishige Co. Ltd., Tokyo, Japan) Narishige three-dimensional manipulators for
coarse

adjustment,

and

Narishige

MMW-23

three-dimensional

hydraulic

micromanipulators for final movements. The optical fiber nanosensor was mounted
on a micropipette holder (World Precision Instruments, Inc., Sarasota, FL). To record
the fluorescence of BaP molecules bound to antibodies at the fiber tip, a Hamamatsu
PMT detector assembly (HC125-2) was mounted in the front port of the Diaphot 300
microscope. The fluorescence emitted by the bound BaP molecules was collected by
the PMT and the data transmitted via a laboratory interface to a PC for data
acquisition and processing.

3.3 Results and Discussion
Before making measurements, the cells were harvested from culture flasks
and transferred to culture dishes. After attachment to the bases of the petri dishes, the
MCF-7 cells were treated with a specified percentage of BaP/ ethanol in DMEM. The
solution of BaP in DMEM was then aspirated and replaced with fresh DMEM. The
nanosensors were gently inserted into individual living cells and incubated for about 5
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Figure 3.4 shows an image of Nikon Diaphot inverted fluorescence
microscope the main component of the laser-induced fluorescence measurement
system
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minutes to allow antibody-BaP interaction, and the fluorescence signal was recorded.
Calibration measurements and five separate trials (each trial repeated five
times) were conducted to determine the limit of detection and the reproducibility of
the nanosensors. In each trial, MCF-7 cells plated in tissue culture petri dishes were
incubated 4 hours prior to experimentation with DMEM solutions ranging from
0.0001-1% BaP/ethanol (concentration range of 10-10 – 10-6 M BaP). In addition, for
each trial, one petri dish (control) was incubated under normal growth conditions,
with DMEM and without the addition of BaP.
Detection and measurements of BaP in single cells using the nanosensor were
carried out using the following procedure. A culture dish of cells was placed on the
pre-warmed microscope stage set at 37oC. The nanosensor, mounted on a
micropipette holder of a micromanipulation system, was moved into position (i.e., in
the same plane as the cells), using bright-field phase contrast microscopic
illumination, so that the tip was just outside of the cell to be probed. The total
magnification used was 600×. The nanosensor was gently micromanipulated into the
cell, past the cell membrane and extending a short way into the cytoplasm. Room
light and microscope illumination light were switched-off; the laser shutter opened,
and laser light allowed to illuminate the optical fiber and excitation light was
transmitted into the fiber tip. First, a signal reading was taken with the nanosensor
inside the cell with the laser shutter closed in order to record the dark signal. During
these micromanipulations, great care was taken not to penetrate the nuclear envelope.
After 5 minutes, the laser shutter was opened and fluorescence readings were
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recorded. Figure 3.5 shows an image of an optical nanosensor prior to insertion and
after insertion into a single MCF-7 cell illustrating how the intracellularmeasurements
were executed and Figure 3.6 shows a schematic of the fluorescence excitation and
detection process.
Figure 3.7 shows the results of test-tube studies of % BaP/ethanol in DMEM
using five nanosensors for each measurement performed in growth medium outside
the cell. The graph consists of the logarithmic scale of the concentration of BaP in
DMEM obtained when measured doses of BaP in ethanol were placed in DMEM, and
the intensity counts acquired upon antibody-BaP complexing. The results showed that
the average fluorescence intensity values increased with increasing concentration and
reached a plateau phase as a result of saturation. Shown in the calibration curve are
error bars that represent a 95% confidence interval (CI). As can be seen on the curve,
error bars of the concentrations 10-8, 10-7, 10-6 M overlap implying that the difference
between the means is not statistically significant (P>0.05). The readings are higher in
test-tube studies as compared to intracellular studies because there is a difference in
diffusional kinetics as a result of the different levels of viscosity of DMEM and the
aqueous cytoplasm. Granted that the inside of a cell is more like a scaffold, with a
complex structure and machinery to transport proteins and other cellular components
to specific sites, hence there is an increased diffusional limitation and this has the
effect of decreasing the levels of BaP close to the silica surface and the rate of
attachment of the BaP to the antibody on the surface. In comparison to the cell, the
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Figure 3.5 shows an image of an optical nanosensor prior to insertion (LEFT)
and after insertion (RIGHT) into a single MCF-7 cell illustrating how the single cell
measurements were performed
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Figure 3.6 shows schematic of the fluorescence excitation and detection
process. A fluorescence signal is detected and measured once the anti-benzo [a]
pyrene (BaP) immobilized on the nanotips bind BaP
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Figure 3.7 shows the results of test-tube studies of % BaP/ethanol in DMEM
using five nanosensors for each measurement performed in growth medium outside
the cell. Each colored line represents an average of five in situ BaP measurements.
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BaP/ ethanol in DMEM in the test-tube is an environment without diffusional
limitations. Figure 3.8 shows the results of intracellular measurements of BaP
performed with nanosensors using both the control and experimental groups of MCF7 cells. MCF-7 cells were incubated with 0.0001-1% BaP (% BaP/ethanol in
DMEM). The graph consists of the final concentration of BaP in DMEM obtained
when measured doses of BaP in ethanol were placed in DMEM (the final mixture was
used for cell culture), and the intensity counts acquired upon antibody-BaP
complexing within a single cell. Each point consists of average intensity value
derived from five measurements performed for each concentration (10-10 – 10-6 M) of
BaP/ ethanol in DMEM using a set of five nanosensors. The results showed that for
the control group of cells, the fluorescence signal detected relative to the level of
background signal was not significant.
Although a background signal was generated, it was not significant enough to
confound the determination of BaP. Moreover, there are no other molecules that
appear to interfere with the fluorescence measurements that would confound the
determination of BaP. The explanation for this is the high specificity of antibody, the
time required for the metabolism of BaP to BPT, and the use of near field excitation.
The application of monoclonal antibodies renders the nanosensors selective for
measurement of BaP. These antibodies are specific against a single structural
determinant and thus capable of discriminating between similar epitopes. They
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Figure 3.8 shows the results of intracellular measurements of BaP performed
using anti-BaP-based optical nanosensors in MCF-7 cells. Each colored line
represents an average of five in situ BaP measurements.
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exhibit very selective binding capabilities for specific structures [70]. As a result, BaP
specific monoclonal antibodies immobilized on a nanosensor tip are useful for
monitoring small quantities of BaP in complex matrices because of their high
specificity for the molecular structure of BaP. These antibodies also exhibit high
affinity.
BaP is metabolized to 7,8-dihydrodiol-benzopyrene, which is metabolized into
the epoxide metabolite of benzopyrene, BPDE, its carcinogenic form. The epoxide
then binds with macromolecules such as protein and DNA (BPDE-DNA) to cause
cytotoxicity. DNA adduct formation of 2.5 µM BaP occurs at 12 hr exposure, after
which BPDE adducts decrease [71]. Metabolism of 3 µM BaP peaks at 9 to 16 hrs
after exposure [72]. By exposing MCF-7 cells to varying concentrations of BaP
(4.464 x 1010- 4.464 x 10-6M) for a 4 hr incubation period, we do not provide
sufficient time for either BaP metabolism or DNA adduct formation. Therefore, BPT
is an unlikely to confound the determination of BaP.
The application of near field excitation contributes to the specificity of the
nanosensor and virtually nullifies any effects that may confound the determination of
BaP. Excitation of BaP lies in the strong evanescent-wave component of near-field
excitation. The near field of the fiber (on the distal end) is where the antibody is
immobilized and antibody-antigen complexing occurs and thus only BaP molecules
that lie on the near-field are excited [61]. Consequently, the nanosensor used to
monitor the cells incubated with % BaP/ ethanol in DMEM transduced a relatively
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higher fluorescent signal as a result of BaP molecules sequestered at the tapered tip of
the antibody-based nanosensor.
Figure 3.9 shows the excellent degree of reproducibility achieved using the
nanosensors to perform the intracellular detection of BaP. This figure shows the
results obtained using five antibody-based nanosensors to probe MCF-7 cells
incubated in 0.01% BaP in DMEM. Similarly, five antibody-based nanosensors were
used to probe MCF-7 cells incubated without BaP/ ethanol in DMEM. The relative
variations from nanosensor to nanosensor with or without bound BaP were
approximately 7-10%. The fluorescence signal obtained using the nanosensors used
to probe cells incubated with BaP/ ethanol in DMEM is relatively higher than the
signal obtained by nanosensors used to probe cells incubated without BaP/ ethanol in
DMEM. Despite reproducibility being a challenging aspect of this project, we
managed to produce highly reproducible nanosensors. Excellent reproducibility was
achieved as a result of improvements and refinements of the input parameters of the
laser based micropipette-pulling device. Optimization of input parameters involved
varying the user input parameters: heat, delay and pull strength. By varying the
heating temperature as well as the tension applied to the fiber, we successfully
produced reproducible tip diameters from fiber to fiber. This was confirmed by
acquiring SEM images of the pulled fibers. The optimization of the input parameters
of the micropipette pulling device enables very good batch reproducibility which is
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Figure 3.9 shows the excellent degree of reproducibility achieved using the
nanosensors to perform the intracellular detection of BaP. This figure shows the
results obtained using five antibody-based nanosensors to probe MCF-7 cells
incubated in 0.01% BaP in DMEM.
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especially essential for a technology aimed to single-use nanosensors allowing
calibration to be done by measurement of the performance of one nanosensor. This
study demonstrated the excellent reproducibility of antibody-based nanosensors.

3.4 Shelf life and Stability of Immobilized Protein
The stability of the immobilized antibody was determined in terms of the
retention of activity after 21 days of storage at 4oC. No significant loss of activity
was observed at the end of this period. In contrast, it was found that after drying, solid
support with immobilized antibody rapidly lost activity within a few days. Therefore
an aqueous environment is recommended for the long-term storage of these
immobilized antibodies. Figure 3.10 shows the side-by-side comparison of
nanosensors that have been utilized immediately after the immobilization of antibody
and another set that have been used 21 days after preparation. The results show that
here is no significant loss of activity by the end of the 21-day period.

3.5 Conclusion
In this work, we demonstrated the development and application of a rapid,
selective and sensitive method for the determination of the carcinogen BaP in single
cells using antibody-based nanosensors targeted to the fluorescent analyte, BaP. The
results obtained in this work demonstrate in situ measurements performed inside
single living cells using an antibody-based nanosensor and the potential application of
antibody-based nanosensors in proteomics. The results obtained also support the
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Figure 3.10 shows the side-by-side comparison of nanosensors that have been
utilized immediately after the immobilization of antibody and another set that have
been used 21 days after preparation. It can be seen from these results that there is no
significant loss of activity by the end of the 21-day period.
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previously reported [7] study involving the development and application of optical
nanosensors for the detection of BPT. The quantification limits were extrapolated
using linear regression and calculated to be ~3.61 x 10-10M. This is the lowest
concentration of BaP estimated in a single MCF-7 cell. This result indicates that BaP
can be monitored and measured using antibody-based optical nanosensors within
single living cells.

3.6 Summary
Optical nanosensors were successfully nanofabricated and applied to measure
BaP both in vitro and in vivo. They have a steep linear response with saturation point
developing fast and a very narrow dynamic range (~5 – 20 nM). They have a low
detection limit ~36.1 nM and excellent reproducibility that was determined from the
percent 10% variability from nanosensor-to-nanosensor in measurements performed
using the. Antibody stability after immobilization was observed when the optical
nanosensors were stored at 4oC in an aqueous environment. Optical nanosensors have
the potential to analyze at the single cell level the activities of specific proteins
participating in cell signaling networks/ pathways. By monitoring these proteins we
can understand how they are regulated at the lowest possible levels.
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Part Four
Antibody-based Optical Nanosensor for the Measurement of Apoptosis
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4.0 Abstract
This work describes the application of optical nanosensor technology to
measure apoptosis whereby the feasibility of antibody-based optical nanosensors for
monitoring apoptosis by detecting protein-protein interaction and identifying protein
activity were demonstrated. It describes the application of these nanosensors for the
in vitro and pseudo in vivo measurement of two key apoptosis proteins cytochrome c
and caspase-9, which are involved in the mitochondrial pathway of apoptosis. The in
vitro and pseudo in vivo measurement involve the application of the antibody-based
optical nanosensor employing the indirect detection scheme or sandwich type
immunoassay whereby one of the partners in the immune interaction is labeled with a
fluorescent molecule. The capture and reporter antibodies bind different epitopes of
the same target biomolecule, and the interactions detected in the evanescent field of
the optical nanosensor. This is a highly sensitive technique especially suitable for
monitoring antibody-antigen interaction [73]. For both the in vitro and pseudo in vivo
measurements, apoptosis was induced using a photodynamic therapy (PDT) agent δaminolevulinic acid (ALA) that initiates the mitochondrial pathway of apoptosis. This
pathway involves cytochrome c release from mitochondria followed by the activation
of caspase-9.

4.1 Introduction
Optical nanosensors are in general small devices, which incorporates a
biological component onto a transducer as a key functional element. They are based
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on a direct spatial coupling between a biologically active compound and a signal
transducer. The biological component is usually an antibody or enzyme immobilized
onto the transducer, the electronic or optic sensing system that detects the
environmental changes brought about by the biological reaction. The colorimetric,
fluorometric or chemiluminescent product of the reaction is often detected by the
transducer [48, 74].
Optical nanosensors based on the antigen–antibody interaction are generally
known as immunosensors. The high specificity and high sensitivity that defines an
antigen–antibody reaction has been used in a vast range of laboratory-based tests
incorporating antibody components. The analytes detected and measured have
included many medical diagnostic molecules, clinical disease markers, bacteria, and
such environmental pollutants as polynuclear aromatic hydrocarbons (PAH’s). There
are two different types of immunosensors, direct and indirect immunosensors. Direct
immunosensors are based on the immobilization of antibodies on a transducer surface
which serve to capture target moleculecules with either colorimetric or fluorescent
properties. Accordingly, they register immunochemical complex formation at the
transducer surface via optical changes for direct detection of target molecules. The
advantage of a direct immunosensor is that measurement of the antigen–antibody
interaction can be accomplished immediately without any need for additional
antibodies or markers such as enzymes or fluorescent labels. On the other hand,
Indirect immunosensors involves the use of antibodies involved in an immune
interaction which includes a capture and reporter antibody. As the naming suggests,

110

the capture antibody functions to bind and immobilize the target molecule, while the
labeled reporter antibody binds to another epitope of the target molecule to “report”
the binding event. These combine the high selectivity of immunoreactions with the
high sensitivity characteristic of the fluorescence effect [73, 75].
In this work, the indirect immunosensing method was used to perform the in
vitro and pseudo in vivo measure two important apoptosis proteins, cytochrome c and
caspase-9. This involved measuring cytochrome c and caspase-9 in cytosolic cell
extract (in vitro) obtained from two cell groups; one in which apoptosis had been
induced and the other in which apoptosis had not been induced. Optical nanosensor
with capture antibody was incubated in cytosolic extract to initially form a primary
immunocomplex. Following primary immunocomplex formation, the optical
nanosensors incubated with Cy5 labeled reporter antibody forming a secondary
immunocomplex. Similarly, pseudo in vivo measurement involved inserting and
incubating an optical nanosensor with capture antibody into a single living cell. The
optical nanosensor was gently withdrawn from within the living cell and incubated in
a phosphate buffered saline (PBS) containing Cy5 labeled reporter antibody resulting
in the formation of a secondary immunocomplex. In both cases, Cy5 label was
excited using evanescent optical waves at the near-field of the optical nanosensors
generated from the 632.8 nm of HeNe and the fluorescence intensity is recorded as a
function of time.
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4.2 Antibody-based Optical Nanosensors
Optical nanosensors used in this work exploit antibodies to monitor apoptosis
proteins. One of the key factors in determining the usefulness of any biosensor is its
specificity, which can be defined as its ability to specifically measure the analyte of
interest, without having other biochemical species interfere with the measurement.
Specificity is an important characteristic because it allows measurements to be made
in complex environments. Since their first use in antibody-based optical biosensors
for the measurement of the carcinogen benzo[a]pyrene[26], antibodies have gained
increasing importance as bioreceptor molecules for optical biosensing applications
[76-83]. Antibodies are immunoglobulins capable of specific combinations with
antigenic molecules that caused their production. They exhibit very selective binding
capabilities for specific structures and can posses both high specificity and binding
affinity for a given antigen or hapten [84]. Two classes of antibodies exist, both of
which have been used in constructing optical biosensors, (i) monoclonal antibodies,
and (ii) polyclonal antibodies. Monoclonal antibodies are often used when the
measurement of a very specific analyte is desired, while polyclonal antibodies exhibit
less specificity. Specificity of monoclonal antibodies makes them extremely efficient
for binding within complex matrices. On the other hand, polyclonal antibodies often
recognize multiple epitopes, making them more tolerant to small changes in the
nature of the antigen. Due to the complex nature of biological systems, the specific
binding abilities of antibodies make them one of the most powerful biorecognition
molecules to be used for constructing nanosensors [19].
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The use of antibodies as biorecognition molecules on optical nanosensors for
measuring apoptosis proteins was performed using the direct and indirect
immunoassay formats respectively. The simpler of the two assay formats is the direct
immunoassay format, which is most compatible when working with molecules that
have intrinsic fluorescent properties. The main advantage of this format is that there is
no need to label the interactants. The working principle of the direct immunoassay
format, involves binding the target biomolecule to immobilized primary antibody, at
which time an optical property e.g., fluorescence intensity, of the target molecule is
measured. The direct immunoassay format is not applicable in cases where an optical
property of a target molecule cannot be measured or is not intrinsically fluorescent
[26], presenting a challenge and limitation. In such cases, this limitation can be
overcome by using the indirect immunoassay format. This immunoassay format is
straightforward and involves a capture antibody and a labeled reporter antibody,
which bind to the non-fluorescent target molecule forming a sandwich type structure
assay. After the sandwich type structure or secondary immunocomplex is formed, the
fluorophore on the reporter antibody can be excited and detected. Typically, the
fluorescent signal produced is representative of the binding event. Therefore, the
indirect immunoassay format enables the measurement of biomolecules that are not
intrinsically fluorescent and in a way makes it possible to study biomolecules in
significant biochemical pathways such as apoptosis [19].
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4.3 Apoptosis
Apoptosis or programmed cell death (PCD) is a highly ordered, genetically
controlled process that plays a fundamental role in both normal biological processes
and disease states. Apoptosis is a combination of the Greek words apo, off, and
ptosis, falling) or programmed cell death, is an orderly and genetically controlled
form of cell death defined distinct morphological and biochemical features. It usually
affects single cells or small groups of cells in an asynchronous fashion. Apoptosis
consist of four key phases [85];
•

The Initiation Phase

•

Decision Phase

•

The Committed or Effector phase

•

The Cellular Degradation Phase

4.3.1 The Initiation Phase
The molecular pathway includes an initiation phase, which starts after
signaling by internal triggers, (a) increases in intracellular Ca2+ (b) activation of
protein kinases A and C (c) increases in protein synthesis C, changes in gene
regulation (d). external triggers such as (a) ligation to distinct receptors or (b).
endogenous mechanisms related to aging or to exogenous irreversible cellular or
nuclear damage.
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4.3.2 The Decision Phase
During the decision phase transduction occurs of the apoptotic signal to
nuclear and cytoplasmic target enzymes, which includes activation of endonucleases
and enzymatic alterations of the cytoskeleton. There are numerous proteins and lipidderived moieties that modulate the apoptotic mechanism in positive or negative
direction.

4.3.3 The Committed or Effector Phase
The committed or effector phase is started when the cell has arrived at a stage
of no return. The nuclear DNA is cleaved in multiples of 180-200 base pairs, the
plasma membrane, integrity and the mitochondria remain initially intact, the cell
splits up into apoptotic bodies, small vesicles which enclose the nuclear and cellular
remnants.

4.3.4 The Cellular Degradation Phase
The cellular degradation phase is arrived, when the apoptotic bodies are
phagocytosed by adjacent cells and macrophages. It is thought that the
pharmacodynamics of anticancer drugs consists of two distinct steps. The first step
includes the interaction with its cellular target; which is not lethal per se. The
commitment of the cell to undergo apoptosis forms the second step. The efficacy of
anticancer drugs is determined by the ability to selectively sensitize tumor cells to
apoptosis.
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4.4 The Importance of Measuring Apoptosis
Specific morphological and biochemical features characterize apoptosis. It is a
normal and abnormal component of the development and health of multi-cellular
organisms. Cells die in response to a variety of stimuli and during apoptosis, they do
so in a controlled, regulated fashion. This makes apoptosis distinct from another form
of cell death called necrosis in which uncontrolled cell death leads to lysis of cells,
inflammatory responses and, potentially, to serious health problems. Apoptosis, by
contrast, is a process in which cells play an active role in their own death, which is
why apoptosis is often referred to as cell suicide.
Over the past decade, the importance of apoptosis has been appreciated, and it
is now thought to be the main mode of cell death in liver diseases, neuronal cell death
in neurodegenerative disease (e.g., Alzheimer’s disease). Apoptosis has been found to
have a role in one mechanism leading neuronal cell death associated with Alzheimer's
disease and in liver disease. On the other hand, the loss of ability of cells to undergo
apoptosis is one of the causes of uncontrollable cell growth leading to cancer. Tumor
growth is determined not only by increased cell division, but also by decreased
tumor-cell attrition. Therefore most, if not all, cancer cells acquire resistance to the
various mechanisms that lead to apoptosis [86, 87].

4.5 Apoptosis Pathways
There are three major apoptosis pathways:
•

Mitochondrial Pathway
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•

Death Receptor Pathway

•

Endoplasmic Reticulum Pathway

The first, Mitochondria Pathway is triggered when mitochondria are irreversibly
damaged. It is mediated by mitochondria, which release apoptogenic proteins, mainly
cytochrome c. Cytochrome c once released into the cytosol binds to a cytosolic
protein apoptotic protease-activating factor (Apaf-1) and this complex in the presence
of dATP or ATP facilitates activation of caspase-9, which in turn activates
downstream caspases [88, 89]
The Death Receptor Pathway triggered by the binding of extracellular ligand,
tumor necrosis factor alpha (TNF-α), Lymphotoxin, Fas ligand (FasL) to their cell
surface receptors leading to caspase-8 activation [90].
The third pathway is initiated by Endoplasmic Reticulum (ER) stress (due to
depletion of ER calcium or accumulation of unfolded proteins) and causes activation
of caspase-12 [91], which recently has been shown to activate caspase-9 [92]. It is
unclear whether this pathway may operate in human cells because a human
homologue of murine caspase-12 has not been found.

4.5.1 Mitochondrial Pathway of Apoptosis
This work is focuses on the mitochondrial pathway of apoptosis (Figure 4.1)
because it is through this apoptosis pathway that the effects of chemotherapeutic and
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Figure 4.1 shows the Mitochondria Pathway of Apoptosis which is triggered
when mitochondria are irreversibly damaged. It is mediated by mitochondria, which
release apoptosis proteins, cytochrome c into the cytosol. Once released into the
cytosol, cytochrome c binds to a cytosolic protein apoptotic protease-activating factor
(Apaf-1) and this complex in the presence of dATP or ATP facilitates activation of
caspase-9, which in turn activates downstream caspases such as caspase-7
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photodynamic therapy (PDT) drugs are realized. The mitochondrial pathway of
apoptosis can be activated by a variety of agents including PDT drugs or
photosensitizers

e.g.,

ALA,

reactive

oxygen

species

e.g.,

H2O2,

and

certainchemotherapy drugs e.g., Tamoxifen. These therapeutic agents cause
mitochondrial damage, which results in lowering of mitochondrial membrane
potential and subsequently altered membrane permeability leading to the release of
cytochrome-c form intermembrane space of mitochondria. Cytochrome c binds to
apoptosis protease activating factor –1 (Apaf-1) and caspase-9, in the process
activating capse-9. Activated caspase-9 cleaves either caspase-3 or caspase-7
resulting in downstream events involved in cell death [93]. Caspase-9, caspase-7 and
caspase-3 are Cysteine aspartate-specific proteases (Caspases) involved in highly
specific proteolytic cleavage events in dying cells. Caspases are specialized cysteinedependent proteases that cleave major structural proteins of the cytoplasm and
nucleus [93] and activation of caspases is often considered a key biochemical
hallmark of apoptosis.
In normal healthy cells caspases exist as poorly active or inactive zymogens
that can be activated by autocleavage or processing by other proteases. Mitochondria
contain both the pro-caspase-9 and comparatively little of the processed, mature form
of caspase-9 and cytochrome c. Upon the induction of apoptosis, cytochrome c is
exported from the mitochondria to the cytoplasm and mitochondrial pro-caspase-9
translocates to the cytosol and to the nucleus. Mitochondria also release mature

119

caspase-9 upon induction of permeability transition in vitro. Cytochrome c and
caspase-9 appear to be equally and functionally important initiators of the apoptosis.

4.5.2 Cytochrome c
Cytochrome c is a protein that is important to the process of creating cellular
energy, the main function of mitochondria. Cytochrome c is an essential component
of the mitochondrial respiratory chain. It is a 15KDa soluble protein, localized in the
intermembrane space and loosely attached to the surface of the inner mitochondrial
membrane. In response to a variety of apoptosis-inducing agents, cytochrome c is
released from mitochondria to the cytosol [94]. When mitochondria are damaged,
cytochrome c is released into the main body of the cell, and if the cell itself is
damaged, into the surrounding tissue. The release of cytochrome c is part of the
cascade of cellular events that lead to apoptosis, or programmed cell death. Apoptosis
is triggered by the genes a cell carries, and differs from necrosis, cell death from
catastrophic outside forces. When some trigger sets off the cycle that leads to
apoptosis, cytochrome c appears outside the mitochondria within one hour.
Cytochrome c is not a factor in necrosis. Cytochrome c release from mitochondrion is
indicative of apoptosis and can be used as evidence that apoptosis is occurring [95].

4.5.3 Caspase-9
Caspase-9 is one of the most important cysteinyl aspartate specific protease
(caspase) among the caspase family members. Caspase-9 is synthesized as inactive
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pro-enzyme that is processed in cells undergoing apoptosis. The processed form
consists of large (35Kda) and small (11Kda) subunits. Antibody can detect the 35Kda
protein corresponding to the large subunit. Caspase-9 is thought to trigger a caspasecascade leading to apoptosis [96]. As a result of mitochondrial membrane
permeabilization, which may set the point-of-no-return of the death process [97, 98]
caspase activators including cytochrome c and caspase-9, are released from the
mitochondria intermembrane space into the cytosol. Cytochrome c release triggers the
assembly of the cytochrome c/ Apaf-A/ pro-caspase-9 activation complex, the
apoptosome [99, 100], moreover, caspases-9 is processed in response to cytochrome
c.

4.6 Photodynamic Therapy (PDT)
Because the focus of this work is the mitochondrial pathway of apoptosis, the
PDT agent or photosensitizer ALA was used to induce apoptosis. PDT is a treatment
modality for various cancers and other diseases associated with selective
accumulation or production of photosensitizers in diseased tissue and cells [101].
PDT induces apoptosis in human carcinoma cells (MCF-7 cells) when the combined
administration of a photosensitizer followed by its activation by light of the
appropriate wavelength is used [102]. Photodamage to mitochondria caused by the
production of reactive oxygen species from the reaction of PDT agents and light
results in immediate loss of mitochondrial membrane potential together with the
release of cytochrome c into the cytosol. This is followed by a rapid activation of
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caspases [103]. Figure 4.2 shows a diagrammatic representation outlining the PDT
process while the photophysics PDT sensitization. The photosensitizer possesses an
absorption maximum at a wavelength corresponding with that of the incident laser
light, and shining light on the photosensitizer causes excitation to the singlet excited
state (1P*). The singlet excited photosensitizer can decay back to the ground state
with release of energy in the form of fluorescence - enabling identification of tumor
tissue. If the singlet state lifetime is suitable (and this is true for many
photosensitizers) it is possible for the singlet to be converted into the triplet excited
state (3P*) which is able to transfer energy to another triplet. One of the very few
molecules with a triplet ground state is oxygen, which is found in most cells. Energy
transfer therefore takes place to afford highly toxic singlet oxygen (1O2) from ground
state oxygen (3O2), provided the energy of the 3P* molecule is higher than that of the
product 1O2. As a result, the reactive oxygen species produced destroys cancer cells.

4.6.1 Photodynamic Therapy Agents or Photosensitizers: δ-Aminolevulinic Acid
Photodynamic therapy agents or photosensitizers are chemical substances or
medications that increase the sensitivity of cells, tissues or organs to irradiation by
optical radiation. Photosensitizers used for PDT are capable of inducing cancer cell
death through apoptosis. Cancer cells are injured by the photosensitizing action of the
PDT agent and cell death results from activation of the internal constituents of the
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Figure 4.2 (i) shows the photodynamic therapy process leading up to
apoptosis. A photosensitizing agent or dye (D) is exposed to light of a particular
wavelength for activation. The excited form of the dye (D*) transfers the energy
acquired from excitation light to molecular oxygen forming oxygen radicals that
causes oxidative damage to cancer cells ultimately destroying them. (ii) shows a
simplified Jablonski diagram of the photophysics of photosensitization (vibrational
levels omitted).
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apoptosis machinery [104]. The photosensitizer used to induce the mitochondrial
pathway of apoptosis is δ-Aminolevulinic (ALA). The photosensitizer ALA is a
precursor of protoporphyrin IX (PpIX) [105]. ALA is converted into PpIX by cells,
which can then be activated by blue or red light [102]. Following light activation,
PpIX is excited to a high-energy triplet state that can transfer its energy to molecular
oxygen to form highly reactive oxygen species [106]. Reactive oxygen species can
induce a number of biological processes including apoptosis [107, 108]. ALA
induced PpIX causes mitochondrial damage and induce apoptosis through release of
cytochrome c and caspase-9 though, some cells, may survive PDT [109]. The
consequence of cytochrome c release is the activation of a series of proteases known
as caspases. The caspase cascade commences with the cleavage of procaspase-9.
Apoptosis has been shown to occur following ALA administration and
photoactivation in pancreatic carcinoma cells [110], V79 Chinese hamster fibroblast
cells, [111], colonic adenocarcinoma cells [111] and MCF-7 cells[112]. ALA
generates signals to the mitochondria that induce the release of cytochrome c [113].
Following its release from the mitochondria, cytochrome c activates the initiator
procaspase-9 producing the activated form, caspase-9, which in turn activates other
effector caspases such as caspae-7 and caspase-3. ALA-PDT induces rapid apoptosis
as early as 2-3 hours after light exposure. This observation and the known localization
of PpIX to the mitochondria following incubation with ALA suggests that ALA-PDT
induces apoptosis by disrupting the mitochondrial transmembrane potential followed
by cytochrome C and subsequent induction of caspases [114].
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4.7 Human Mammary Adenocarcinoma Cells: MCF-7 cells
For this work, the human mammary adenocarcinoma cell line, MCF-7 was
used. MCF-7 is a tumorigenic cell line (American Type Culture Collection (ATCC),
Rockford, MD), derived from human breast tumor. These cell are self-adherent and
amendable to manipulation. These cells are maintained as monolayers and are
commonly used to study apoptosis in breast cancer cells. MCF7 cells are significant
because they are known to cause breast cancer in 8-10 percent of the female
population in the US. Breast cancer is the most common malignancy and the most
frequent cause of cancer related death among women (Cancer Facts & Figures- 2001,
American Cancer Society (ACS). The MCF7 cells are also one of the most commonly
used cells for breast cancer research, are well characterized, and have been found to
be tumorigenic in nude mice. In addition, the initiation of apoptosis in MCF-7 cells
has been reported using photosensitizers in combination with laser irradiation doses
[115]. Another reason for opting to work with MCF-7 cells is that some have been
found to lose their ability to bind chemotherapeutic agents such as tamoxifen [116]. It
is also important to look for alternative forms of inducing apoptosis tat can lead to the
discovery and development of new therapies to treat cancer cells that have developed
resistance to chemotherapy drugs.
Induction of apoptosis by photosensitizers has been previously examined
using MCF-7 cells, which have been reported to extensively release large amounts of
cytochrome c and subsequently activate caspase-9 2-3h after exposure to ALA and
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photoactivation. It has been shown the response to photosensitizer-induced apoptosis
in MCF-7 cells is due to activation of the caspase cascade downstream of cytochrome
c release [117].
MCF-7 cells are self-adherent and usually for adherent cells, mechanical
stresses applied to cells, such as scraping them from the surface or using trypsinEDTA, can trigger a variety of cellular responses. Additionally, most cells express
abundant adhesion proteins that provide a structural link between the cytoskeleton
and extracellular surfaces (extra cellular matrix). Forces applied to remove cells can
trigger immediate and long-term changes in cellular physiology. For adherent cells,
mechanical manipulation prior to the time of sampling can interfere with
measurements of cellular biochemistry. If perturbations occur before sampling,
substantial changes in the physiology of the cell can occur for instance changes in ion
concentration or enzyme activation, especially enzymes that are normally confined to
cellular sub-compartments. For example proteases often escape from damaged
lysosomes and once in the cytosol, the proteases cleave inappropriate targets, i.e.,
proteins or peptides to which they normally do not have access. In addition
compartmentalized enzymes that released into the cytoplasm may have sufficient time
to encounter and modify inappropriate substrates [118]. Spatial localization of
proteins particularly enzymes has been identified as a mechanism to regulate the flow
of information through signaling cascades in cells [119]. The absence of manipulation
prior to performing cell measurements results in minimal effects on the cell [8]. For
this reason, the ability to perform minimally invasive measurements within intact
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single living cells with temporal and spatial resolution is important for the analysis of
a cell as a system. Optical nanosensors can perform such measurements and reveal
the intricacies of biochemical pathways in intact living cells.

4.7.1 Cell Culture: Maintaining and Propagating MCF-7 Cells
MCF-7 cells obtained from American Type Culture Collection (Rockville,
MD, USA, Cat-no. HTB22) were cultured as monolayers in T-25 plastic tissue
culture flask. Cells were maintained in Dulbecco's minimally essential media
(DMEM) with phenol red, supplemented with 10% fetal calf serum, 1% L-glutamine,
3.5 g/l glucose, and 1% penicillin and streptomycin, and incubated at 37 oC in
humidified air with 5% CO2. MCF-7 cells were routinely monitored under a phase
contrast microscope until they achieved confluency (80-90%) to warrant propagation.
MCF-7 cells were split and propagated every 3-5 days. The process involves
emptying the culture medium from the respective T-25 tissue culture flasks, rinsing
with 5ml PBS and then gently resuspending the cells in the T-25 flask surface using
trypsin (sterile process). The proteolytic enzyme trypsin was brought to room
temperature and a 1ml was pipetted into each of the T-25 culture flasks. The trypsin
was left to sit in flasks for about 3-5 minutes at 37oC giving sufficient time for the
trypsin to detach the adherent MCF-7 cells from the base of the tissue culture flask.
After the 3-5 minute period expired, the cells are briefly visualized under the inverted
phase contrast microscope to ensure the cells are fully detached. At this point the cells
appear circular in shape. Into each of the flasks, 5ml of DMEM is pipetted to
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neutralize the action of trypsin. From the total 6 ml of each tissue culture flask,
0.25ml is transferred into two T-25 tissue culture flasks, each containing 5 ml. The
cells are then incubated at 37oC, 5% CO2 and 86% humidity. The cells were
examined daily using the inverted phase contrast microscope to determine the degree
of confluency. The DMEM medium should appear red as a result of phenol red. In
cases where DMEM turns yellow before achieving at least 75% confluency, the
acidic medium is replaced with fresh DMEM. After 3-5 days the cells are split and
propagated. Some of the cells are harvested and preserved at –70oC for future use.
Freezing can be lethal to the cells due to the effects of damage by ice crystals,
dehydration, alterations in concentration of analytes and changes in pH. To minimize
the effects of freezing, the cryoprotective agent DMSO is used. The freezing medium
consists of 90% DMEM and 10% DMSO.

4.8 Experimental Protocol
As stated previously, the objective of this project is to use optical nanosensor
based on evanescent fluorescence to measure apoptosis in single living cells by
monitoring cytochrome c and caspase-9. Prior to measuring cytochrome c and
caspase-9, preliminary experiments were performed to determine the photocytoxicity
of ALA and to confirm if ALA induced the mitochondrial pathway of apoptosis.
After completing the preliminary studies, experiments were performed whereby
apoptosis was induced using ALA and both cytochrome c and caspase-9 were
detected and identified using the antibody-based optical nanosensor. These
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experiments were first performed in vitro and second, pseudo in vivo using the
sandwich immunoassay format. The in vitro measurement were performed in
cytosolic cell extract while the pseudo in vivo measurements were performed in the
following way; the optical nanosensors with capture antibody were incubated in
single cells, withdrawn and then incubated in a solution containing labeled reporter
antibody. For both measurement formats, evanescent optical waves generated in the
near field of the optical nanosensor were used to excite the fluorophore labeled
reporter antibody after secondary immunocomplex formation. The fluorescent signal
generated was recorded and is representative of the binding events.

4.8.1 Photocytotoxicity Study
The cellular events occurring after mitochondria receive the apoptotic signal,
involve the mitochondrial outer membrane becoming permeable (lowering of
mitochondrial membrane potential) to cytochrome c, which is translocated from
mitochondria to the cytosol. Once released into the cytosol, cytochrome c activates
downstream caspases, leading to the rapid disintegration of the cell [88]. The
objective of this study was to explore the in vitro photosensitizing potential of ALA
generated PpIX and its capacity to induce apoptosis in human mammary carcinoma
cells, MCF-7. The photosensitizing process involves the combination of light and
light sensitive ALA, in an oxygen-rich environment. ALA absorbs energy from
photons and transfers this energy to surrounding oxygen molecules. This leads to the
formation of toxic oxygen species such as singlet oxygen and free radicals. These are
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very reactive and can damage proteins, lipids, nucleic acids and other cellular
components leading to cell death. MCF-7 cells were incubated with ALA for two
hours followed by exposure to 11 J cm–2 of visible light from a HeNe laser.
Photocytotoxicity was assessed at 24 hours, 48 hours, 72 hours, and 96 hours using a
coulter counter to perform dead cell count assay.

4.8.2 Experimental Procedure: Photocytotoxicity Study of ALA
MCF-7 cells were grown in Dulbecco's Modified Eagle's Medium ((DMEM)
(Mediatech, Inc., Herndon, VA)) supplemented with 1 mM L-Glutamine (Gibco,
Grand Island, NY) and 10% fetal bovine serum (Gibco, Grand Island, NY). Baseline
static culture productivity for each cell line was established in growth medium
(described above) in standard T25 flasks (Corning, Corning, NY). The flasks were
incubated at 37°C, 5% CO2 and 86% humidity. Cell growth was monitored daily by
microscopic observation until a 75% state of confluence was achieved. The growth
conditions were chosen so that the cells would be in log phase growth during
photosensitizer treatment. The cells were harvested from the T25 flasks and 0.25ml
(4.0 x 105 cells/ ml) seeded into T-75 flasks. From a 1mM stock solution of δaminolevulinic acid, 0.5mM [120] solutions was prepared by adding the δaminolevulinic acid, solution in DMEM. The prepared solutions were added to
multiple T-25 culture flasks of the experimental group and treated control group left
in contact with the cells for a 2-3-hour incubation period. Following incubation of the
MCF-7 cells with δ-aminolevulinic acid; the medium containing δ-aminolevulinic
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acid was replaced with fresh DMEM. The ALA taken up by the MCF-7 cells was
activated using 632.8 nm HeNe laser. Photocytotoxicity was assessed 24 hours, 48
hours, 72 hours, 96 hours and 120 hours using dead cell count assay.

4.8.3 Experimental Section
The photocytotoxicity test was performed to determine the effect of the
photosensitizer ALA on cell growth. This was accomplished by performing a series
of tests were performed whereby MCF-7 cells were exposed to the following
experimental conditions; Group I MCF-7 cells were incubated in the dark at 37°C
with 0.5 mM ALA in DMEM for 2-3 hours followed by exposure to 632.8 nm red
light from a HeNe laser at (2.22 J/cm2) in DMEM with 10% FCS. To determine the
influence of light on MCF-7 cells, Group II were incubated with 0.5 mM ALA in
DMEM for 2-3 hours, exposed to red light from a HeNe laser at (2.22 J/cm2). To
determine the influence of ALA on MCF-7 cells, Group III MCF-7 cells were
incubated in the dark at 37°C with 0.5 mM ALA in DMEM for 2-3 hours. Group IV,
MCF-7 cells were incubated in the dark at 37°C without ALA and were not exposed
to 632.8 nm red light from a HeNe laser. All procedures after addition of ALA were
performed in the dark. For statistical significance, five T-25 flasks were used for each
treatment group The dead cell count data obtained using the coulter counter were
compared for Groups I – IV. Typically, dead MCF-7 cells detach from the base of
tissue culture flasks and remain suspended in growth medium because, when they die,
they lose their self-adherence capability. Therefore, after administering the various
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cell treatments, cells in the experimental groups die and lose their capability for selfadherence. The media containing un-bound MCF-7 cells are passed through a G20
syringe to generate a single cell suspension. Fresh growth media is introduced into the
tissue culture flasks after aspirating un-bound cells to be counted. Cell mortality was
compared for Groups I - IV and expressed as the effect of the different forms of
treatment they received. To statistically validate the dead cell count results obtained
from the replicate experiments performed, a student t-test was performed.

4.9 Student’s t-test
As mentioned above, the dead cell count was obtained routinely at set time
points on successive days from the flasks with the treatment Groups I - IV. Each
treatment was performed in replicate to statistically validate the outcome. As
mentioned previously, in order to validate the results obtained from Groups I – IV, of
the photocytotoxicity study a student’s t-test was performed. The t-test was used to
determine if the results of Groups I -IV differ on a single variable, photodynamic
treatment. This study was used to determine whether cell death differs among cells
exposed to different experimental treatment regiments of ALA-PDT. Here, it was
particularly useful in analyzing scores of Groups I – IV on the particular variable,
ALA-PDT. The null hypothesis (H0) was stated based on the assumption that there is
no difference in parameters (mean, variance) for Groups I – IV. According to the null
hypothesis, any observed difference in samples is due to chance or sampling error and
not the variable ALA-PDT.
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The software application program, MS Excel was used to calculate the pvalues of the t-tests and determine the significance of the results. Data points obtained
from Groups I – IV acquired using LabView data acquisition program were converted
using MS Excel Text Wizard to obtain a data format compatible with the MS Excel
interface. The type of t-test used was two sample unequal variance and a 2-tailed
distribution with a threshold of 0.05 (5%). This means that if the p-value is less than
0.05, then the null hypothesis is rejected and it can be stated with a 95% level of
confidence that the two parameters are not the same. The calculated p-value is
compared with the desired significance level set for the t-test and, if it is smaller, the
result is significant. That is, if the null hypothesis will be rejected at the 5%
significance level, and this is reported as "p < 0.05".

4.10 Results and Discussion: Photocytotoxicity Study
The aim of the photocytoxicity study of ALA was to determine the effect of
ALA on MCF-7 cells. The outcome of the treatments administered, Groups I – IV
were determined by dead cell count using a coulter counter. These results were
plotted and are shown in Figure 4.3. The outcome of the photocytotoxicity study
revealed that in the first five days following treatment, cell death was observed only
in the experimental treatment Group I, ALA(+) PDT(+). Increasing cell death is
evident from the graph peaking on day three. However, from the dead cell count
results obtained for Group II -ALA(+) PDT(-), Group III -ALA(-) PDT(+) and Group
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Figure 4.3 shows the results of the dead cell count assay. On five successive
days, three T-25 flasks were obtained from the incubator and the unbound (dead)
MCF-7 cells counted. Each bar shows the average MCF-7 cells obtained and counted
from three T-25 flasks. The calculated p-values for the students t-test are 0.039972,
0.039906, 0.039914 (ALL p<0.05). These p-value results obtained from the student-t
test indicate that (+)ALA(+)PDT treatment significantly affects MCF-7 cell
proliferation compared to (+)ALA(-)PDT, (-)ALA(+)PDT and (-)ALA(-)PDT. The
error bars represent 95% confidence interval (CI).
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IV -ALA(-) PDT(-), there was no significant increase cell mortality. Using the t-test,
it was confirmed that the results of Groups I -IV differ on the single variable,
photodynamic treatment. The calculated p-values determine the null hypothesis is
unlikely to be true. It indicates the strength of evidence for rejecting the null
hypothesis rather than simple concluding that apoptosis is a concerted effect of ALA
and photoactivation. The finding that apoptosis is a concerted effect of ALA and
photoactivation achieved statistical significance as shown by the results obtained
using the t-test. The calculated p-values of students t-test were 0.039972, 0.039906,
0.039914 (p<0.05). These p-value results obtained from the student-t test indicate that
(+)ALA(+)PDT significantly affect MCF-7 cell proliferation compared to (+)ALA()PDT, (-)ALA(+)PDT and (-)ALA(-)PDT. In summary, no photocytotoxicity was
observed for either laser irradiation without ALA, or ALA without laser radiation, but
cell death was observed and determined for the combination of ALA and laser
radiation. Additionally, Groups II and III, ALA(+) PDT(-) and ALA(-) PDT(+) reveal
the absence of dark and light toxicity. Therefore, it can be concluded that incubation
of MCF-7 cells with 0.5 mM ALA for 3 h and subsequent photoactivation with light
from a HeNe laser results in a significant increase in cell death compared with Groups
II – IV.

4.11 In Vitro and Pseudo In Vivo Measurement of Apoptosis
Optical nanosensors based on evanescent fluorescence sandwich type
immunoassay were developed and used for the in vitro and pseudo in-vivo analysis of
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cytochrome c and caspase-9. In vitro analysis of cytochrome c and caspase-9 was
performed using cytosolic cell extract. However, pseudo-in vivo analysis involves
probing a single cell with antibody-based optical nanosensor and then withdrawing
the optical nanosensor from within the cell and incubating it with Cy5 labeled
reporter antibody. The two measurement schemes employ the indirect immunoassay
technique that involves using primary (capture) and dye conjugated secondary
(reporter) antibody. The distinction of the two techniques lies in the first step of
binding the target molecule with capture antibody. The pseudo in vivo technique
involves incubating optical nanosensor in single living cells and then incubating the
optical nanosensors with Cy5 labeled reporter antibody solution in a microfuge tubes.
Based on the previous photocytotoxicity study, two groups were used for in vitro and
pseudo in vivo studies: Group I, control group of cells PDT(-) ALA(-), and Group II,
experimental group of cells PDT(+) ALA(+). For these studies, cytochrome c and
caspase-9 antibody were immobilized on optical nanosensors to bind cytochrome c
and caspase-9 respectively. Optical nanosensors were then incubated in the cytosolic
cell extract obtained from Group I, (+)ALA (+)PDT, and Group II, (-)ALA (-)PDT.
This was be followed by binding Cy5 labeled reporter antibody which facilitates the
fluorescence detection of the secondary immunocomplex formed after excitation
using a 632.8 nm HeNe laser. The fluorescence signals generated are detected using a
PMT, and acquired and processed using LabView.
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4.11.1Materials and Methods
Plastic clad silica (PCS) fibers with a 600-µm-size core (Fiberguide
Industries, Stirling, New Jersey). Indirect immunoassay capture and reporter antibody
for cytochrome c and caspase-9 measurement, cytochrome c (Ab-3): capture Ab,
cytochrome c (Ab-4): reporter Ab, caspase-9 (Ab-1): capture Ab, caspase-9 (Ab-2):
reporter Ab were purchased from purchased from Santa Cruz Biotechnology, Santa
Cruz, CA.

4.11.2 Cytosolic Cell Extraction (Cell Fractionation Protocol)
MCF-7 cells were grown to 70–80% confluency and exposed to 0.5mM ALA
to induce apoptosis. Concurrently control groups of MCF-7 cells were cultured
without induction. Cytosolic protein was extracted as described Tikkanen et al. [121].
Briefly, cells were rinsed in calcium- and magnesium-free Hanks’ balanced salt
solution and lifted with 3mM EDTA. Detached cells were rinsed and collected by
centrifugation at 3000 RPM for 5 minutes at 4oC and washed in ice cold PBS. The
cells were centrifuged again at 3000 RPM for 5 minutes at 4oC and the supernatant
removed. The cells were then lysed in hypotonic buffer containing 10 mM Tris-Cl,
pH 7.5, 1 mM EDTA, 1 mM DTT, 0.5 mM 4-(2-aminoethyl) benzenesulfonyl
fluoride, 10 mM leupeptin, 2 µg/ml aprotinin, and 4 µM pepstatin and incubated on
ice for 10 minutes. The cells were immediately centrifuged at 3000 rpm for 10 min at
4 °C and the supernatant was collected as cytosol.
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4.11.3 Fluorescent Measurement System and Procedure
Figure 4.4 shows a schematic representation of the fluorescence measurement
system. The 632.8 nm laser line of a HeNe laser (Melles Griot, <15mW laser power)
was focused onto a 600-µm-delivery fiber that is terminated with a subminiature A
(SMA) connector. The antibody-immobilized nanosensor was coupled to the delivery
fiber through the SMA connector and secured to the microscope with
micromanipulators. The fluorescence emitted from the tip of the nanosensor was
collected by the microscope objective and passed through a Cy5 long pass filter
(Chroma, Brattleboro, VT) and then focused onto a PMT for detection. The output
from the PMT was recorded using a universal counter, and a personal computer (PC)
with custom-designed software (LabView platform) for data treatment and
processing. The experimental setup used to probe single cells was adapted to this
purpose

from

a

standard

micromanipulation/microinjection

apparatus.

The

micromanipulation equipment used consisted of MN-2 (Narishige Co. Ltd., Tokyo,
Japan) Narishige three-dimensional manipulators for coarse adjustment, and
Narishige MMW-23 three-dimensional hydraulic micromanipulators for final
movements. The optical fiber nanosensor was mounted on a micropipette holder
(World Precision Instruments, Inc., Sarasota, FL). To record the fluorescence of Cy5
labeled secondary immunocomplex, a Hamamatsu PMT detector assembly (HC1252) was mounted in the front port of the Diaphot 300 microscope.
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Figure 4.4 shows a diagrammatic representation of the Laser-induced fluorescence
measurement system
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The fluorescence emitted when Cy5 fluoresced was collected using the optical
configuration in the inverted fluorescent microscope and delivered to a PMT mounted
on the frontal port. The fluorescent signal detected was converted to a measurable
electrical signal and transmitted to a PC for data acquisition and processing.

4.11.4 In Vitro Measurement of Apoptosis using Cytosolic Cell Extract
The functionalized tips of the nanosensor were divided into Group I, (+)ALA
(+)PDT, and Group II, (-)ALA (-)PDT, corresponding to the treatment groups and the
measurements performed in replicate. The nanotips were immersed in solutions of
capture antibody, cytochrome c (Ab-3) and caspase-9 (Ab-1) respectively, and
allowed to incubate for 12 hours at 4oC. The nanosensors were then inserted into
microfuge tubes containing cytosolic cell extract in PBS and incubated for 5-10
minutes. The microfuge tubes contained cell lysates from both Group I, (+)ALA
(+)PDT, and Group II, (-)ALA (-)PDT. Finally, the nanosensors were incubated in
microfuge tubes containing either Cy5 labeled cytochrome c (Ab-4) reporter antibody
or Cy5 labeled caspase-9 (Ab-2) reporter antibody 30 minutes. The nanosensors were
sequentially secured onto an x-y-z micromanipulator mounted on an inverted
fluorescence microscope (Figure 4.5). Using the microscope eyepiece for observation
the nanosensor was positioned using an x-y-z micromanipulator to within the field of
view and the excitation source tuned on. The Cy5 labeled reporter antibody is excited
using evanescent optical waves and the fluorescence signal generated is collected
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Figure 4.5 shows an image of Nikon Inverted fluorescence microscope, the
main component of the laser-induced fluorescence measurement system. Red (LEFT
and RIGHT) arrows point to the fine x-y-z micromanipulator mounted on the inverted
fluorescence microscope. Yellow (LEFT and RIGHT) arrows point to the coarse x-yz micromanipulator. The white arrow points to the plexiglass incubator. Orange
(LEFT) arrow points to the optical nanosensor. Green (RIGHT) arrow points to the
petri dish with cells
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using the fluorescence microscope optics, and detected with a PMT and recorded.
Figure 4.6 shows a diagrammatic representation of the fluorescence excitation and
detection process.

4.11.5 Results of In Vitro Studies using Cytosolic Cell Extract
Figure 4.7 shows the results. The first bar represents the averaged results of
Group II while the second bar represents the averaged results of Group I. In the case
of Group II, it is evident that secondary immunocomplex formation did not occur
because Cy5 fluorescence was not detected and thus it can be said that apoptosis was
not induced. For Group I, secondary immunocomplex formation was evident by the
detection of Cy5 fluorescence. These results (Figure 4.11) indicate that positive
detection and identification of cytochrome c and caspase-9.

4.11.6 Pseudo In Vivo Measurement of Apoptosis
The functionalized nanotips were used for experimental and control
measurements, which were performed in replicates. The nanotips were incubated in
solutions of capture antibody, cytochrome c (Ab-3) and caspase-9 (Ab-1)
respectively, and allowed to incubate for 12 hours at 4oC. The nanosensors were
inserted into single live MCF-7 cells (Figure 4.8) and incubated for 5-10 minutes. The
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Figure 4.6 shows a schematic representation of the components of the laserinduced fluorescence measurement system and outlining the fluorescence excitation
and detection process
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Figure 4.7 shows the collective mean results of the in vitro measurement of
cytochrome c and caspase-9, including the background signal (scattered room light)
and with the detector off. Each bar represents the mean of replicate measurements
with the error bars represent 95% confidence interval (CI).
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(i)

(ii)

Figure 4.8 shows the intracellular measurement of apoptosis in a single MCF-7 cell.
The top image (i) shows an optical nanosensor prior to insertion and a single MCF-7
cell while the BOTTOM image (ii) shows the optical nanosensor inserted into the
MCF-7 cell.
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MCF-7 cells used were from both the experimental (apoptosis induced) and control
(without apoptosis induction) study groups. Finally, the nanosensors were incubated
in microfuge tubes containing either Cy5 labeled cytochrome c (Ab-4) reporter
antibody or Cy5 labeled caspase-9 (Ab-2) reporter antibody 30 minutes. The
nanosensors were sequentially secured onto an x-y-z micromanipulator mounted on
an inverted fluorescence microscope. Using the microscope eyepiece for observation,
the nanosensor was positioned using an x-y-z micromanipulator to within the field of
view and the excitation source tuned on. The Cy5 labeled reporter antibody is excited
using evanescent optical waves and the fluorescence signal generated is collected
using the optical configuration of the fluorescence microscope and detected with a
PMT.

4.11.7 Results for Pseudo In Vivo Measurement of Apoptosis
Figure 4.9 shows the comprehensive results of the measurement of
cytochrome c and caspase-9 obtained using the pseudo in vivo measurement
technique. The results are represent averages obtained from a series of replicate
measurements performed. As can be seen from the results obtained from the control
cells (-)ALA (-)PDT and experimental cells, (+)ALA (+)PDT, there is no significant
increase in the fluorescence signal obtained for the experimental cells therefore
confounding the in vivo detection and identification of cytochrome c and caspase-9.
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Figure 4.9 shows the results obtained for pseudo in vivo measurement of
apoptosis. Each bar represents the mean of replicate measurements with the error bars
represent 95% confidence interval (CI).
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In this case, the pseudo in vivo immunoassay technique did not facilitate the detection
of secondary immunocomplex formation of either cytochrome c or caspse-9,
suggesting that secondary antibody binding was unsuccessful. The results revealed
that secondary immunocomplex formation did not occur and therefore the inability to
detect Cy5 fluorescence that would have been emitted if the reporter antibody was
bound. This suggests one of two possible scenarios. One, the physical action of
withdrawing the optical nanosensors from within the cells after incubation could have
disrupted the structural stability of the bound target molecule (cytochrome c or
caspase-9) and as a consequence, direct spatial coupling could not be achieved. On
the other hand, it could have been the effect of insufficient cytochrome c or caspase-9
bound to the capture antibody during primary immunocomplex formation and this
could have limited the sensitivity of detection after secondary immunocomplex
formation.

4.12 Summary
This work described the application of optical nanosensors for the sensitive
and selective recognition of cytochrome c and caspase-9 in situ in cytosolic cell
extracts. Apoptosis was induced using a photodynamic therapy (PDT) agent δaminolevulinic acid (ALA) that initiates the mitochondrial pathway of apoptosis. This
pathway involves cytochrome c release from mitochondrial followed by the activation
of caspase-9. To measure cytochrome c and caspase-9, capture antibody targeted
towards cytochrome c or capase-9, is immobilized onto functionalized nanotips to
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bind these respective proteins. Once these proteins are bound, the nanotips containing
the primary immunocomplex are complexed with Cy5 labeled reporter antibody
forming a secondary immunocomplex. The Cy5 labeled reporter antibody facilitates
the detection and identification of secondary immunocomplex formation when Cy5 is
excited using 632.8 nm light from helium/neon (HeNe) laser and fluorescence
emission occurs in the far-red at about 667 nm. Fluorescence signals were detected
for in vitro studies providing for sensitive and selective recognition of both
cytochrome c and caspase-9 while the same did not occur for the pseudo in vivo
studies. Unfortunately, I was unable to detect cytochrome c and caspase-9 within
single living cells using the pseudo in vivo technique. The experimental data obtained
from in vitro measurement of apoptosis indicated that optical nanosensor coupled
with the indirect fluorescent immunoassay can be used to detect and identify specific
antibodies directed against cytochrome c and caspase-9. However, the experimental
data obtained from pseudo in vivo studies reveal that the pseudo in vivo immunoassay
technique is not capable of measuring of apoptosis. This was demonstrated by the
inability of the technique to detect and identify cytochrome c and caspase-9 and
therefore, I could not implicate these proteins involved in the regulation of
mitochondrial cell death using antibody-based optical nanosensors.
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5.0 Abstract

We demonstrate for the first time, the application and utility of a unique
optical nanosensor for monitoring the onset of the mitochondrial pathway of
apoptosis in a single living cell by detecting enzymatic activities of caspase-9.
Minimally invasive analysis of single live MCF-7 cells for caspase-9 activity is
demonstrated using the optical nanosensor which employs a modification of an
immunochemical assay format for the immobilization of non-fluorescent enzyme
substrate,

Leucine-GlutamicAcid-Histidine-AsparticAcid-7-amino-4-methyl

coumarin (LEHD-AMC). LEHD-AMC covalently attached on the tip of an optical
nanosensor is cleaved during apoptosis by caspase-9 generating free AMC. An
evanescent field is used to excite cleaved AMC and the resulting fluorescence signal
is detected. By quantitatively monitoring the changes in fluorescence signals,
caspase-9 activity within a single living MCF-7 cell was detected. By comparing of
the fluorescence signals from apoptotic cells induced by photodynamic treatment, and
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non-apoptotic cells, we successfully detected caspase-9 activity, which indicates the
onset of apoptosis in the cells.

5.1 Introduction
In this work, we describe the optical nanosensor for the in vivo measurement
of apoptosis. The basic optical technique used by optical nanosensors, is total internal
reflection excitation through the transmission of fluorophore excitation along optical
nanosensor followed by filtering the signal in order to separate out the higher
wavelengths of interest. TIR excitation is typically used to study the interaction of
materials on optically transparent surfaces as well as serving the purpose of being the
basis of optical nanosensors. The principle of TIR excitation occurs at the interface of
two optically transparent media of different refractive indices. Light is typically
introduced into the medium of greater refractive index (n1). At the interface of the
two media, all energy associated with the light beam is not confined to the nanotips,
some energy, evanescent optical waves, is lost from this beam into the less dense
medium (n2) which could be the cytoplasm of a cell under investigation, with the
intensity of the energy decaying rapidly with the penetration depth of the energy into
the less dense medium. Evanescent optical waves are used to excite surface bound
fluorophores which subsequently emit radiation at a different wavelength. This
technique is very well suited for the investigation of surface association or
dissociation events that occur at the distal ends of the optical nanosensors as the
material in the cytoplasm or bulk solution at distances of greater than several hundred
of nanometers away from the surface are not interrogated by the evanescent wave
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[54]. This means that good discrimination between species bound to the nanotips over
unbound material is achieved.
Minimally invasive analysis of cellular signaling pathways inside single live
cells is becoming increasingly important fundamentally because cells in a population
respond asynchronously to external stimuli [122]. There is a need to further our
understanding of basic cellular signaling processes in order to yield new information
that is not available from population-averaged cellular measurements. In addition,
many cellular signaling pathways act on timescales of a few seconds and there is
critical need for single-cell measurement techniques with similar time resolution. Not
only is there a need to temporally resolve such measurements, there is also a need to
spatially resolve them. For these reasons, continued progress in cellular physiology
requires new measurement strategies, which can be applied to individual cells [7]
with great temporal and spatial resolution. For this purpose, the optical nanosensor is
a suitable technology with great potential for obtaining intracellular measurements of
biological entities as will be demonstrated in this work.
Biosensors have played a key role in the development of minimally invasive,
highly sensitive, and selective technologies for biochemical analysis [19]. One of the
most recent advances in the field of biosensors has been the development of optical
nanosensors capable of detecting and responding to the interaction between analytes
of biomedical interest and their corresponding antibody within single live cells [1618]. Minimally invasive analysis of living cells involves penetrating individual live
cells without causing physiological or biological damage with resultant biochemical
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consequences. Intracellular measurements are made possible by the small scale of the
nanosensor in comparison to the dimensions of the cell, typically one to two orders of
magnitude. Optical nanosensors are thus crucial for minimally invasive analysis
because they allow the penetration and sampling of individual live cells in their
physiological state without disrupting their normal functions, hence allowing the
continuation of vital cellular processes such as mitosis [123]. These antibody-based
optical nanosensors rely on excitation using the evanescent field generated by total
internal reflection at the tip of the nanosensor, thus exciting only molecules in close
proximity to the boundary interface of the optical nanosensor tip. The evanescent
field generated at the tip of the nanosensor is a result of the nanosensor tip being
smaller than the wavelength of the laser beam, leading to a diffraction-limited
condition that does not allow photons from the laser beam to be transmitted through
the tip of the nanosensor, but rather allows energy to be transmitted in the form of an
interfacial leaky surface mode, which is propagated as the evanescent field exciting
only molecules on the periphery of the tip.
We have developed a unique enzyme optical nanosensor based on an enzymesubstrate probe to detect and identify surface dependent cleavage events of caspase-9
in a single live MCF-7 cell. The modified assay format consists of a solid phase for
the

immobilization

of

caspase-9

substrate,

Leucine-GlutamicAcid-Histidine-

AsparticAcid-7-amino-4-methyl coumarin (LEHD-AMC), which consists of a
tetrapeptide, LEHD, coupled to a fluorescent molecule, AMC. LEHD-AMC exists as
a non-fluorescent substrate prior to cleavage by caspase-9, and after cleavage, free
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AMC fluoresces when excited at 325nm. Figure 5.1 shows the excitation and
emission spectrum of AMC and cleavage process of LEHD-AMC to produce free
fluorescent AMC.
The excitation and emission spectra of AMC were acquired using a
Fluoromax-3 spectrofluorimeter (Jobin Yvon Inc, Edison, NJ). The excitation
spectrum represents the relative ability of various wavelengths to stimulate AMC
fluorescence emission, while the emission spectrum represents the relative
fluorescence intensity when AMC is excited. In contrast to traditional, discontinuous,
non-equilibrium ELISA-type cleavage assays that cannot accurately model dynamic
binding mechanisms, the optical nanosensor permits investigation of surface cleavage
phenomena, in addition to providing a simple way to detect caspase-9 in single cells.
Caspase-9 is a prominent member of a family of death-specific enzymes known as
cysteine-dependent aspartate-specific proteases, the caspases [124]. Caspase-9 is
activated via mitochondrial involvement in the apoptotic pathway. Cells exposed to
apoptotic stimuli release cytochrome c from mitochondria into the cytosol. In the
cytosol, cytochrome c interacts with apoptotic protease activating factor-1 (Apaf-1)
[125]. The cytochrome c/Apaf-1 complex cleaves the inactive caspase-9 proenzyme
to generate active caspase-9 enzyme [114]. Activated caspase-9 exhibits distinct
substrate recognition properties and initiates the proteolytic activities of other
downstream caspases, which degrade a variety of substrates, resulting in the
systematic disintegration of the cell [126-128] and ultimately, cell death.
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Induction of Apoptosis
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Caspase-9 activation
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Figure 5.1 (i) shows the absorption spectrum of AMC (10-3 M), while (ii)
shows the emission spectrum of AMC (10-3 M). Excitation and emission spectra were
acquired to determine where to excite and detect AMC. (iii) shows a diagrammatic
representation of ALA induced apoptosis, involving the activation of caspase-9
followed by the cleavage of Leucine-Glutamate-Histidine-Aspartate-7-amino-4methyl coumarin (LEHD-AMC) and subsequent detection of free AMC.
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The enzyme substrate-based optical nanosensor works on the same principle
of evanescent field excitation by means of an exponentially decaying surface energy
wave with a penetration depth that allows only AMC molecules in close proximity to
the boundary interface of the optical nanosensor tip to be excited and detected. This
feature is important because it underlines the operating principle of the nanosensor in
the sense that only the cleaved AMC will be excited in the near field of the optical
nanosensor. An additional feature of the nanosensor is its selectivity. Selectivity is
dependent upon the selective cleavage capabilities for specific sequences by caspase9. Another advantage of the optical nanosensors’ feature of excitation and detection
in the evanescent field is the reduction of sources of background, particularly specular
scattering, Rayleigh scattering, and Raman scattering from regions outside the
nearfield. The optical nanosensors’ mode of excitation and detection unlike other
techniques for molecular detection does not compromise throughput and signal-tonoise ratio. Furthermore, due to its nanoscale size, the optical nanosensor does not
compromise the integrity of the cell when performing intracellular analysis. This has
been illustrated in a previous study whereby a single cell was microscopically
monitored after probing the cytoplasm of the cell with an optical nanosensor. The cell
was observed and it was found that the cell carried out normal cellular activities,
specifically mitosis [123].
In this work, we demonstrate for the first time, the application and utility of
optical nanosensors for the detection and identification the onset of the mitochondrial
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pathway of apoptosis in a single live MCF-7 cell by detecting the enzymatic activity
of caspase-9. To perform these measurements, we covalently immobilized caspase-9
substrate, LEHD-AMC onto the tip of the nanofiber. Photodynamic therapy (PDT)
protocols (Figure 5.2) employing δ-aminolevulinic acid (ALA) were used to induce
apoptosis [129] in MCF-7 cells. Briefly, caspase-9 is present in the cell after
apoptosis has been induced. It typically exists in a proenzyme form procaspase-9,
prior to apoptosis induction. MCF-7 cells exposed to apoptotic stimuli release
cytochrome c from mitochondria into the cytosol. In the cytosol, cytochrome c
interacts with apoptotic protease activating factor-1 (Apaf-1) [125]. The cytochrome
c/Apaf-1 complex cleaves the inactive procaspase-9, a proenzyme to generate the
active enzyme, caspase-9

[114]

. Activated caspase-9 then initiates the proteolytic

activities of other downstream caspases. These caspases degrade a variety of
substrates, resulting in the systematic disintegration of the cell. Caspase-9 is capable
of cleaving multiple LEHD-AMC substrates. This is a typical mechanism of action
characteristic of enzymes, the ability to hydrolyze multiple substrates because they do
not undergo change when they are involved in the cleavage reactions and they can
therefore be applied to multiple substrates. Our measurement system consists of the
tetrapeptide substrate Leucine-Glutamic Acid-Histidine-Aspartic Acid-7-amino-4methoxy coumarin (LEHD-AMC), which is selectively cleaved by activated caspase9. The principle of this system is the selective detection of caspase-9 activity by
detecting the fluorescent cleavage product of LEHD-AMC, AMC. When LEHD-
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Figure 5.2 shows a diagrammatic representation of the aminolevulinic acid
(ALA) photoactivation process in a MCF-7 cell. On the left is representation of a
MCF-7 cell prior to the induction of apoptosis and similarly on the right is a
representation of a MCF-7 cell shortly after the induction of apoptosis showing the
activation of caspase-9 which ultimately leading to apoptosis.
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AMC is cleaved by activated caspase-9, AMC is no longer tethered to the tetrapeptide
LEHD that effectively quenches the fluorescence of AMC. Free AMC can therefore
be excited in the near-field of the optical nanosensors and the fluorescence signal
generated can be detected and measured. By comparing the fluorescence from an
apoptotic MCF-7 cell and uninduced control MCF-7 cell, caspase activity can be
detected. In this context, caspases-9 recognizes the specific tetrapeptide sequence
LEHD and cleaves the substrate LEHD-AMC. The substrate LEHD-AMC is cleaved
by caspase-9 and the released AMC molecules are excited and emitted a fluorescence
signal. By comparing the fluorescence from an apoptotic cell and an uninduced
control, we detected and identified caspase-9 activity.

5.2 Materials and Methods
5.2.1 Chemicals and Reagents
δ-aminolevulinic acid (ALA), phosphate buffered saline (PBS), hydrochloric
acid

(HCl), nitric acid (HNO3), glycidoxypropyltrimethoxysilane (GOPS), 1,1’-

carbonyldiimidazole (CDI), and anhydrous acetonitrile were purchased from SigmaAldrich, St. Louis, MO. Caspase-9 substrate, LEHD-7-amino-4-methyl coumarin
(AMC), 2x reaction buffer, dithiothreitol (DTT), and dimethylsulfoxide (DMSO)
were purchased from BD Biosciences, Palo Alto. CA.
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5.2.2 Cell Lines
Human breast cancer cell line, MCF-7, was obtained from American Type
Culture Collection (Rockville, MD, USA, Cat-no. HTB22). MCF-7 cells were grown
in Dulbecco's Modified Eagle's Medium ((DMEM) (Mediatech, Inc., Herndon, VA))
supplemented with 1 mM L-glutamine (Gibco, Grand Island, NY) and 10% fetal
bovine serum (Gibco, Grand Island, NY). Baseline static culture productivity for each
cell line was established in growth medium (described above) in standard T25 tissue
culture flasks (Corning, Corning, NY). The flasks were incubated in a humidified
incubator at 37°C, 5% CO2 and 86% humidity. Cell growth was monitored daily by
microscopic observation until a 60–70% state of confluence was achieved. The
growth conditions were chosen so that the cells would be in log phase growth during
photosensitizer treatment with ALA, but would not be so close to confluence that a
confluent monolayer would form by the termination of the chemical exposure

[25]

. In

preparation for experiments, cells were harvested from the T25 flasks and 0.1ml (105
cells/ ml) aliquots were seeded into 60 mm tissue culture dishes (Corning Costar
Corp., Corning, NY) for overnight attachment. The MCF-7 cells were studied as three
separate groups with the first group being the experimental, exposed to 0.5 mM ALA
for 3 h followed by photoactivation [120]. This involved incubating the cells at 37o C in
5% CO2 for 3 h with 0.5mM ALA. Following incubation the MCF-7 cells were
exposed to red light from a HeNe laser (λ 632.8 nm, <15mW, Melles Griot, Carlsbad,
CA) positioned about 5.0 cm above the cells for five minutes at a fluence of 5.0
mJ/cm2 to photoactivate ALA and subsequently induce apoptosis. The second group
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was the “treated control” and was exposed to 0.5 mM ALA for 3 hours without
photoactivation. The third group was the “untreated control,” which received neither
ALA nor photoactivation.

5.2.3 Preparation of Enzyme Substrate-based Nanosensors
Preparation of enzyme substrate-based optical nanosensors involves cutting
and polishing plastic clad silica (PCS) fibers with a 600-µm-diameter core
(Fiberguide Industries, Stirling, New Jersey). The optical fibers were pulled to a final
tip diameter of 50 nm using the current state-of-the-art in micropipette pulling
technology, the P-2000 system (Sutter Instruments, Novato, CA), and then coated
with 100 nm of silver metal (99.999% pure) using a thermal evaporation deposition
system (Cooke Vacuum Products, South Norwalk, CT) achieving a final diameter of
150nm. Figure 5.3 (ii) shows an image of silver-coated optical nanofiber. The
nanotips were derivatized to allow the immobilization of enzyme substrate.
Derivatization involved a multistep procedure. The fused silica optical fibers were
acid-cleaned followed by several rinses with distilled water and then allowed to air
dry at room temperature in a dust free environment. The nanotips were silanized by
treatment with an organic cross-linking reagent, 10% GOPS in H2O (v/v) at 90oC for
3 h. The silanized fibers were washed with anhydrous acetonitrile and dried overnight
in a vacuum oven at 105oC. Soon after overnight incubation, the nanotips were
activated by being suspended in saturated CDI in acetonitrile for 30 min followed by
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Figure 5.3: (i) Schematic diagram of fluorescence measurement system used
for data acquisition and processing (ii) Scanning electron micrograph of a nanotip
after coating with 100nm of silver metal, achieving a final tip diameter of 150 nm (iii)
Image of optical nanosensor inserted into a single live MCF-7 cell. This image shows
how we performed the intracellular measurements of MCF-7 cells.
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rinsing with acetonitrile. The silanized and activated nanotips were immersed in a
solution containing DMSO, 2X reaction buffer, PBS, and LEHD-AMC, and allowed
to incubate for 3 h at 37oC. The LEHD-AMC bound using this procedure remained
securely immobilized during washing and subsequent manipulations in immunoassay
procedures, in contrast to procedures that would use adsorption to attach proteins [130,
131]

. The optical nanosensors prepared were subdivided into groups to perform parallel

experimental and control measurements using MCF-7 cells.

5.2.4 Measurement System and Procedure
Figure 5.3(i) shows (above) a schematic representation of the fluorescence
measurement system. The major components of this system include a HeCd laser
(Omnichrome, <5mW laser power), a Nikon Diaphot 300 inverted microscope
(Nikon, Inc., Melville, NY), Hamamatsu PMT detector assembly (HC125-2), and a
personal computer (PC). To perform the intracellular fluorescence measurements, the
325 nm laser line of a HeCd laser was focused onto a 600-µm-delivery fiber that was
terminated with a subminiature A (SMA) connector. The optical nanosensor was
coupled to the delivery fiber through the SMA connector and secured to the
microscope with micromanipulators. The fluorescence emitted from the cells was
collected by the microscope objective and passed through a 330nm barrier filter and
then focused using the internal optics of the microscope onto the PMT for detection.
The output from the PMT was recorded using a universal counter and a PC with
custom-designed software for data acquisition and processing.
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The experimental setup used to probe single cells was adapted to this purpose
from a standard micromanipulation/microinjection apparatus. The Nikon Diaphot 300
inverted microscope, having a Diaphot 300/Diaphot 200 Incubator to maintain the
cell cultures at 37°C on the microscope stage, was used for these experiments. The
micromanipulation equipment consisted of MN-2 (Narishige Co. Ltd., Tokyo, Japan)
Narishige three-dimensional manipulators for coarse adjustment, and Narishige
MMW-23 three-dimensional hydraulic micromanipulators for fine movements. The
optical nanosensor was mounted on a micropipette holder (World Precision
Instruments, Inc., Sarasota, FL). To record the fluorescence of AMC in the
evanescent field of the optical nanosensor, a Hamamatsu PMT detector assembly
(HC125-2) was mounted in the front port of the Diaphot 300 microscope.
Before making measurements, the cells were harvested from culture flasks
and transferred to culture dishes. After attachment to the bases of the petri dishes, the
experimental group of MCF-7 cells was treated with 0.5 mM ALA with subsequent
photoactivation, the treated control received 0.5 mM ALA without photoactivation
while the untreated control group did not receive any treatment. For the experimental
and treated control group, the solution of ALA was aspirated after a 3-hour incubation
period and replaced with fresh cell culture media. The experimental group of cells
was then irradiated with HeNe laser to photoactivate ALA for a period of five
minutes.
Using the experimental group of cells, three separate trials were conducted to
determine the presence of caspase-9 activity. In addition, three separate trials were
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performed for the treated control and untreated control respectively. Determination of
the presence or absence of caspase-9 activity using the nanosensor was carried out
using the following procedure. A culture dish of cells was placed on the pre-warmed
microscope stage set at 37oC. The enzyme optical nanosensor shown in figure 5.3(ii)
(above) is mounted on a micropipette holder of a micromanipulation system, was
moved into position (i.e., in the same plane as the cells), using bright-field phase
contrast microscopic illumination, so that the tip was just outside of the cell to be
probed. The total magnification was 600×. The nanosensor was gently
micromanipulated into the cell, past the cell membrane and extending a short way
into the cytoplasm. During these micromanipulations, great care was taken not to
penetrate the nuclear envelope and compromise the integrity of the nucleus. Room
light and microscope illumination light were switched-off; the laser shutter opened,
and laser light allowed to illuminate the optical fiber and excitation light was
transmitted into the fiber tip. First, a signal reading was taken with the nanosensor
inside the cell with the laser shutter closed in order to record the dark signal. After
five min, the laser shutter was opened allowing the excitation light to be transmitted
to the nanosensor tip and fluorescence readings were recorded. Figure 5.3 (iii)
(above) shows an image illustrating an intracellular measurement performed in a
single MCF-7 cell after micromanipulation.
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5.3 In Vitro Determination of Caspase-9 Activity
We performed a calibration measurement of caspase-9 outside the cell using
caspase-9 obtained from cytosolic cell extract of cell groups after apoptosis was
induced and without the induction of apoptosis. This was done by inducing apoptosis
in a group of cells using ALA-PDT and having a control group without ALA-PDT.
The cells were harvested and the cytosolic extract placed in picofuge tubes. Optical
nanosensors were incubated in the picofuges containing the cytosolic cell extract, one
set presumably containing activated caspase-9 while the other set devoid caspse-9.
After incubating MCF-cells using the following treatment groups,
experimental group [+]ALA[+]PDT (with ALA-PDT), and the control group []ALA[-]PDT (without ALA-PDT), MCF-7 cells were washed with PBS solution, pH
7.4, and then resuspended in lysis buffer (100 mM HEPES, pH 7.4, 10% sucrose,
0.1% 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS), 1
mM EDTA, 10 mM dithiothreitol (DTT), 1 mM phenylmethylsulphonyl fluoride
(PMSF), 10 mg/ml pepstatin, 10 mg/ml leupeptin) and left on ice for 45 minutes. The
cells were then repeatedly passed through a syringe with a 25-gauge needle until most
of the cell membrane was disrupted, and centrifuged at 1500 RPM for 10 min.
Activity of caspases was measured using fluorogenic substrate peptides; LEHD-AMC
for caspase-9 immobilized on the nanotips of the optical nanosensors. The release of
AMC was measured after incubating optical nanosensors in picofuge tubes containing
the cell lysates from the various treatment groups and using a HeCd laser (excitation
325 nm) to excite AMC. Caspase activity was expressed as fluorescence intensity of
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AMC as a function of equivalent nanomoles of LEHD-AMC. We plotted the results
of the in vitro measurement of caspase-9 activity. The curves for each fluorescent
measurement of AMC were plotted for each as a function of nanomoles of AMC.
Caspase-9 activity was determined by incubation of optical nanosensors with the
substrate LEHD-7-amino-4-methylcoumarin (AMC) in cell lysate (~105 cells)
obtained from the following treatment groups; experimental group (with ALA-PDT),
and the control group (without ALA-PDT), and measured the release of AMC. The
release of AMC was measured after excitation using HeCd laser (325 nm) and
collecting the fluorescence signal using a 380 nm longpass filter. Peak emission
wavelength of AMC is about 440 nm.

5.4 In Vivo Determination of Caspase-9 Activity
To perform the intracellular measurements, the optical nanosensor was
positioned using the 3-dimensional micromanipulator mounted on the inverted
microscope. Using the microscope eyepiece for observation the optical nanosensor
was micropositioned within the field of view and, once within the same plane as the
cell under investigation, micromanipulated into the cytoplasm of the cell. After
incubation at 37°C for 5 min, the HeCd laser excitation source was turned on and
fluorescence at λmax 380 nm was measured using a 330nm barrier filter. About 1.5-2.0
h after the induction of apoptosis, the cleavage of LEHD-AMC by caspase-9 occurs
and the released AMC molecules were excited at 325nm and the fluorescence
emission was measured. The fluorescence signal emitted by AMC was collected by
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the fluorescence microscope optics and detected with the PMT. The fluorescence
emission was collected as a function of time and the data is transmitted via a HP
53131A (225 MHz) universal counter that serves as an interface, to a PC for data
acquisition and processing. Data acquisition and processing is performed using
custom software built on LabView platform.

5.5 Results and Discussion
The examination of caspase-9 activity was first performed in vitro using cell
lysate, and in vivo¸ within single MCF-7 cells using enzyme optical nanosensors.
Caspase-9 cleaves the substrate tetrapeptide (LEHD-AMC) between D and AMC,
releasing the fluorophore AMC that is measured upon excitation by HeCd laser.
Figure 5.4 shows the results in vitro study of the experimental group (with ALAPDT) and the control group (without ALA-PDT). These results show a difference of
about an order of magnitude in the mean fluorescence intensity measurements we
obtained for the experimental group and the control group. This difference is
significant enough to detect and positively identify caspase-9 activity in vitro. These
results were expected because it is the collective effect of ALA and photoactivation
that result in the induction of apoptosis and neither ALA nor photoactivation.
Figure 5.5 shows the background-subtracted results of a series of three
intracellular measurements performed with enzyme optical nanosensors using the
experimental and control group of MCF-7 cells. This graph consists of the
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measurements of AMC for the in vitro detection of caspase-9 activity in experimental
group of MCF-7 cells, which received both ALA and photoactivation and the control
measurements for the in vitro detection of caspase-9 activity in control group of
MCF-7 cells, which received neither ALA nor photoactivation. These results
represent replicate studies for the measurement of caspase-9 activity with the error
bars representing 95% Confidence Interval (CI).
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Figure 5.5: (i) Graph showing the background-corrected fluorescence intensity
measurements of AMC for the intracellular detection of caspase-9 activity in
experimental group of MCF-7 cells, which received both ALA and photoactivation.
These results represent replicate studies for the measurement of caspase-9 activity.
(ii) Graph showing the background-corrected control measurements for the
intracellular detection of caspase-9 activity in control group of MCF-7 cells, which
received neither ALA nor photoactivation. These results represent replicate studies
for the control measurement of caspase-9 activity
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fluorescence intensity of AMC fluorescence as a function of time. The results show
that for the control group of cells, the fluorescence signal relative to the experimental
group was not significant enough to confound the determination of AMC. Moreover,
there are no other molecules that appear to interfere with the fluorescence
measurements that would confound the determination of AMC due to the use of nearfield excitation and detection. The application of near-field excitation contributes to
the specificity of the nanosensor and virtually diminishes any background effects that
may confound the determination of AMC because excitation of AMC occurs only in
the evanescent-wave component of near-field excitation. Furthermore, the likelihood
of interfering species existing within the near field is extremely small in comparison
to AMC. Accordingly, the nanosensor used to monitor the experimental group of cells
transduced a higher fluorescent signal as a result of the detection of AMC molecules
momentarily sequestered at the tip of the optical nanosensor.
Figure 5.6 shows the results of intracellular measurements performed using
the enzyme optical nanosensors on the treated control groups of MCF-7 cells. The
first treatment group received ALA without photoactivation while the second group
received photoactivation without ALA. These graphs consist of the fluorescence
intensity of AMC acquired as a function of time using three optical nanosensors
toperform three independent measurements on MCF-7 cells. The results show that for
the treated control groups, the fluorescence signal detected relative to the
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Figure 5.6: (i) shows the background-corrected treated control measurements
for the intracellular detection of caspase-9 activity in MCF-7 cells, which received
ALA without photoactivation. These results represent replicate studies for the treated
control measurement of caspase-9 activity within single live MCF-7 cells. (ii) Graph
showing the background-corrected treated control measurements of for the
intracellular detection of caspase-9 activity in MCF-7 cells, which did not receive
ALA but were photoactived. These results represent replicate studies for the treated
control measurement of caspase-9 activity within single live MCF-7 cells.
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experimental group was not significant enough to confound the determination of
AMC. Once again, these results affirm the excellent degree of reproducibility
achieved using optical nanosensors for the intracellular detection of AMC.
Excellent reproducibility was achieved as a result of optimization of the input
parameters of the laser-based micropipette-pulling device. For instance, after
determining the optimum heating temperature as well as tension applied to pull the
fiber, we successfully produced reproducible tip diameters from nanofiber to
nanofiber (Figure 5.7). This was confirmed by acquiring several scanning electron
microscope (SEM) images of the pulled fibers using a Hitachi S-4700 field emission
SEM. The optimization of the input parameters of the micropipette pulling device
enables very good batch-to-batch reproducibility, which is especially essential for a
technology aimed to single-use nanosensors.
For the in vivo studies, caspase-9 activities were analyzed in ALA-PDT
treated cells (Experimental group 1 in Figure 5.7) by measuring the fluorescence
signal from AMC generated after the cleavage of the peptide substrate LEHD-AMC.
Likewise, the same was done for the control groups (Experimental group 2, 3, 4 in
Figure 5.7) of cells which received either [+]ALA[-]PDT, [-]ALA[+]PDT or []ALA[-]PDT. Figure 5.7 (ii) shows the background-subtracted results of the
intracellular determination of caspase-9 activity using six replicate nanosensors, one
for each measurement. The graph consists of the fluorescence intensity of AMC
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Figure 5.7: (i) shows the reproducibility study performed using optical
nanosensors. The calculated percent variability from optical nanosensor to optical
nanosensor is within 10%. (ii) Graph showing a side-by-side comparison of
intracellular measurement of caspase-9 activity in experimental group of MCF-7 cells
and control groups.
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fluorescence as a function of illumination time. The fluorescent intensity
measurements obtained for these treatment groups were then compared. As shown in
Figure 5.7, in untreated cells, [-]ALA[-]PDT, no level of LEHD-AMC cleavage
activity was detected. Likewise, the same was observed for the treated control groups,
[+]ALA[-]PDT and [-]ALA[+]PDT. However, in treated cells, [+]ALA[+]PDT,
significant LEHD-AMC cleavage activity via the measurement of AMC fluorescence
was detected. As shown in Figure 5.7, the initiator substrates (LEHD-AMC) of
caspase-9 were cleaved into the fluorogenic AMC forms in cells treated with ALAPDT. This demonstrates the involvement of caspase-9, a member of the family of
cysteine proteases that cleave after aspartic acid, in mediating apoptosis. The results
obtained here demonstrated the presence of active pathways of caspase-9 during
ALA-PDT induced apoptosis in MCF-7 cells.
The fluorescence signals obtained from the cells that were both incubated with
ALA and photoactivated were much higher than the signal obtained from both control
groups. Statistical analysis was performed on the three sets of results. The mean value
of these analyses revealed that the fluorescence signal obtained using the nanosensors
used to probe cells incubated with photoactivated ALA was much higher than the
signal obtained by nanosensors used to probe untreated and treated control cell
groups. A larger mean value for the experimental group affirms the detection of AMC
and hence the detection of caspase-9 activity.
The results obtained in this work demonstrate measurements performed inside
single living cells using an enzyme substrate-based optical nanosensor and the
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potential application of such a nanosensor in protein-protein profiling in biochemical
pathways.
We have prepared enzyme substrate-based optical nanosensors using covalent
coupling of enzyme substrate to nanotips and demonstrated the application of these
sensors for the determination of the cleavage product of LEHD-AMC, AMC, in
single live MCF-7 cells. The presence and detection of cleaved AMC in single live
MCF-7 cells as a result of this design is representative of caspase-9 activity and a
hallmark of apoptosis. These results indicate that AMC, and hence apoptosis, can be
monitored and measured using optical nanosensors within single living cells. These
results also show the possibility of cataloging cellular components, which can play an
important role in understanding the role of these components, and how they work
together in a cell.
The studies performed in this work show the possibility of studying individual
cells without having to disrupt their physiological make-up, which in the process can
negatively interfere with cellular biochemistry. Mechanical and electrical
manipulations such as cell lysis that can lead to cell disruption prior to the time of
sampling may interfere with measurements of cellular biochemistry by initiating
cellular repair mechanisms. Since many cellular signaling pathways act on timescales
of a few seconds, there is critical need for single cell measurement techniques with
time resolution to perform intracellular measurements. The optical nanosensor is a
suitable technology that can be applied to solitary cells and has great potential for
intracellular measurement of biological entities as demonstrated in this work.
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In this work, an optical nanosensor enabled the measurement of a cellular
process, in this case the functioning of an apoptosis enzyme, caspase-9, in its native
environment. This work demonstrated a tool that has the potential to shed light on the
principles that govern cell-signaling organization. Future work will involve studies
that will attempt to carry out similar analysis on other proteins involved in
biochemical cellular pathways.
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Part Six
Optical Nanosensor for Measuring Apoptosis in a Single Cell
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6.0 Abstract
This work demonstrates the application of tetrapeptide-based optical
nanosensors for bioanalysis and measuring apoptosis in single living cells. The
activation of caspases is one of the earliest biomarkers of apoptosis, making caspases
an early and ideal target for measuring apoptosis. Tetrapeptide-based optical
nanosensors are a new class of biosensors that are capable of reporting the activity of
specific caspases with high sensitivity and specificity. These properties make them
promising for the detection and visualization of target caspases in single living cells
during apoptosis. By detecting and identifying specific caspases, we confirm proteins
involved in the regulation of apoptosis at the lowest possible levels. This article
focuses on our recent research in exploring the potential of using tetrapeptide-based
optical nanosensors for monitoring of apoptosis in single living cells.

6.1 Introduction
In the past decade, we have witnessed unprecedented advances in fields such
as biosciences and optical biosensor technology. Although advances in each of these
fields have provided exciting new insights and capabilities, it is the integration of
these fields that revolutionary advances are being made. This work is an
amalgamation of these fields and focuses on the development of novel optical
nanosensors for single cell analysis. These biosensors are devices having crosssection of less than 250 nm and are capable of detecting a chemical or biological
event using an optical signal. Furthermore, they are capable of monitoring single live
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cells with the potential for subcellular analysis. They consist of nanoscale optical
fiber

equipped

with

covalently

immobilized

profluorescent

tetrapeptide

biorecognition molecules. At this scale, optical nanosensors are capable of playing a
significant role in single cell analysis for example, analyzing proteins or proteinprotein interactions within living cells, thereby enabling minimally invasive dynamic
monitoring and visualization of molecular events within single living cells. This
advantage is important because we can only obtain the most representative
information of a cell as a system in vivo when the intracellular machinery is intact. In
this context, optical nanosensors can play a significant role in helping to understand
cell signaling and transduction and, in so doing, advancing the capability and
technologies available for single cell analysis.
As we have gained a better understanding of bulk cell assays over time, and
achieved a greater understanding of many macroscopic biological processes, we have
been driven to rethink the purpose of an increasingly smaller entity -the single cell.
Technologies for performing sensitive and selective biochemical analyses of single
living cells still remain one of the key challenges in cell biology. Monitoring key
cellular events and conquering functional biochemical pathways of a single cell, as
heterogeneous as it is, would be an accomplishment in itself at this present time. This
is mainly because of the scale required for analysis, and second, for the inability to
achieve spatial and temporal resolution at the single cell level scale. The development
of new technologies for single cell analysis is important because native biochemical
events and reactions within living cells can be deciphered only if we have access to
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their cellular distribution and location in a non-destructive and minimally invasive
manner. Similarly, as our desire to visualize and decipher biochemical events
progresses from bulk cell assays to single cell studies, high demands are placed on
measurement technologies. Perhaps no recent technology has greater potential for this
application than optical nanosensors. Previous work in our group has demonstrated
the functionality and suitability of optical nanosensors for performing measurements
in single living cells based on such figures of merit as sensitivity, reproducibility and
selectivity [17-19]. These characteristics are important mainly for applications in
areas of protein detection, protein-protein interaction profiling, and possibly
measurement of critical cellular processes such as apoptosis.
The overall nature of apoptosis in bulk cell assays has been studied over time
and is a fairly well understood process in vitro [108, 126, 129, 132]. It is also well
known and widely accepted that cells in a population behave asynchronously to
external stimuli such as chemically induced apoptosis. This is a result of the operation
of the cell cycle, and the fact that the single-cell growth rates and cell division rates
depend on cellular content; each cell contains different quantities of proteins, DNA,
and RNA. Consequently, cell properties are distributed among the cells of the
population leading to asynchronous behavior [133]. Hence, a cell population is a
heterogeneous system and to study the nature of apoptosis in vivo in single living
cells requires a measurement technology capable of performing minimally-to-noninvasive analysis of single cells with their biochemical pathways intact. Optical
nanosensors are capable of minimally-to-non-invasive analysis of single living cells
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as demonstrated in their application in the measurement of carcinogenic compounds
within single living cells [17, 18]. This work will involve the application of a similar
nanosensor though with a different type of immunochemical format. We adapted the
previously used antibody-based optical nanosensor and developed a secondgeneration tetrapeptide-based optical nanosensor to measure apoptosis in single
MCF-7 cells. The focus of this work is in exploring the potential of the secondgeneration tetrapeptide-based optical nanosensor for measuring apoptosis in single
living MCF-7 cells.
In the classical model of apoptosis [134], caspases are divided into initiator
caspases and effector caspases according to their function and their sequence of
activation. Initiator caspases include caspase-8, -9, while effector caspases include,
caspases-3, -6 and –7 [127, 135]. The activation of caspases is one of the earliest
biomarkers of apoptosis making caspases an early and ideal target for measuring
apoptosis. Apoptosis, or programmed cell death, is a mode of cell death characterized
by specific morphological and biochemical features. It is both a normal and abnormal
component of the development and health of multi-cellular organisms. Cells die in
response to a variety of stimuli and during apoptosis they do so in a controlled,
regulated fashion. This makes apoptosis distinct from another form of cell death
called necrosis in which uncontrolled cell death leads to lysis of cells, inflammatory
responses and, potentially, to serious health problems. Apoptosis, by contrast, is a
process in which cells play an active role in their own death, which is why apoptosis
is often referred to as cell suicide. Over the past decade, the importance of apoptosis
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has been appreciated, and it is now thought to be the main mode of cell death in liver
diseases, and neuronal cell death in neurodegenerative disease. Apoptosis has been
found to have a role in one mechanism leading neuronal cell death associated with
Alzheimer's disease and in liver disease. [86, 87, 136]. On the other hand, the loss of
ability of cells to undergo apoptosis is one of the causes of uncontrollable cell growth
leading to cancer. Tumor growth is determined not only by increased cell division,
but also by decreased tumor-cell attrition. Therefore most, if not all, cancer cells
acquire resistance to the various mechanisms that lead to apoptosis. In this context,
optical nanosensors would open the way to monitoring caspase activity and in the
process measure apoptosis in single living cells. This would be especially useful for a
number of reasons. For example, we will be treating the cell as a system and not as a
component of a system. Since the single cell is in its own capacity an individual
entity, we will be able to obtain more representative information about intracellular
biochemical events as opposed to if the cell was part of a population of cells. In
addition, we will be analyzing proteins in their native form and environment. This is
essential for cataloging the functional and hierarchical organization of proteins in
various cellular pathways such as caspases in apoptosis. The results obtained in these
experiments can be used to complement data obtained from in vitro studies or
computational modeling studies.
Since caspases play a central role in the induction of apoptosis, tetrapeptidebased optical nanosensors were used to determine their role in response to a
photodynamic therapy (PDT) agent, δ-aminolevulinic acid (ALA) in the well-
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characterized human breast carcinoma cell line, MCF-7. MCF-7 cells were exposed
to the photosensitizer ALA to explore ALA-PDT induced apoptosis by monitoring
caspase-9 and caspase-7 activity. Caspase-9 and caspase-7 protease activity was
assessed in single living MCF-7 cells with the known caspase-9 and caspase-7
substrates,

Leucine-aspartic-histidine-glutamic

(LEHD-AMC)

and

aspartic-glutamic

acid

7-amino-4-methylcoumarin

acid-valine-aspasrtic

acid

7-amino-4-

methylcoumarin (DEVD-AMC) respectively, covalently immobilized to the nanotips
of optical nanosensors. Upon the induction of apoptosis, activated target caspases
recognize the tetrapeptide sequence it specifically cleaves. The recognition of
substrate by caspases is immediately followed by a cleavage reaction yielding the
fluorescent AMC which can be excited with a Helium-Cadmium (HeCd) laser to
generate a measurable fluorescence signal (Figure 6.1). By comparing the
fluorescence signal generated from AMC within cells with activated caspases and
from those with inactive caspases, we are able to successfully detect caspase activity
within a single living MCF-7 cell.

6.2 Material and Methods
6.2.1 Chemicals and Reagents
δ-aminolevulinic acid (ALA), phosphate buffered saline (PBS), hydrochloric
acid

(HCl), nitric acid (HNO3), Glycidoxypropyltrimethoxysilane (GOPS), 1,1’-

Carbonyldiimidazole (CDI), and anhydrous acetonitrile were purchased from SigmaAldrich, St. Louis, MO. Caspase-9 substrate, Leucine-Glutamate-Histidine-Aspartate-
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Figure 6.1 shows an illustration of caspase-9 substrate, Leucine-GlutamateHistidine-Aspartate-7-amino-4-methylcoumarin

(LEHD-AMC),

and

caspase-7

substrate, Aspartate-Glutamte-Valine-Aspartate-7-amino-4-methylcoumarin (DEVDAMC) cleavage reaction. Free AMC can be excited and the fluorescence emitted is
representation of the enzymatic cleavage reaction
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7-amino-4-methylcoumarin (LEHD-AMC), Caspase-7 substrate, Aspartate-GlutamteValine-Aspartate-7-amino-4-methylcoumarin (DEVD-AMC), 2x reaction buffer,
dithiothreitol (DTT), and dimethylsulfoxide (DMSO) were purchased from BD
Biosciences, Palo Alto. CA.

6.2.2 Cell Lines
Human breast cancer cell line, MCF-7, was obtained from American Type
Culture Collection (Rockville, MD, USA, Cat-no. HTB22). MCF-7 cells were grown
in Dulbecco's Modified Eagle's Medium ((DMEM) (Mediatech, Inc., Herndon, VA))
supplemented with 1 mM L-glutamine (Gibco, Grand Island, NY) and 10% fetal
bovine serum (Gibco, Grand Island, NY). Baseline cell culture was established in
growth medium (described above) in standard T25 tissue culture flasks (Corning,
Corning, NY). The flasks were incubated in a humidified incubator at 37°C, 5% CO2
and 86% humidity. Cell growth was monitored daily by microscopic observation until
a 60–70% state of confluence was achieved. The growth conditions were chosen so
that the cells would be in log phase growth during photosensitizer treatment with
ALA, but would not be so close to confluence that a confluent monolayer would form
by the termination of the chemical exposure [18]. In preparation for experiments,
cells were harvested from the T25 flasks and 0.1ml (105 cells/ ml) aliquots were
seeded into 60 mm tissue culture dishes (Corning Costar Corp., Corning, NY) for
overnight attachment. The MCF-7 cells were studied as four separate groups with the
first group, Group I, being the experimental, exposed to 0.5 mM ALA for 3 h
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followed by photoactivation ([+]ALA[+]PDT) [120, 129]. This involved incubating
the cells at 37o C in 5% CO2 for 3 h with 0.5mM ALA. Following incubation the
MCF-7 cells were exposed to red light from a HeNe laser (λ 632.8 nm, <15mW,
Melles Griot, Carlsbad, CA) positioned about 5.0 cm above the cells for five minutes
at a fluence of 5.0 mJ/cm2 to photoactivate ALA and subsequently induce apoptosis.
The second and third groups, Group II and III respectively, served as the “treated
control” and were exposed to 0.5 mM ALA for 3 hours without photoactivation
([+]ALA[-]PDT) and photoactivation without 0.5 mM ALA ([-]ALA[+]PDT])
respectively. The fourth group, Group IV was the “untreated control,” which received
neither ALA nor photoactivation ([-]ALA[-]PDT).

6.3 Experimental Protocol
6.3.1 Preparation of Enzyme Substrate-based Optical Nanosensors
Preparation of similar optical nanosensors has been previously described [16,
36, 61, 123]. Briefly, this process involved cutting and polishing plastic clad silica
(PCS) fibers with a 600-µm-size core (Fiberguide Industries, Stirling, New Jersey).
The fibers were pulled to a final tip diameter of 50 nm and then coated with ~100 nm
of silver metal (99.999% pure) using a thermal evaporation deposition system (Cooke
Vacuum Products, South Norwalk, CT) achieving a final diameter of 150 nm. The
fused silica nanotips were acid-cleaned followed by several rinses with distilled
water. Finally, the substrates were allowed to air dry at room temperature in a dust
free environment. The nanotips were then silanized and treated with an organic
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coupling agent, 10% Glycidoxypropyltrimethoxysilane (GOPS) in distilled water.
The silanization agent covalently binds to the silica surface of the nanotips modifying
the hydroxyl group to a terminus that is compatible with the organic cross-linking
reagent, 1’1, Carbonyldiimidazole (CDI). The use of CDI for activation introducing
an imidazole-terminal group was particularly attractive since the protein to be
immobilized could be used without chemical modification. Proteins bound using this
procedure

remained

securely

immobilized

during

washing

or

subsequent

manipulations in immunoassay procedures, as opposed to procedures that use
adsorption to attach proteins [130, 131]. The silanized and activated nanotips for
measuring caspase-9 activity were immersed in a solution containing DMSO, 2X
reaction buffer, PBS, and LEHD-AMC, and allowed to incubate for 3 h at 37oC,
while those for measuring caspase-7 activity were immersed in a solution containing
DMSO, 2X reaction buffer, PBS, and DEVD-AMC, and allowed to incubate for 3 h
at 37oC.

6.3.2 Measurement System and Procedure
A schematic representation of the experimental setup used in this work is
shown in Figure 6.2 .The components included a HeCd laser (Omnichrome, <5mW
laser power) for excitation, an optical fiber for delivery of excitation light to the
optical nanosensor, a Nikon Diaphot 300 inverted fluorescence microscope (Nikon,
Inc., Melville, NY), a photon counting photomultiplier tube (PMT) and a PC for data
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Figure 6.2 (i) Laser-induced fluorescence measurement system used for
fluorescence signal acquisition, data recording and processing. (ii) Scanning electron
micrograph of optical nanosensor after coating with ~100nm of silver metal.
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acquisition and processing. This experimental set-up, used to probe single cells, was
adapted for this purpose from a standard micromanipulation and microinjection
apparatus. The Nikon Diaphot 300 inverted microscope was equipped with a Diaphot
300/Diaphot 200 Incubator to maintain the cell cultures at 37°C on the microscope
stage, during these experiments. The micromanipulation equipment consisted of MN2 (Narishige Co. Ltd., Tokyo, Japan) Narishige three-dimensional manipulators for
coarse

adjustment,

and

Narishige

MMW-23

three-dimensional

hydraulic

micromanipulators for fine adjustments. The optical nanosensor was gently mounted
on a micropipette holder (World Precision Instruments, Inc., Sarasota, FL). The 325
nm laser line of a HeCd laser was focused onto a 600-µm-delivery fiber that is
terminated with a subminiature A (SMA) connector. The enzyme substrate-based
optical nanosensor was coupled to the delivery fiber through the SMA connector and
secured to a Nikon inverted microscope with micromanipulators. To record the
fluorescence generated by AMC molecules at the nanotips, a Hamamatsu PMT
detector assembly (HC125-2) was mounted in the front port of the Diaphot 300
microscope. The fluorescence emitted by AMC from the measurement made using
single live cells was collected by the microscope objective and passed through a 330380 nm filter set and then focused onto a PMT for detection. The output from the
PMT was recorded using a universal counter interfaced to a personal computer (PC)
with custom-designed LabView software for data treatment and processing.
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6.3.3 In Vitro Determination of Caspase Activity
After incubation using the following treatment groups, group (I) [+]ALA[+]PDT, group II -[+]ALA[-]PDT, group III -[-]ALA[+]PDT, and group IV [-]ALA[-]PDT, MCF-7 cells were washed with PBS solution, pH 7.4, and then
resuspended in lysis buffer (100 mM HEPES, pH 7.4, 10% sucrose, 0.1% 3-[(3cholamidopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS), 1 mM EDTA,
10 mM dithiothreitol (DTT), 1 mM phenylmethylsulphonyl fluoride (PMSF), 10
mg/ml pepstatin, 10 mg/ml leupeptin) and left on ice for 45 minutes. The cells were
then repeatedly passed through a syringe with a 25-gauge needle until most of the cell
membrane was disrupted, and centrifuged at 1500 RPM for 10 min. Activity of
caspases was measured using fluorogenic substrate peptides; LEHD-AMC for
caspase-9 and DEVD-AMC for caspase-7. The release of AMC was measured after
incubating optical nanosensors in picofuge tubes containing the cell lysates from the
various treatment groups and using a HeCd laser (excitation 325 nm) to excite AMC.
Caspase activity was expressed as fluorescence intensity of AMC as a function of
equivalent nanomoles of LEHD-AMC and DEVD-AMC respectively.
We plotted the results of the in vitro measurement of caspase-9 and caspase-7
activity. The curves for each fluorescent measurement of AMC were plotted for each
as a function of AMC concentration. Caspase-9 activity was determined by
incubation

of

optical

nanosensors

with

the

substrate

LEHD-7-amino-4-

methylcoumarin (AMC) in cell lysate (~105 cells) obtained from the following
treatment groups; group I, II, III and IV, described earlier in the article. The release of
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AMC was measured after excitation using HeCd laser (325 nm) and collecting the
fluorescence signal using a 380 nm longpass filter. The peak emission wavelength of
AMC is about 440 nm. Likewise, Caspase-7 activity was determined by incubation in
cell lysate (~105 cells) obtained from the following treatment groups I, II, III, and IV.
The release of AMC was measured after excitation using a HeCd laser (325 nm) and
collecting the fluorescence signal using a 380 nm longpass filter.

6.3.4 In Vivo Determination of Caspase Activity
Using the treatment group I and the control group IV from above, replicate
experiment and control measurements were conducted to measure caspase-9 and
caspase-7 activity in vivo. Determination of the presence or absence of caspase-9 and
-7 activities using the optical nanosensor was carried out using the following
procedure. A culture dish with sparsely distributed MCF-7 cells was placed on the
pre-warmed microscope stage set at 37oC. The optical nanosensor, mounted on a
micropipette holder of a micromanipulation system, was moved into position, in the
same plane as the cells, using bright-field phase contrast microscopic illumination, so
that the tip was just outside of the cell to be probed. The total magnification was
600×. The optical nanosensor was gently micromanipulated into the cell using the
hydraulic fine adjustments, past the cell membrane and extending a short way into the
cytoplasm. During these micromanipulations, great care was taken not to penetrate
the nuclear envelope and compromise the integrity of the nucleus. Room light and
microscope illumination light were switched-off; the laser shutter opened, and laser
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light allowed illuminating the optical nanosensor with excitation light being
transmitted into the nanotip. First, a signal reading was taken with the nanosensor
inside the cell with the laser shutter closed in order to record the dark signal. After
five min, the laser shutter was opened, allowing the excitation light to be transmitted
to the nanosensor tip, and fluorescence readings were recorded. Figure 6.3 (i-iv)
shows images illustrating intracellular measurements performed in a single MCF-7
cell using micromanipulation. Once inside the cell, the nanosensor detects and
identifies the activity of caspase-9. The fluorescence signal generated is collected by
the objective, and passes through spectral and spatial filters before detection with a
photomultiplier tube (PMT). The PMT signal is amplified and recorded via a
universal counter on a personal computer. Data acquisition and recording are
controlled using a LabView custom-written program. Additionally, the entire
experiment is imaged using a CCD camera coupled to the side port of the Nikon
inverted fluorescence microscope to verify that individual cells are probed. A typical
experiment measurement takes ~ 5 minutes.

6.4 Results and Discussion
The examination of caspase-9 and caspase-7 activity was first performed in
vitro using cell lysate, and in vivo¸ within single MCF-7 cells using optical
nanosensors. Caspase-9 cleaves the substrate tetrapeptide (LEHD-AMC) between D
and AMC, releasing the fluorophore AMC that is measured upon excitation by the
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(i)

(ii)

(iii)

(iv)

Figure 6.3: shows digital images of the single cell measurement procedure.
LEFT TO RIGHT, (i) optical nanosensor outside MCF-7 cell (ii) right before
insertion into MCF-7 cell (iii) inserted into MCF-7 cell, and (iv) extracted from MCF7 cell
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HeCd laser. Similarly, caspase-7 cleaves the substrate tetrapeptide (DEVD-AMC)
between D and AMC, releasing the same fluorophore AMC for measurement.
Apoptotic cells containing activated caspase-9 or caspase-7 yield a fluorescence
emission as opposed to non-apoptotic cells, which do not yield a fluorescent signal.
Briefly, for the in vitro study, to measure caspase-9 and caspase-7 activity, MCF-7
cells were harvested and centrifuged at 1500 RPM for 10 minutes. The cell
suspension (~105 cells) was mixed with PBS followed by addition of 1:10, 1:20,
1:100 and 1:200 dilutions of 1mM LEHD-AMC and DEVD-AMC respectively, to
each cellular reaction. The liberated AMC fluorescence was measured using
tetrapeptide-based optical nanosensors.
Figure 6.4 shows the results of the in vitro study of caspase-9 and caspase-7
involving the treatment groups, Group I and Group IV. These results show a disparity
of an order of magnitude in the mean fluorescent intensity measurements we observed
for Group I and IV. This difference is significant enough to determine caspase-9 and
caspase-7 activity in vitro. Group II and III which were the treated control groups had
mean fluorescent measurements similar to the control, Group IV. This result was
expected because it is the collective effect of ALA and photoactivation that results in
the induction of apoptosis and neither ALA nor photoactivation alone. For the in vivo
studies, caspase-9 activities were analyzed in ALA-PDT treated cells (group I) by
measuring the fluorescence signal from AMC generated after the cleavage of the
peptide substrate LEHD-AMC. Likewise, the same was done for the control groups
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Figure 6.4 shows the results of the in vitro study of caspase-9 and caspase-7
involving the treatment groups, Group I: [+]ALA [+]PDT, and Group IV: [-]ALA []PDT. These results represent Caspase-9 and Caspase-7 activity of MCF-7 cells with
aminolevulinic acid (ALA) induced apoptosis. Following ALA treatment and
apoptosis induction, MCF-7 cells were harvested and analyzed for caspase activity.
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(II, III and IV) of cells which received either [+]ALA[-]PDT, [-]ALA[+]PDT or []ALA[-]PDT. The fluorescent intensity measurements obtained for these treatment
groups were then compared. As shown in Figure 6.5, there was no level of LEHDAMC cleavage activity was detected for the untreated cells, [-]ALA[-]PDT. Likewise,
the same was observed for the treated control groups, [+]ALA[-]PDT and []ALA[+]PDT. However, in treated cells, [+]ALA[+]PDT, significant LEHD-AMC
cleavage activity was detected via the measurement of AMC fluorescence. As shown
in Figure 6.5, the initiator substrates (LEHD-AMC) of caspase-9 are cleaved into the
fluorogenic AMC forms in cells treated with ALA-PDT. This demonstrates the
involvement of caspase-9, which cleaves after aspartic acid residue, in mediating
apoptosis. The results obtained here demonstrated the presence of active pathways of
caspase-9 during ALA-PDT induced apoptosis in MCF-7 cells. The fluorescence
signals obtained from the cells that were both incubated with ALA and photoactivated
were significantly higher than the signals obtained from the untreated control and the
two treated control groups. Statistical analysis was performed on the three sets of
results. The mean value of this analysis revealed that the fluorescence signal obtained
using optical nanosensors used to probe the experimental group of cells (Group I) was
about 4.59 (± 0.02). The mean value of these analyses revealed that the fluorescence
signal obtained using optical nanosensors used to probe the control group of cells
(Group II, III and IV) was about 3.56 (± 0.02). The mean value of this analysis
revealed that the fluorescence signal obtained using the nanosensors used to probe
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Figure 6.5 shows the result of in vivo measurement of caspase-9 activity. The
Experiment type refers to the four different treatment groups, Group I
[+]ALA[+]PDT, Group II [+]ALA[-]PDT, Group III [-]ALA[+]PDT, Group IV []ALA[-]PDT. Each bar represents an average of three intracellular measurements of
caspase-9 activity in MCF-7 cells done in triplicate. The error bars shown represent a
95% confidence interval (CI).
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cells in Group I was up to an order of magnitude higher than the signal obtained by
nanosensors used to probe the control (Group IV), untreated (Group II) and treated
(Group III) control cell groups. A larger mean value for the experimental group
confirms the detection of AMC and hence the detection of caspase-9 activity.
For the in vivo studies to assay caspase-7 activity, MCF-7 cells were treated
with ALA-PDT, and caspase-7 activity was monitored by measuring the fluorescence
generated by AMC after cleavage of DEVD-AMC. After exposure to ALA- PDT,
AMC fluorescence was detected and measured using optical nanosensors. As shown
in Figure 6.6, in untreated cells, no level of DEVD-AMC cleavage activity was
detected with [+]ALA[-]PDT, [-]ALA[+]PDT or [-]ALA[-]PDT. However, a
significant DEVD-AMC cleavage activity via the detection of AMC fluorescence was
observed after [+]ALA[+]PDT treatment. Figure 6.6 also shows the backgroundsubtracted results of intracellular measurements performed with nanosensors on two
treated control groups (Group II and III) of MCF-7 cells. The first group was treated
with [+]ALA[-]PDT, while the second was treated with [-]ALA[+]PDT. These results
were similar on average meaning that neither of the two treated control groups were
capable of inducing apoptosis. This is in total agreement with the expected outcome
of this experiment, as photodynamic therapy is a cooperative effort of the
photosensitizer and light. When comparing these results to those obtained from the
experimental group, [+]ALA[+]PDT, the fluorescence intensity was almost an order
of magnitude lower than that of the experimental group. These results clearly
demonstrate the determination of caspase-7 activity within single living cells.

211

60000

Fluorescence Intensity (RFU)

50000

40000

30000

20000

10000

0
Group I: (+)ALA (+)PDT

Group II: (+)ALA (-)PDT

Group III: (-)ALA (+)PDT

Group IV: (-)ALA (-)PDT

Figure 6.6: shows the result of the in vivo measurement of caspase-7 activity.
The Experiment type refers to the four different treatment groups, Group I
[+]ALA[+]PDT, Group II [+]ALA[-]PDT, Group III [-]ALA[+]PDT, Group IV []ALA[-]PDT. Each bar represents an average of three intracellular measurements of
caspase-7 activity in MCF-7 cells done in triplicate. The error bars shown represent a
95% confidence interval (CI).
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6.5 Summary
We successfully prepared tetrapeptide-based optical nanosensors using a
covalent coupling technique to immobilize profluorescent substrates onto nanotips
and demonstrated their application in the determination of the cleavage products of
LEHD-AMC and DEVD-AMC, AMC, in single living MCF-7 cells. The presence
and detection of cleaved fluorogenic AMC in single live MCF-7 cells as a result of
this design is representative of caspase-9 and -7 activity, hallmarks of apoptosis or
programmed cell death [127]. These results indicate that AMC, and hence apoptosis,
can be monitored and measured using optical nanosensors within single living cells
during apoptosis. These results also demonstrate the capability of performing
measurements inside single living cells consequently with the potential application in
protein detection and protein-protein profiling in cellular biochemical pathways.
Due to its nanoscale size, the optical nanosensor does not compromise the
integrity of the cell when performing intracellular analysis [123]. This advantage is
evident this work which demonstrates the capability of optical nanosensors to study
cells without having to disrupt the physiological make-up, thereby not interfering
with cellular biochemistry. Mechanical manipulation can lead to cell disruption prior
to sampling and this may interfere with measurements of cellular biochemistry. With
the optical nanosensors, absence of cell manipulation prior to measurement results in
no effects on the cell at the time of sampling. Tetrapeptide-based optical nanosensors
are extremely sensitive and have very specific activities, since a single enzyme along
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with its respective cofactor or coenzyme can catalyze many reactions and in the
process produce a sufficient quantity of the fluorogenic reaction product AMC. This
feature together with excitation and detection in the near-field of the optical
nanosensor are important because they underline the sensitivity and spatial selectivity
conferred by the operating principle of the nanosensor in the sense that only the AMC
produced will be excited in the near field of the optical nanosensor. An additional
feature of the nanosensor is its biochemical selectivity. Selectivity is dependent upon
the selective cleavage capabilities for specific sequences by either caspase-9 or
caspase-7.
Tetrapeptide-based optical nanosensors for investigating intact living cells
hold promise for minimally invasive dynamic analyses of proteins in biochemical
pathways within single living cells. Optical nanosensors provide a new method in
cell-based assays offering highly miniaturized, hands-on, nano-scaled devices that
make cell-based analysis accessible at the single cell level. Future work will involve
studies that will attempt to diversify the application of the optical nanosensor for
analysis of protein-protein interactions and similar analyses of other proteins involved
in cellular biochemical pathways.
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